Risk and special populations

(Unterschied zwischen Versionen)
Wechseln zu: Navigation, Suche
Zeile 776: Zeile 776:
 
===008===weiter dann
 
===008===weiter dann
  
{{tp|p=32413158|t=2020. Headaches During COVID-19: My Clinical Case and Review of the Literature.|pdf=|usr=008}}
+
 
 
{{tp|p=32451362|t=2020. Do underlying cardiovascular diseases have any impact on hospitalised patients with COVID-19?|pdf=|usr=008}}
 
{{tp|p=32451362|t=2020. Do underlying cardiovascular diseases have any impact on hospitalised patients with COVID-19?|pdf=|usr=008}}
 
{{tp|p=32425272|t=2020. Early manifestation of ARDS in COVID-19 infection in a 51- year-old man affected by Mounier-Kuhn Syndrome.|pdf=|usr=008}}
 
{{tp|p=32425272|t=2020. Early manifestation of ARDS in COVID-19 infection in a 51- year-old man affected by Mounier-Kuhn Syndrome.|pdf=|usr=008}}
{{tp|p=32410761|t=2020. Cardiac Valves: Another "Disaster-Hit Area" of COVID-19 Patients?|pdf=|usr=008}}
+
 
 
{{tp|p=32457005|t=2020. Flattening the disability curve: Rehabilitation and recovery after COVID-19 infection.|pdf=|usr=008}}
 
{{tp|p=32457005|t=2020. Flattening the disability curve: Rehabilitation and recovery after COVID-19 infection.|pdf=|usr=008}}
{{tp|p=32425273|t=2020. Pulmonary embolism and Sars-Cov-2 infection: A new indication for surgical pulmonary endarterectomy?|pdf=|usr=008}}
+
 
{{tp|p=32405457|t=2020. Cardiac injury, Arrhythmia and Sudden death in a COVID-19 patient.|pdf=|usr=008}}
+
 
 
{{tp|p=32450334|t=2020. The interplay of hypertension, ACE-2 and SARS-CoV-2: Emerging data as the "Ariadne's thread" for the "labyrinth" of COVID-19.|pdf=|usr=008}}
 
{{tp|p=32450334|t=2020. The interplay of hypertension, ACE-2 and SARS-CoV-2: Emerging data as the "Ariadne's thread" for the "labyrinth" of COVID-19.|pdf=|usr=008}}
{{tp|p=32522617|t=2020. Outbreak of SARS-CoV2: Pathogenesis of infection and cardiovascular involvement.|pdf=|usr=008}}
+
 
{{tp|p=32534109|t=2020. Involvement of Cardiovascular System As The Critical Point in Coronavirus Disease 2019 (COVID-19) Prognosis and Recovery.|pdf=|usr=008}}
+
{{tp|p=32405288|t=2020. Acute upper limb ischemia in a patient with COVID-19.|pdf=|usr=008}}
+
{{tp|p=32509818|t=2020. SARS-CoV-2 and liver damage: a possible pathogenetic link.|pdf=|usr=008}}
+
 
{{tp|p=32440857|t=2020. Clinical course of COVID-19 in patients with pre-existing decompensated cirrhosis: initial report from China.|pdf=|usr=008}}
 
{{tp|p=32440857|t=2020. Clinical course of COVID-19 in patients with pre-existing decompensated cirrhosis: initial report from China.|pdf=|usr=008}}
 
{{tp|p=32386449|t=2020. Liver injury is associated with severe Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of retrospective studies.|pdf=|usr=008}}
 
{{tp|p=32386449|t=2020. Liver injury is associated with severe Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of retrospective studies.|pdf=|usr=008}}
 
{{tp|p=32359177|t=2020. Longitudinal association between markers of liver injury and mortality in COVID-19 in China.|pdf=|usr=008}}
 
{{tp|p=32359177|t=2020. Longitudinal association between markers of liver injury and mortality in COVID-19 in China.|pdf=|usr=008}}
{{tp|p=32514586|t=2020. Myokarditis in der Ara von SARS-CoV-2: ein einzelnes Teilchen eines komplexen Puzzles?|pdf=|usr=008}}
+
 
 
{{tp|p=32527699|t=2020. El SRAA y el SARS-CoV-2: el acertijo a resolver.|pdf=|usr=008}}
 
{{tp|p=32527699|t=2020. El SRAA y el SARS-CoV-2: el acertijo a resolver.|pdf=|usr=008}}
 
{{tp|p=32451303|t=2020. Hipertension y COVID-19: cuidados con los manguitos de presion arterial.|pdf=|usr=008}}
 
{{tp|p=32451303|t=2020. Hipertension y COVID-19: cuidados con los manguitos de presion arterial.|pdf=|usr=008}}
{{tp|p=32451564|t=2020. Temporare Hyposmie bei COVID-19-Patienten.|pdf=|usr=008}}
+
 
 
{{tp|p=32439915|t=2020. Downregulation of ACE2 induces overstimulation of the renin-angiotensin system in COVID-19: should we block the renin-angiotensin system?|pdf=|usr=008}}
 
{{tp|p=32439915|t=2020. Downregulation of ACE2 induces overstimulation of the renin-angiotensin system in COVID-19: should we block the renin-angiotensin system?|pdf=|usr=008}}
 
{{tp|p=32523133|t=2020. SARS-CoV-2 downregulation of ACE2 and pleiotropic effects of ACEIs/ARBs.|pdf=|usr=008}}
 
{{tp|p=32523133|t=2020. SARS-CoV-2 downregulation of ACE2 and pleiotropic effects of ACEIs/ARBs.|pdf=|usr=008}}
 
{{tp|p=32483311|t=2020. COVID-19 patients with hypertension have more severe disease: a multicenter retrospective observational study.|pdf=|usr=008}}
 
{{tp|p=32483311|t=2020. COVID-19 patients with hypertension have more severe disease: a multicenter retrospective observational study.|pdf=|usr=008}}
 
{{tp|p=32436403|t=2020. Evidence That Renin-Angiotensin System Inhibitors Should Not Be Discontinued Due to the COVID-19 Pandemic.|pdf=|usr=008}}
 
{{tp|p=32436403|t=2020. Evidence That Renin-Angiotensin System Inhibitors Should Not Be Discontinued Due to the COVID-19 Pandemic.|pdf=|usr=008}}
{{tp|p=32426230|t=2020. Encephalopathy and seizure activity in a COVID-19 well controlled HIV patient.|pdf=|usr=008}}
+
 
{{tp|p=32395425|t=2020. Spontaneous pneumomediastinum occurring in the SARS-COV-2 infection.|pdf=|usr=008}}
+
 
{{tp|p=32523872|t=2020. Can COVID 19 present like appendicitis?|pdf=|usr=008}}
+
 
{{tp|p=32523871|t=2020. Acute symptomatic hyponatremia in setting of SIADH as an isolated presentation of COVID-19.|pdf=|usr=008}}
+
 
{{tp|p=32514399|t=2020. A case of Bacillus cereus bacteremia in a COVID-19 patient treated with steroids.|pdf=|usr=008}}
+
 
{{tp|p=32514394|t=2020. Symmetrical polyneuropathy in coronavirus disease 2019 (COVID-19).|pdf=|usr=008}}
+
{{tp|p=32483526|t=2020. First description of SARS-CoV-2 in ascites.|pdf=|usr=008}}
+
{{tp|p=32483524|t=2020. Isolated severe thrombocytopenia in a patient with COVID-19: A case report.|pdf=|usr=008}}
+
 
{{tp|p=32461911|t=2020. Progression of CXR features on a COVID-19 survivor.|pdf=|usr=008}}
 
{{tp|p=32461911|t=2020. Progression of CXR features on a COVID-19 survivor.|pdf=|usr=008}}
{{tp|p=32501397|t=2020. "The ancient and the new": is there an interaction between cytomegalovirus and SARS-CoV-2 infection?|pdf=|usr=008}}
+
 
 
{{tp|p=32457811|t=2020. The lethal sex gap: COVID-19.|pdf=|usr=008}}
 
{{tp|p=32457811|t=2020. The lethal sex gap: COVID-19.|pdf=|usr=008}}
 
{{tp|p=32473971|t=2020. Are there any association between COVID-19 severity and immunosuppressive therapy?|pdf=|usr=008}}
 
{{tp|p=32473971|t=2020. Are there any association between COVID-19 severity and immunosuppressive therapy?|pdf=|usr=008}}
 
{{tp|p=32489118|t=2020. Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitors.|pdf=|usr=008}}
 
{{tp|p=32489118|t=2020. Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitors.|pdf=|usr=008}}
 
{{tp|p=32405087|t=2020. Continue ACE inhibitors/ ARB'S till further evidence in Coronavirus disease 2019 (COVID-19).|pdf=|usr=008}}
 
{{tp|p=32405087|t=2020. Continue ACE inhibitors/ ARB'S till further evidence in Coronavirus disease 2019 (COVID-19).|pdf=|usr=008}}
{{tp|p=32425236|t=2020. Acute Pulmonary Embolism: An unseen villain in COVID-19.|pdf=|usr=008}}
+
 
 
{{tp|p=32405088|t=2020. Cardiological society of India position statement on COVID-19 and heart failure.|pdf=|usr=008}}
 
{{tp|p=32405088|t=2020. Cardiological society of India position statement on COVID-19 and heart failure.|pdf=|usr=008}}
{{tp|p=32461419|t=2020. Commentary: Exploring the transmission of COVID-19 through the ocular surface.|pdf=|usr=008}}
 
{{tp|p=32461418|t=2020. Presence of viral RNA of SARS-CoV-2 in conjunctival swab specimens of COVID-19 patients.|pdf=|usr=008}}
 
 
{{tp|p=32317806|t=2020. Carpal Fracture and COVID-19 Infection: Observation from Thailand.|pdf=|usr=008}}
 
{{tp|p=32317806|t=2020. Carpal Fracture and COVID-19 Infection: Observation from Thailand.|pdf=|usr=008}}
 
{{tp|p=32410003|t=2020. Pathophysiology of COVID-19: Why Children Fare Better than Adults?|pdf=|usr=008}}
 
{{tp|p=32410003|t=2020. Pathophysiology of COVID-19: Why Children Fare Better than Adults?|pdf=|usr=008}}
{{tp|p=32519260|t=2020. Thalassemic Child Presenting with Anosmia due to COVID-19.|pdf=|usr=008}}
+
 
 
{{tp|p=32504454|t=2020. Manifestations in Neonates Born to COVID-19 Positive Mothers.|pdf=|usr=008}}
 
{{tp|p=32504454|t=2020. Manifestations in Neonates Born to COVID-19 Positive Mothers.|pdf=|usr=008}}
 
{{tp|p=32495219|t=2020. Clinical Features and Treatment Protocol in Eleven Chinese Children with Mild COVID-19.|pdf=|usr=008}}
 
{{tp|p=32495219|t=2020. Clinical Features and Treatment Protocol in Eleven Chinese Children with Mild COVID-19.|pdf=|usr=008}}
 
{{tp|p=32370577|t=2020. Risk factors for disease progression in hospitalized patients with COVID-19: a retrospective cohort study.|pdf=|usr=008}}
 
{{tp|p=32370577|t=2020. Risk factors for disease progression in hospitalized patients with COVID-19: a retrospective cohort study.|pdf=|usr=008}}
 
{{tp|p=32462545|t=2020. Treatments Administered to the First 9152 Reported Cases of COVID-19: A Systematic Review.|pdf=|usr=008}}
 
{{tp|p=32462545|t=2020. Treatments Administered to the First 9152 Reported Cases of COVID-19: A Systematic Review.|pdf=|usr=008}}
{{tp|p=32449121|t=2020. Detailed hemodynamics of fulminant myocarditis caused by COVID-19.|pdf=|usr=008}}
+
 
 
{{tp|p=32415334|t=2020. Recurrence of COVID-19 after recovery: a case report from Italy.|pdf=|usr=008}}
 
{{tp|p=32415334|t=2020. Recurrence of COVID-19 after recovery: a case report from Italy.|pdf=|usr=008}}
{{tp|p=32410112|t=2020. Contribution of anosmia and dysgeusia for diagnostic of COVID-19 in outpatients.|pdf=|usr=008}}
+
 
 
{{tp|p=32394344|t=2020. COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients.|pdf=|usr=008}}
 
{{tp|p=32394344|t=2020. COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients.|pdf=|usr=008}}
 
{{tp|p=32390091|t=2020. Clinical characteristics of 194 cases of COVID-19 in Huanggang and Taian, China.|pdf=|usr=008}}
 
{{tp|p=32390091|t=2020. Clinical characteristics of 194 cases of COVID-19 in Huanggang and Taian, China.|pdf=|usr=008}}
{{tp|p=32388676|t=2020. Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis.|pdf=|usr=008}}
+
 
{{tp|p=32532948|t=2020. Clinical experience with therapeutic dose of Low-Molecular-Weight Heparin.|pdf=|usr=008}}
+
 
{{tp|p=32532945|t=2020. Risk of hepatic failure in COVID-19 patients. A systematic review and meta-analysis.|pdf=|usr=008}}
+
 
 
{{tp|p=32532944|t=2020. Prognosis of COVID-19: Changes in laboratory parameters.|pdf=|usr=008}}
 
{{tp|p=32532944|t=2020. Prognosis of COVID-19: Changes in laboratory parameters.|pdf=|usr=008}}
 
{{tp|p=32532943|t=2020. Differences among confirmed and not-confirmed COVID-19 patients at "D.Cotugno" hospital, Naples (Italy): what we learned from first suspected cases?|pdf=|usr=008}}
 
{{tp|p=32532943|t=2020. Differences among confirmed and not-confirmed COVID-19 patients at "D.Cotugno" hospital, Naples (Italy): what we learned from first suspected cases?|pdf=|usr=008}}
{{tp|p=32532939|t=2020. The rationale for Low-Molecular Weight Heparin (LMWH) use in SARS-CoV-2 infection|pdf=|usr=008}}
+
 
 
{{tp|p=32532938|t=2020. COVID-19 and pregnancy: a review of current knowledge.|pdf=|usr=008}}
 
{{tp|p=32532938|t=2020. COVID-19 and pregnancy: a review of current knowledge.|pdf=|usr=008}}
{{tp|p=32532937|t=2020. Neurologic aspects of covid-19: a concise review.|pdf=|usr=008}}
+
 
{{tp|p=32532936|t=2020. COVID-19 and gastrointestinal injury: a brief systematic review and data from Bulgaria.|pdf=|usr=008}}
+
 
{{tp|p=32532935|t=2020. Bacterial and fungal infections among patients with SARS-CoV-2 pneumonia.|pdf=|usr=008}}
+
 
{{tp|p=32532932|t=2020. Should lCU COVID-19 patients empirically receive therapeutic doses of anticoagulant?|pdf=|usr=008}}
+
 
{{tp|p=32488318|t=2020. Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms.|pdf=|usr=008}}
+
 
 
{{tp|p=32397011|t=2020. Epidemiological, clinical, and virological characteristics of 465 hospitalized cases of coronavirus disease 2019 (COVID-19) from Zhejiang province in China.|pdf=|usr=008}}
 
{{tp|p=32397011|t=2020. Epidemiological, clinical, and virological characteristics of 465 hospitalized cases of coronavirus disease 2019 (COVID-19) from Zhejiang province in China.|pdf=|usr=008}}
 
{{tp|p=32516795|t=2020. Asthma and the Coronavirus Disease 2019 Pandemic: A Literature Review.|pdf=|usr=008}}
 
{{tp|p=32516795|t=2020. Asthma and the Coronavirus Disease 2019 Pandemic: A Literature Review.|pdf=|usr=008}}
{{tp|p=32363809|t=2020. Smell and taste symptom-based predictive model for COVID-19 diagnosis.|pdf=|usr=008}}
 
{{tp|p=32410386|t=2020. Smell and taste alterations in Covid-19: a cross-sectional analysis of different cohorts.|pdf=|usr=008}}
 
{{tp|p=32395917|t=2020. Self-reported olfactory loss in COVID-19: is it really a favorable prognostic factor?|pdf=|usr=008}}
 
{{tp|p=32395913|t=2020. Reply to: Self-reported olfactory loss in COVID-19: is it really a favorable prognostic factor?|pdf=|usr=008}}
 
{{tp|p=32271490|t=2020. A primer on viral-associated olfactory loss in the era of COVID-19.|pdf=|usr=008}}
 
{{tp|p=32279441|t=2020. Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms.|pdf=|usr=008}}
 
 
{{tp|p=32418736|t=2020. Why are women better protected from COVID-19: Clues for men? Sex and COVID-19.|pdf=|usr=008}}
 
{{tp|p=32418736|t=2020. Why are women better protected from COVID-19: Clues for men? Sex and COVID-19.|pdf=|usr=008}}
{{tp|p=32471650|t=2020. Acute pulmonary embolism in COVID-19 disease: Preliminary report on seven patients.|pdf=|usr=008}}
+
 
 
{{tp|p=32425514|t=2020. Covid-19 and COPD: A Personal Reflection.|pdf=|usr=008}}
 
{{tp|p=32425514|t=2020. Covid-19 and COPD: A Personal Reflection.|pdf=|usr=008}}
 
{{tp|p=32410206|t=2020. Clinical characteristics and drug therapies in patients with the common-type coronavirus disease 2019 in Hunan, China.|pdf=|usr=008}}
 
{{tp|p=32410206|t=2020. Clinical characteristics and drug therapies in patients with the common-type coronavirus disease 2019 in Hunan, China.|pdf=|usr=008}}
 
{{tp|p=32266754|t=2020. COVID-19: Risk groups, mechanistic insights and challenges.|pdf=|usr=008}}
 
{{tp|p=32266754|t=2020. COVID-19: Risk groups, mechanistic insights and challenges.|pdf=|usr=008}}
{{tp|p=32458395|t=2020. Bowel perforation in a Covid-19 patient: case report.|pdf=|usr=008}}
+
 
{{tp|p=32383189|t=2020. Re: Chilblain-like lesions on feet and hands during the COVID-19 pandemic.|pdf=|usr=008}}
+
{{tp|p=32437936|t=2020. Viral exanthem with "Spins and needles sensation" on extremities of a COVID-19 patient: A self-reported case from an Indonesian medical frontliner.|pdf=|usr=008}}
+
 
{{tp|p=32492533|t=2020. Clinical Features and Short-term Outcomes of Elderly Patients With COVID-19.|pdf=|usr=008}}
 
{{tp|p=32492533|t=2020. Clinical Features and Short-term Outcomes of Elderly Patients With COVID-19.|pdf=|usr=008}}
 
{{tp|p=32470606|t=2020. Clinical Characteristics of Critically Ill Patients Co-infected with SARS-CoV-2 and the Influenza Virus in Wuhan, China.|pdf=|usr=008}}
 
{{tp|p=32470606|t=2020. Clinical Characteristics of Critically Ill Patients Co-infected with SARS-CoV-2 and the Influenza Virus in Wuhan, China.|pdf=|usr=008}}
 
{{tp|p=32464272|t=2020. Uganda's First 100 COVID-19 Cases: Trends and Lessons.|pdf=|usr=008}}
 
{{tp|p=32464272|t=2020. Uganda's First 100 COVID-19 Cases: Trends and Lessons.|pdf=|usr=008}}
{{tp|p=32447121|t=2020. Unheralded Lower Limb Threatening Ischemia in a COVID-19 Patient.|pdf=|usr=008}}
+
 
 
{{tp|p=32417248|t=2020. SARS-CoV-2 infection diagnosed only by cell culture isolation before the local outbreak in an Italian seven-week-old suckling baby.|pdf=|usr=008}}
 
{{tp|p=32417248|t=2020. SARS-CoV-2 infection diagnosed only by cell culture isolation before the local outbreak in an Italian seven-week-old suckling baby.|pdf=|usr=008}}
{{tp|p=32437935|t=2020. Cardiac injuries in patients with coronavirus disease 2019: Not to be ignored.|pdf=|usr=008}}
+
 
{{tp|p=32526392|t=2020. Oral mucosal lesions in a COVID-19 patient: new signs or secondary manifestations?|pdf=|usr=008}}
+
 
 
{{tp|p=32535301|t=2020. Comparison of Hospitalized Patients with pneumonia caused by COVID-19 and influenza A in children under 5 years.|pdf=|usr=008}}
 
{{tp|p=32535301|t=2020. Comparison of Hospitalized Patients with pneumonia caused by COVID-19 and influenza A in children under 5 years.|pdf=|usr=008}}
{{tp|p=32535294|t=2020. Could sudden sensorineural hearing loss be the sole manifestation of COVID-19? An investigation into SARS-COV-2 in the etiology of sudden sensorineural hearing loss.|pdf=|usr=008}}
 
 
{{tp|p=32497798|t=2020. A Follow-up Study of Recovered Patients with COVID-19 in Wuhan, China.|pdf=|usr=008}}
 
{{tp|p=32497798|t=2020. A Follow-up Study of Recovered Patients with COVID-19 in Wuhan, China.|pdf=|usr=008}}
{{tp|p=32497796|t=2020. Combination of thrombolytic and immunosuppressive therapy for coronavirus disease 2019: A case report.|pdf=|usr=008}}
+
 
 
{{tp|p=32335337|t=2020. Hypertension prevalence in human coronavirus disease: the role of ACE system in infection spread and severity.|pdf=|usr=008}}
 
{{tp|p=32335337|t=2020. Hypertension prevalence in human coronavirus disease: the role of ACE system in infection spread and severity.|pdf=|usr=008}}
 
{{tp|p=32444771|t=2020. Insight into the relationship between obesity-induced low-level chronic inflammation and COVID-19 infection.|pdf=|usr=008}}
 
{{tp|p=32444771|t=2020. Insight into the relationship between obesity-induced low-level chronic inflammation and COVID-19 infection.|pdf=|usr=008}}
Zeile 875: Zeile 858:
 
{{tp|p=32458212|t=2020. Patients with chronic kidney disease have a poorer prognosis of coronavirus disease 2019 (COVID-19): an experience in New York City.|pdf=|usr=008}}
 
{{tp|p=32458212|t=2020. Patients with chronic kidney disease have a poorer prognosis of coronavirus disease 2019 (COVID-19): an experience in New York City.|pdf=|usr=008}}
 
{{tp|p=32451579|t=2020. The baby lung and the COVID-19 era.|pdf=|usr=008}}
 
{{tp|p=32451579|t=2020. The baby lung and the COVID-19 era.|pdf=|usr=008}}
{{tp|p=32435823|t=2020. Prothrombotic phenotype in COVID-19 severe patients.|pdf=|usr=008}}
+
 
{{tp|p=32435822|t=2020. Incidence of pulmonary embolism in patients with COVID-19.|pdf=|usr=008}}
+
 
{{tp|p=32430514|t=2020. SARS-CoV-2 pulmonary infection revealed by subcutaneous emphysema and pneumomediastinum.|pdf=|usr=008}}
+
 
{{tp|p=32424482|t=2020. Systemic arterial thrombosis and acute mesenteric ischemia in a patient with COVID-19.|pdf=|usr=008}}
+
 
{{tp|p=32415314|t=2020. Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19.|pdf=|usr=008}}
+
 
{{tp|p=32415313|t=2020. Clinical features and development of sepsis in patients infected with SARS-CoV-2: a retrospective analysis of 150 cases outside Wuhan, China.|pdf=|usr=008}}
+
{{tp|p=32533197|t=2020. Acute kidney injury in critically ill patients with COVID-19.|pdf=|usr=008}}
+
 
{{tp|p=32385628|t=2020. Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?|pdf=|usr=008}}
 
{{tp|p=32385628|t=2020. Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?|pdf=|usr=008}}
 
{{tp|p=32474850|t=2020. Clinical features of 1487 COVID-19 patients with outpatient management in the Greater Paris: the COVID-call study.|pdf=|usr=008}}
 
{{tp|p=32474850|t=2020. Clinical features of 1487 COVID-19 patients with outpatient management in the Greater Paris: the COVID-call study.|pdf=|usr=008}}
{{tp|p=32440985|t=2020. Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment.|pdf=|usr=008}}
+
 
 
{{tp|p=32430652|t=2020. COVID-19: counter-intuitive data on smoking prevalence and therapeutic implications for nicotine.|pdf=|usr=008}}
 
{{tp|p=32430652|t=2020. COVID-19: counter-intuitive data on smoking prevalence and therapeutic implications for nicotine.|pdf=|usr=008}}
 
{{tp|p=32424634|t=2020. Antagonizing the renin-angiotensin-aldosterone system in the era of COVID-19.|pdf=|usr=008}}
 
{{tp|p=32424634|t=2020. Antagonizing the renin-angiotensin-aldosterone system in the era of COVID-19.|pdf=|usr=008}}
 
{{tp|p=32514683|t=2020. Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?: Comment.|pdf=|usr=008}}
 
{{tp|p=32514683|t=2020. Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?: Comment.|pdf=|usr=008}}
  
{{tp|p=32514682|t=2020. Managing anticoagulation in the COVID-19 era between lockdown and reopening phases.|pdf=|usr=008}}
+
 
{{tp|p=32504198|t=2020. The burden of thrombotic complications in critically ill patients with COVID-19: charting the uncharted.|pdf=|usr=008}}
+
{{tp|p=32531341|t=2020. Ocular manifestations and viral shedding in tears of pediatric patients with coronavirus disease 2019: a preliminary report.|pdf=|usr=008}}
+
 
{{tp|p=32470485|t=2020. Does asthma affect morbidity or severity of Covid-19?|pdf=|usr=008}}
 
{{tp|p=32470485|t=2020. Does asthma affect morbidity or severity of Covid-19?|pdf=|usr=008}}
 
{{tp|p=32450087|t=2020. ACE2, TMPRSS2, and furin gene expression in the airways of people with asthma-implications for COVID-19.|pdf=|usr=008}}
 
{{tp|p=32450087|t=2020. ACE2, TMPRSS2, and furin gene expression in the airways of people with asthma-implications for COVID-19.|pdf=|usr=008}}
 
{{tp|p=32417136|t=2020. COVID-19 in a patient with severe chronic rhinosinusitis with nasal polyps during therapy with dupilumab.|pdf=|usr=008}}
 
{{tp|p=32417136|t=2020. COVID-19 in a patient with severe chronic rhinosinusitis with nasal polyps during therapy with dupilumab.|pdf=|usr=008}}
 
{{tp|p=32417445|t=2020. Asthma prolongs intubation in COVID-19.|pdf=|usr=008}}
 
{{tp|p=32417445|t=2020. Asthma prolongs intubation in COVID-19.|pdf=|usr=008}}
{{tp|p=32387668|t=2020. Reply to: "Reply: A dermatologic manifestation of COVID-19: Transient livedo reticularis".|pdf=|usr=008}}
+
 
{{tp|p=32387666|t=2020. Reply to: "A dermatologic manifestation of COVID-19: Transient livedo reticularis".|pdf=|usr=008}}
+
{{tp|p=32479979|t=2020. Pernio-like skin lesions associated with COVID-19: a case series of 318 patients from 8 countries.|pdf=|usr=008}}
+
{{tp|p=32446827|t=2020. Acral findings during the COVID-19 outbreak: Chilblain-like lesions should be preferred to acro-ischemic lesions.|pdf=|usr=008}}
+
{{tp|p=32446824|t=2020. Comment on: "Acral findings during the COVID-19 outbreak: Chilblain-like lesions should be preferred to acro-ischemic lesions".|pdf=|usr=008}}
+
{{tp|p=32446821|t=2020. Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients - the "Gabrin sign".|pdf=|usr=008}}
+
{{tp|p=32442700|t=2020. Reply to "Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients": To consider varicella-like exanthem associated with COVID-19, virus varicella zoster and virus herpes simplex must be ruled out.|pdf=|usr=008}}
+
{{tp|p=32442697|t=2020. Response to "Reply to 'Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients': To consider varicella-like exanthem associated with COVID-19, virus varicella zoster and virus herpes simplex must be ruled out".|pdf=|usr=008}}
+
{{tp|p=32442696|t=2020. Cutaneous manifestations related to coronavirus disease 2019 (COVID-19): A prospective study from China and Italy.|pdf=|usr=008}}
+
{{tp|p=32425285|t=2020. Retrospective Analysis of Smell and Taste Disturbances Associated with Dermatological Medications Reported to the United States Food and Drug Administration and Relevance to COVID-19 Infections.|pdf=|usr=008}}
+
{{tp|p=32422225|t=2020. Cutaneous Manifestations of COVID-19: A Preliminary Review.|pdf=|usr=008}}
+
{{tp|p=32417420|t=2020. Algorithm for the classification of COVID-19 rashes.|pdf=|usr=008}}
+
 
{{tp|p=32405123|t=2020. Optimizing Care for Atopic Dermatitis Patients During COVID-19 Pandemic.|pdf=|usr=008}}
 
{{tp|p=32405123|t=2020. Optimizing Care for Atopic Dermatitis Patients During COVID-19 Pandemic.|pdf=|usr=008}}
{{tp|p=32502585|t=2020. CHILBLAIN-LIKE ACRAL LESIONS DURING THE COVID-19 PANDEMIC ("COVID TOES"): HISTOLOGIC, IMMUNOFLUORESCENCE AND IMMUNOHISTOCHEMICAL STUDY OF 17 CASES.|pdf=|usr=008}}
+
 
{{tp|p=32534082|t=2020. Outbreak of chilblain-like acral lesions in children in the metropolitan area of Milan, Italy, during the COVID-19 pandemic.|pdf=|usr=008}}
+
 
{{tp|p=32497698|t=2020. Reply to: "Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak".|pdf=|usr=008}}
+
{{tp|p=32305440|t=2020. Big data and cutaneous manifestations of COVID-19.|pdf=|usr=008}}
+
{{tp|p=32407771|t=2020. Acute Myocardial Injury at Hospital Admission is Associated with All-cause Mortality in COVID-19.|pdf=|usr=008}}
+
{{tp|p=32479784|t=2020. High prevalence of deep vein thrombosis in mechanically ventilated COVID-19 patients.|pdf=|usr=008}}
+
 
{{tp|p=32470515|t=2020. Ramipril in High Risk Patients with COVID-19.|pdf=|usr=008}}
 
{{tp|p=32470515|t=2020. Ramipril in High Risk Patients with COVID-19.|pdf=|usr=008}}
{{tp|p=32517963|t=2020. Prevalence and Impact of Myocardial Injury in Patients Hospitalized with COVID-19 Infection.|pdf=|usr=008}}
+
 
{{tp|p=32517962|t=2020. Takotsubo Cardiomyopathy in Males with Covid-19.|pdf=|usr=008}}
+
{{tp|p=32422349|t=2020. Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection.|pdf=|usr=008}}
+
 
{{tp|p=32383778|t=2020. A Unique Presentation of Delirium in a Patient with Otherwise Asymptomatic COVID-19.|pdf=|usr=008}}
 
{{tp|p=32383778|t=2020. A Unique Presentation of Delirium in a Patient with Otherwise Asymptomatic COVID-19.|pdf=|usr=008}}
 
{{tp|p=32383809|t=2020. Risk Factors for Mortality in 244 Older Adults With COVID-19 in Wuhan, China: A Retrospective Study.|pdf=|usr=008}}
 
{{tp|p=32383809|t=2020. Risk Factors for Mortality in 244 Older Adults With COVID-19 in Wuhan, China: A Retrospective Study.|pdf=|usr=008}}
 
{{tp|p=32329525|t=2020. Characteristics and Palliative Care Needs of COVID-19 Patients Receiving Comfort-Directed Care.|pdf=|usr=008}}
 
{{tp|p=32329525|t=2020. Characteristics and Palliative Care Needs of COVID-19 Patients Receiving Comfort-Directed Care.|pdf=|usr=008}}
 
{{tp|p=32379114|t=2020. Characteristics and Early Prognosis of COVID-19 Infection in Fracture Patients.|pdf=|usr=008}}
 
{{tp|p=32379114|t=2020. Characteristics and Early Prognosis of COVID-19 Infection in Fracture Patients.|pdf=|usr=008}}
{{tp|p=32490908|t=2020. COVID-19 pneumonia: a risk factor for pulmonary thromboembolism?|pdf=|usr=008}}
+
 
{{tp|p=32519505|t=2020. COVID-19: a major cause of cachexia and sarcopenia?|pdf=|usr=008}}
+
 
 
{{tp|p=32417380|t=2020. Coronavirus Disease-2019 in Heart Transplant Recipients in Southeastern Michigan: A Case Series.|pdf=|usr=008}}
 
{{tp|p=32417380|t=2020. Coronavirus Disease-2019 in Heart Transplant Recipients in Southeastern Michigan: A Case Series.|pdf=|usr=008}}
{{tp|p=32417379|t=2020. Unique Patterns of Cardiovascular Involvement in Coronavirus Disease-2019.|pdf=|usr=008}}
+
 
 
{{tp|p=32439095|t=2020. Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19.|pdf=|usr=008}}
 
{{tp|p=32439095|t=2020. Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19.|pdf=|usr=008}}
 
{{tp|p=32400044|t=2020. The importance of repeat testing in detecting coronavirus disease 2019 (COVID-19) in a coronary artery bypass grafting patient.|pdf=|usr=008}}
 
{{tp|p=32400044|t=2020. The importance of repeat testing in detecting coronavirus disease 2019 (COVID-19) in a coronary artery bypass grafting patient.|pdf=|usr=008}}
Zeile 932: Zeile 894:
 
{{tp|p=32474332|t=2020. Tetralogy of Fallot palliation in a COVID-19 positive neonate.|pdf=|usr=008}}
 
{{tp|p=32474332|t=2020. Tetralogy of Fallot palliation in a COVID-19 positive neonate.|pdf=|usr=008}}
 
{{tp|p=32450473|t=2020. Elevated cardiac biomarkers are associated with increased mortality for inpatients with COVID-19: A retrospective case-control study.|pdf=|usr=008}}
 
{{tp|p=32450473|t=2020. Elevated cardiac biomarkers are associated with increased mortality for inpatients with COVID-19: A retrospective case-control study.|pdf=|usr=008}}
{{tp|p=32504963|t=2020. Cardiac arrest during emergency intubation in an elderly patient with confirmed coronavirus disease 2019.|pdf=|usr=008}}
+
 
{{tp|p=32405183|t=2020. Gastrointestinal and Liver Manifestations of COVID-19.|pdf=|usr=008}}
+
 
{{tp|p=32521707|t=2020. Non-Overt Coagulopathy in Non-ICU Patients with Mild to Moderate COVID-19 Pneumonia.|pdf=|usr=008}}
+
 
 
{{tp|p=32516940|t=2020. COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge.|pdf=|usr=008}}
 
{{tp|p=32516940|t=2020. COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge.|pdf=|usr=008}}
 
{{tp|p=32512688|t=2020. A Cohort of Patients with COVID-19 in a Major Teaching Hospital in Europe.|pdf=|usr=008}}
 
{{tp|p=32512688|t=2020. A Cohort of Patients with COVID-19 in a Major Teaching Hospital in Europe.|pdf=|usr=008}}
 
{{tp|p=32489501|t=2020. Serious Conditions in COVID-19 Accompanied With a Feature of Metabolic Syndrome.|pdf=|usr=008}}
 
{{tp|p=32489501|t=2020. Serious Conditions in COVID-19 Accompanied With a Feature of Metabolic Syndrome.|pdf=|usr=008}}
{{tp|p=32453100|t=2020. Novel Coronavirus (COVID-19)-Associated Guillain-Barre Syndrome: Case Report.|pdf=|usr=008}}
+
 
{{tp|p=32414622|t=2020. Intravenous Thrombolysis for Stroke in a COVID-19 Positive Filipino Patient, a Case Report.|pdf=|usr=008}}
+
 
{{tp|p=32410788|t=2020. Facial diplegia, a possible atypical variant of Guillain-Barre Syndrome as a rare neurological complication of SARS-CoV-2.|pdf=|usr=008}}
+
 
 
{{tp|p=32412150|t=2020. COVID-19 and Indigenous Peoples: An imperative for action.|pdf=|usr=008}}
 
{{tp|p=32412150|t=2020. COVID-19 and Indigenous Peoples: An imperative for action.|pdf=|usr=008}}
{{tp|p=32274342|t=2020. COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies.|pdf=|usr=008}}
 
{{tp|p=32274341|t=2020. Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease.|pdf=|usr=008}}
 
{{tp|p=32309152|t=2020. What Has the COVID-19 Pandemic Taught Us so Far? Addressing the Problem from a Hepatologist's Perspective.|pdf=|usr=008}}
 
 
{{tp|p=32485619|t=2020. Epidemiological and clinical features of 200 hospitalized patients with corona virus disease 2019 outside Wuhan, China: A descriptive study.|pdf=|usr=008}}
 
{{tp|p=32485619|t=2020. Epidemiological and clinical features of 200 hospitalized patients with corona virus disease 2019 outside Wuhan, China: A descriptive study.|pdf=|usr=008}}
 
{{tp|p=32278300|t=2020. Challenges of SARS-CoV-2 and lessons learnt from SARS in Guangdong Province, China.|pdf=|usr=008}}
 
{{tp|p=32278300|t=2020. Challenges of SARS-CoV-2 and lessons learnt from SARS in Guangdong Province, China.|pdf=|usr=008}}
Zeile 950: Zeile 909:
 
{{tp|p=32361323|t=2020. Clinical features of pediatric patients with coronavirus disease (COVID-19).|pdf=|usr=008}}
 
{{tp|p=32361323|t=2020. Clinical features of pediatric patients with coronavirus disease (COVID-19).|pdf=|usr=008}}
 
{{tp|p=32311650|t=2020. Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China.|pdf=|usr=008}}
 
{{tp|p=32311650|t=2020. Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China.|pdf=|usr=008}}
{{tp|p=32305883|t=2020. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past.|pdf=|usr=008}}
+
 
 
{{tp|p=32305882|t=2020. Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome.|pdf=|usr=008}}
 
{{tp|p=32305882|t=2020. Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome.|pdf=|usr=008}}
 
{{tp|p=32454427|t=2020. Children are protected against SARS-CoV-2 infection.|pdf=|usr=008}}
 
{{tp|p=32454427|t=2020. Children are protected against SARS-CoV-2 infection.|pdf=|usr=008}}
Zeile 959: Zeile 918:
 
{{tp|p=32333494|t=2020. Racial variations in COVID-19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti-androgens a potential treatment for COVID-19?|pdf=|usr=008}}
 
{{tp|p=32333494|t=2020. Racial variations in COVID-19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti-androgens a potential treatment for COVID-19?|pdf=|usr=008}}
 
{{tp|p=32402680|t=2020. COVID-19 in lung-transplanted and cystic fibrosis patients: Be careful.|pdf=|usr=008}}
 
{{tp|p=32402680|t=2020. COVID-19 in lung-transplanted and cystic fibrosis patients: Be careful.|pdf=|usr=008}}
{{tp|p=32425356|t=2020. Unique skin manifestations of COVID-19: Is drug eruption specific to COVID-19?|pdf=|usr=008}}
+
 
 
{{tp|p=32521120|t=2020. Does glycemic control rescue type 2 diabetic patients from COVID-19-related deaths?|pdf=|usr=008}}
 
{{tp|p=32521120|t=2020. Does glycemic control rescue type 2 diabetic patients from COVID-19-related deaths?|pdf=|usr=008}}
 
{{tp|p=32509886|t=2020. Novel coronavirus disease 2019 and perinatal outcomes.|pdf=|usr=008}}
 
{{tp|p=32509886|t=2020. Novel coronavirus disease 2019 and perinatal outcomes.|pdf=|usr=008}}
{{tp|p=32456959|t=2020. The Ocular Manifestations and Transmission of COVID-19: Recommendations for Prevention.|pdf=|usr=008}}
+
 
{{tp|p=32519200|t=2020. A COVID-19 pneumonia case report of autoimmune polyendocrine syndrome type 1 in Lombardy, Italy: letter to the editor.|pdf=|usr=008}}
+
{{tp|p=32504458|t=2020. A case of subacute thyroiditis associated with Covid-19 infection.|pdf=|usr=008}}
+
{{tp|p=32488726|t=2020. SARS-CoV-2: a potential trigger for subacute thyroiditis? Insights from a case report.|pdf=|usr=008}}
+
{{tp|p=32488724|t=2020. Endocrine complications of COVID-19: what happens to the thyroid and adrenal glands?|pdf=|usr=008}}
+
{{tp|p=32386459|t=2020. Histologic features of long-lasting chilblain-like lesions in a paediatric COVID-19 patient.|pdf=|usr=008}}
+
{{tp|p=32386448|t=2020. Acute Generalized Exanthematous Pustulosis with Erythema Multiforme-Like lesions in a COVID-19 woman.|pdf=|usr=008}}
+
{{tp|p=32386447|t=2020. Urticaria-like lesions in COVID-19 patients are not really urticaria - a case with clinicopathological correlation.|pdf=|usr=008}}
+
{{tp|p=32386446|t=2020. Atypical erythema multiforme palmar plaques lesions due to Sars-Cov-2.|pdf=|usr=008}}
+
{{tp|p=32386442|t=2020. Localized mid-face miliaria as a consequence of filtering face piece respirator use during the COVID-19 pandemic.|pdf=|usr=008}}
+
 
{{tp|p=32386431|t=2020. SARS-CoV-2 asymptomatic infection in a patient under treatment with dupilumab.|pdf=|usr=008}}
 
{{tp|p=32386431|t=2020. SARS-CoV-2 asymptomatic infection in a patient under treatment with dupilumab.|pdf=|usr=008}}
{{tp|p=32294262|t=2020. Comment on: Cutaneous manifestations in COVID-19: a first perspective. Safety concerns of clinical images and skin biopsies.|pdf=|usr=008}}
+
 
 
{{tp|p=32414666|t=2020. A severe-type COVID-19 case with prolonged virus shedding.|pdf=|usr=008}}
 
{{tp|p=32414666|t=2020. A severe-type COVID-19 case with prolonged virus shedding.|pdf=|usr=008}}
{{tp|p=32402522|t=2020. Prophylactic anticoagulant therapy for reducing the risk of stroke and other thrombotic events in COVID-19 patients.|pdf=|usr=008}}
+
 
{{tp|p=32517166|t=2020. Azole-Resistant COVID-19-Associated Pulmonary Aspergillosis in an Immunocompetent Host: A Case Report.|pdf=|usr=008}}
+
 
 
{{tp|p=32410276|t=2020. RNA conversion of COVID-19 in respiratory and alimentary specimens during asymptomatic convalescence.|pdf=|usr=008}}
 
{{tp|p=32410276|t=2020. RNA conversion of COVID-19 in respiratory and alimentary specimens during asymptomatic convalescence.|pdf=|usr=008}}
{{tp|p=32531002|t=2020. Pancreatic involvement in SARS-CoV-2: case report and living review.|pdf=|usr=008}}
+
 
 
{{tp|p=32530994|t=2020. COVID-19 in a Patient with Liver Cirrhosis.|pdf=|usr=008}}
 
{{tp|p=32530994|t=2020. COVID-19 in a Patient with Liver Cirrhosis.|pdf=|usr=008}}
 
{{tp|p=32530989|t=2020. Abnormal Liver Function Tests of Patients with Coronavirus Disease 2019 in Mainland China: A Systematic Review and Meta- Analysis.|pdf=|usr=008}}
 
{{tp|p=32530989|t=2020. Abnormal Liver Function Tests of Patients with Coronavirus Disease 2019 in Mainland China: A Systematic Review and Meta- Analysis.|pdf=|usr=008}}
 
{{tp|p=32519326|t=2020. Independent Correlates of Hospitalization in 2040 Patients with COVID-19 at a Large Hospital System in Michigan, United States.|pdf=|usr=008}}
 
{{tp|p=32519326|t=2020. Independent Correlates of Hospitalization in 2040 Patients with COVID-19 at a Large Hospital System in Michigan, United States.|pdf=|usr=008}}
{{tp|p=32519322|t=2020. Self-Reported Loss of Smell and Taste in SARS-CoV-2 Patients: Primary Care Data to Guide Future Early Detection Strategies.|pdf=|usr=008}}
+
 
 
{{tp|p=32495088|t=2020. Prevalence of SARS-CoV-2 Antibodies Among Healthcare Workers at a Tertiary Academic Hospital in New York City.|pdf=|usr=008}}
 
{{tp|p=32495088|t=2020. Prevalence of SARS-CoV-2 Antibodies Among Healthcare Workers at a Tertiary Academic Hospital in New York City.|pdf=|usr=008}}
{{tp|p=32387155|t=2020. Digital Ischemia in COVID-19 Patients: Case Report.|pdf=|usr=008}}
+
 
 
{{tp|p=32362394|t=2020. First cases of COVID-19 in heart transplantation from China.|pdf=|usr=008}}
 
{{tp|p=32362394|t=2020. First cases of COVID-19 in heart transplantation from China.|pdf=|usr=008}}
 
{{tp|p=32362390|t=2020. COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal.|pdf=|usr=008}}
 
{{tp|p=32362390|t=2020. COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal.|pdf=|usr=008}}
 
{{tp|p=32253113|t=2020. COVID-19: Yet another coronavirus challenge in transplantation.|pdf=|usr=008}}
 
{{tp|p=32253113|t=2020. COVID-19: Yet another coronavirus challenge in transplantation.|pdf=|usr=008}}
 
{{tp|p=32340870|t=2020. COVID-19 in a lung transplant recipient.|pdf=|usr=008}}
 
{{tp|p=32340870|t=2020. COVID-19 in a lung transplant recipient.|pdf=|usr=008}}
{{tp|p=32362977|t=2020. Abnormal Hemostatic Parameters and Risk of Thromboembolism Among Patients With COVID-19 Infection.|pdf=|usr=008}}
+
 
 
{{tp|p=32522278|t=2020. Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis.|pdf=|usr=008}}
 
{{tp|p=32522278|t=2020. Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis.|pdf=|usr=008}}
 
{{tp|p=32473194|t=2020. Liver tests abnormalities in COVID-19: trick or treat?|pdf=|usr=008}}
 
{{tp|p=32473194|t=2020. Liver tests abnormalities in COVID-19: trick or treat?|pdf=|usr=008}}
{{tp|p=32473193|t=2020. Single cell RNA sequencing analysis did not predict hepatocyte infection by SARS-CoV-2.|pdf=|usr=008}}
 
{{tp|p=32454042|t=2020. SARS-CoV-2 related liver impairment - perception may not be the reality.|pdf=|usr=008}}
 
 
{{tp|p=32446714|t=2020. High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry.|pdf=|usr=008}}
 
{{tp|p=32446714|t=2020. High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry.|pdf=|usr=008}}
 
{{tp|p=32445883|t=2020. Lack of genetic evidence that fatty liver disease predisposes to COVID-19.|pdf=|usr=008}}
 
{{tp|p=32445883|t=2020. Lack of genetic evidence that fatty liver disease predisposes to COVID-19.|pdf=|usr=008}}
 
{{tp|p=32437831|t=2020. Reply to: 'Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis'.|pdf=|usr=008}}
 
{{tp|p=32437831|t=2020. Reply to: 'Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis'.|pdf=|usr=008}}
 
{{tp|p=32526252|t=2020. High rates of 30-day mortality in patients with cirrhosis and COVID-19.|pdf=|usr=008}}
 
{{tp|p=32526252|t=2020. High rates of 30-day mortality in patients with cirrhosis and COVID-19.|pdf=|usr=008}}
{{tp|p=32502510|t=2020. SARS-CoV-2: is the liver merely a bystander to severe disease?|pdf=|usr=008}}
+
 
 
{{tp|p=32434789|t=2020. Diffuse pneumonitis from coronavirus HKU1 on checkpoint inhibitor therapy.|pdf=|usr=008}}
 
{{tp|p=32434789|t=2020. Diffuse pneumonitis from coronavirus HKU1 on checkpoint inhibitor therapy.|pdf=|usr=008}}
 
{{tp|p=32423535|t=2020. Comparison of short-term mortality between mechanically ventilated patients with COVID-19 and influenza in a setting of sustainable healthcare system.|pdf=|usr=008}}
 
{{tp|p=32423535|t=2020. Comparison of short-term mortality between mechanically ventilated patients with COVID-19 and influenza in a setting of sustainable healthcare system.|pdf=|usr=008}}
  
{{tp|p=32310612|t=2020. Cardiac Manifestations Of Coronavirus (COVID-19)|pdf=|usr=008}}
+
 
 
{{tp|p=32371823|t=2020. Respiratory Distress in Postanesthesia Care Unit: First Presentation of Coronavirus Disease 2019 in a 17-Year-Old Girl: A Case Report.|pdf=|usr=008}}
 
{{tp|p=32371823|t=2020. Respiratory Distress in Postanesthesia Care Unit: First Presentation of Coronavirus Disease 2019 in a 17-Year-Old Girl: A Case Report.|pdf=|usr=008}}
 
{{tp|p=32516467|t=2020. Testing Asymptomatic Emergency Department Patients for Coronavirus of 2019 (COVID-19) in a Low Prevalence Region.|pdf=|usr=008}}
 
{{tp|p=32516467|t=2020. Testing Asymptomatic Emergency Department Patients for Coronavirus of 2019 (COVID-19) in a Low Prevalence Region.|pdf=|usr=008}}
 
{{tp|p=32344458|t=2020. Characteristics of Emergency Department Patients With COVID-19 at a Single Site in Northern California: Clinical Observations and Public Health Implications.|pdf=|usr=008}}
 
{{tp|p=32344458|t=2020. Characteristics of Emergency Department Patients With COVID-19 at a Single Site in Northern California: Clinical Observations and Public Health Implications.|pdf=|usr=008}}
{{tp|p=32475635|t=2020. Acute Mesenteric Ischemia in Severe Coronavirus-19 (COVID-19): Possible Mechanisms and Diagnostic Pathway.|pdf=|usr=008}}
+
 
{{tp|p=32425479|t=2020. MRI evaluation of the olfactory clefts in patients with SARS-CoV-2 infection revealed an unexpected mechanism for olfactory function loss.|pdf=|usr=008}}
+
 
 
{{tp|p=32418781|t=2020. COVID-19 and Gynecomastia: What is the Relationship?|pdf=|usr=008}}
 
{{tp|p=32418781|t=2020. COVID-19 and Gynecomastia: What is the Relationship?|pdf=|usr=008}}
{{tp|p=32427468|t=2020. Autonomic Brain Centers and Pathophysiology of COVID-19.|pdf=|usr=008}}
+
 
 
{{tp|p=32425432|t=2020. Renin-Angiotensin System Inhibitors and COVID-19: Potential Therapeutics Rather Than Perpetrators.|pdf=|usr=008}}
 
{{tp|p=32425432|t=2020. Renin-Angiotensin System Inhibitors and COVID-19: Potential Therapeutics Rather Than Perpetrators.|pdf=|usr=008}}
{{tp|p=32430637|t=2020. COVID-19-associated meningoencephalitis complicated with intracranial hemorrhage: a case report.|pdf=|usr=008}}
+
 
 
{{tp|p=32444942|t=2020. Are patients with Down syndrome vulnerable to life-threatening COVID-19?|pdf=|usr=008}}
 
{{tp|p=32444942|t=2020. Are patients with Down syndrome vulnerable to life-threatening COVID-19?|pdf=|usr=008}}
{{tp|p=32524537|t=2020. A complication of coronavirus disease 2019: delirium.|pdf=|usr=008}}
+
 
{{tp|p=32412088|t=2020. Neurological Manifestations of COVID-19: A systematic review and current update.|pdf=|usr=008}}
+
 
 
{{tp|p=32386441|t=2020. Public Health Agency of Sweden's Brief Report: Pregnant and postpartum women with severe acute respiratory syndrome coronavirus 2 infection in intensive care in Sweden.|pdf=|usr=008}}
 
{{tp|p=32386441|t=2020. Public Health Agency of Sweden's Brief Report: Pregnant and postpartum women with severe acute respiratory syndrome coronavirus 2 infection in intensive care in Sweden.|pdf=|usr=008}}
 
{{tp|p=32386440|t=2020. Severe maternal morbidity and mortality associated with COVID-19: The risk should not be downplayed.|pdf=|usr=008}}
 
{{tp|p=32386440|t=2020. Severe maternal morbidity and mortality associated with COVID-19: The risk should not be downplayed.|pdf=|usr=008}}
{{tp|p=32406606|t=2020. Positive detection of SARS-CoV-2 combined HSV1 and HHV6B virus nucleic acid in tear and conjunctival secretions of a non-conjunctivitis COVID-19 patient with obstruction of common lacrimal duct.|pdf=|usr=008}}
+
 
{{tp|p=32519994|t=2020. Vertigo and hearing loss during the COVID-19 pandemic - is there an association?|pdf=|usr=008}}
+
 
{{tp|p=32466862|t=2020. Alteraciones del olfato en la COVID-19, revision de la evidencia e implicaciones en el manejo de la pandemia.|pdf=|usr=008}}
+
 
 
{{tp|p=32521068|t=2020. COVID-19 is milder in children possibly due to cross immunity.|pdf=|usr=008}}
 
{{tp|p=32521068|t=2020. COVID-19 is milder in children possibly due to cross immunity.|pdf=|usr=008}}
{{tp|p=32450058|t=2020. Paniculitis eosinofilica secundaria a infeccion por COVID-19.|pdf=|usr=008}}
+
 
{{tp|p=32401723|t=2020. COVID-19 y piel.|pdf=|usr=008}}
+
 
 
{{tp|p=32395673|t=2020. Clinical and Radiographic Presentations of COVID-19 among Patients Receiving Radiation Therapy for Thoracic Malignancies.|pdf=|usr=008}}
 
{{tp|p=32395673|t=2020. Clinical and Radiographic Presentations of COVID-19 among Patients Receiving Radiation Therapy for Thoracic Malignancies.|pdf=|usr=008}}
{{tp|p=32504450|t=2020. Dysfunctional Coagulation in COVID-19: From Cell to Bedside.|pdf=|usr=008}}
+
 
{{tp|p=32527987|t=2020. Potential mechanisms of hemorrhagic stroke in elderly COVID-19 patients.|pdf=|usr=008}}
+
 
 
{{tp|p=32458356|t=2020. The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing.|pdf=|usr=008}}
 
{{tp|p=32458356|t=2020. The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing.|pdf=|usr=008}}
 
{{tp|p=32390064|t=2020. COVID-19 in older adults.|pdf=|usr=008}}
 
{{tp|p=32390064|t=2020. COVID-19 in older adults.|pdf=|usr=008}}
 
{{tp|p=32489711|t=2020. Comorbid Chronic Diseases are Strongly Correlated with Disease Severity among COVID-19 Patients: A Systematic Review and Meta-Analysis.|pdf=|usr=008}}
 
{{tp|p=32489711|t=2020. Comorbid Chronic Diseases are Strongly Correlated with Disease Severity among COVID-19 Patients: A Systematic Review and Meta-Analysis.|pdf=|usr=008}}
 
{{tp|p=32509416|t=2020. Acute Respiratory Decompensation Requiring Intubation in Pregnant Women with SARS-CoV-2 (COVID-19).|pdf=|usr=008}}
 
{{tp|p=32509416|t=2020. Acute Respiratory Decompensation Requiring Intubation in Pregnant Women with SARS-CoV-2 (COVID-19).|pdf=|usr=008}}
{{tp|p=32509415|t=2020. Heart Failure with Preserved Ejection Fraction in a Postpartum Patient with Superimposed Preeclampsia and COVID-19.|pdf=|usr=008}}
+
 
 
{{tp|p=32400858|t=2020. Are Patients With Alcohol Use Disorders at Increased Risk for Covid-19 Infection?|pdf=|usr=008}}
 
{{tp|p=32400858|t=2020. Are Patients With Alcohol Use Disorders at Increased Risk for Covid-19 Infection?|pdf=|usr=008}}
{{tp|p=32402090|t=2020. Review article: COVID-19 and liver disease-what we know on 1st May 2020.|pdf=|usr=008}}
+
 
 
{{tp|p=32406119|t=2020. Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic.|pdf=|usr=008}}
 
{{tp|p=32406119|t=2020. Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic.|pdf=|usr=008}}
 
{{tp|p=32406090|t=2020. Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic. Authors' reply.|pdf=|usr=008}}
 
{{tp|p=32406090|t=2020. Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic. Authors' reply.|pdf=|usr=008}}
Zeile 1.041: Zeile 989:
 
{{tp|p=32498691|t=2020. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease.|pdf=|usr=008}}
 
{{tp|p=32498691|t=2020. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease.|pdf=|usr=008}}
 
{{tp|p=32512291|t=2020. Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease.|pdf=|usr=008}}
 
{{tp|p=32512291|t=2020. Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease.|pdf=|usr=008}}
{{tp|p=32425197|t=2020. Cardiovascular comorbidities, cardiac injury, and prognosis of COVID-19 in New York City.|pdf=|usr=008}}
+
 
 
{{tp|p=32502882|t=2020. Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial.|pdf=|usr=008}}
 
{{tp|p=32502882|t=2020. Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial.|pdf=|usr=008}}
{{tp|p=32470634|t=2020. COVID-19 pandemic-Some cardiovascular considerations from the trench.|pdf=|usr=008}}
+
 
 
{{tp|p=32414525|t=2020. COVID-19 in healthcare workers.|pdf=|usr=008}}
 
{{tp|p=32414525|t=2020. COVID-19 in healthcare workers.|pdf=|usr=008}}
 
{{tp|p=32386808|t=2020. Prevalence of IgG antibodies to SARS-CoV-2 among emergency department employees.|pdf=|usr=008}}
 
{{tp|p=32386808|t=2020. Prevalence of IgG antibodies to SARS-CoV-2 among emergency department employees.|pdf=|usr=008}}
{{tp|p=32499176|t=2020. Coronavirus disease 2019 (COVID-19) and ischemic colitis: An under-recognized complication.|pdf=|usr=008}}
+
 
 
{{tp|p=32475761|t=2020. Dexmedetomidine and worsening hypoxemia in the setting of COVID-19: A case report.|pdf=|usr=008}}
 
{{tp|p=32475761|t=2020. Dexmedetomidine and worsening hypoxemia in the setting of COVID-19: A case report.|pdf=|usr=008}}
{{tp|p=32473756|t=2020. Neuroleptic malignant syndrome in patients with COVID-19.|pdf=|usr=008}}
+
 
{{tp|p=32425321|t=2020. Neurologic complications of COVID-19.|pdf=|usr=008}}
+
{{tp|p=32425319|t=2020. COVID-19 infection with extensive thrombosis: A case of phlegmasia cerulea dolens.|pdf=|usr=008}}
+
 
{{tp|p=32444295|t=2020. Atypical presentation of COVID-19.|pdf=|usr=008}}
 
{{tp|p=32444295|t=2020. Atypical presentation of COVID-19.|pdf=|usr=008}}
{{tp|p=32414522|t=2020. Weakness and elevated creatinine kinase as the initial presentation of coronavirus disease 2019 (COVID-19).|pdf=|usr=008}}
+
 
{{tp|p=32467503|t=2020. Acute Portal Vein Thrombosis in SARS-CoV-2 Infection: A Case Report.|pdf=|usr=008}}
+
{{tp|p=32453053|t=2020. COVID-19 and the Digestive System.|pdf=|usr=008}}
+
{{tp|p=32516204|t=2020. Gastrointestinal Bleeding in Patients with Severe SARS-CoV-2.|pdf=|usr=008}}
+
{{tp|p=32453058|t=2020. Moderately Severe Diarrhea and Impaired Renal Function With COVID-19 Infection.|pdf=|usr=008}}
+
{{tp|p=32427677|t=2020. Three Cases of COVID-19 Disease With Colonic Manifestations.|pdf=|usr=008}}
+
 
{{tp|p=32427676|t=2020. Shanghai Zhongshan Experience on Digestive Endoscopic Procedures During 2020 COVID-19 Pandemic.|pdf=|usr=008}}
 
{{tp|p=32427676|t=2020. Shanghai Zhongshan Experience on Digestive Endoscopic Procedures During 2020 COVID-19 Pandemic.|pdf=|usr=008}}
{{tp|p=32425470|t=2020. Altered Mental Status as a Novel Initial Clinical Presentation for COVID-19 Infection in the Elderly.|pdf=|usr=008}}
 
{{tp|p=32527141|t=2020. Prevalence and Recovery From Olfactory and Gustatory Dysfunctions in Covid-19 Infection: A Prospective Multicenter Study.|pdf=|usr=008}}
 
 
{{tp|p=32519406|t=2020. Prolonged SARS-CoV-2 shedding and mild course of COVID-19 in a patient after recent heart transplantation.|pdf=|usr=008}}
 
{{tp|p=32519406|t=2020. Prolonged SARS-CoV-2 shedding and mild course of COVID-19 in a patient after recent heart transplantation.|pdf=|usr=008}}
 
{{tp|p=32515085|t=2020. COVID-19 in recent kidney transplant recipients.|pdf=|usr=008}}
 
{{tp|p=32515085|t=2020. COVID-19 in recent kidney transplant recipients.|pdf=|usr=008}}
{{tp|p=32471002|t=2020. It is currently unknown whether SARS-CoV-2 is viable in semen or whether COVID-19 damages spermatozoa.|pdf=|usr=008}}
+
 
 
{{tp|p=32524732|t=2020. Worse progression of COVID-19 in men: Is Testosterone a key factor?|pdf=|usr=008}}
 
{{tp|p=32524732|t=2020. Worse progression of COVID-19 in men: Is Testosterone a key factor?|pdf=|usr=008}}
 
{{tp|p=32520728|t=2020. Anesthesiologists' and intensive care providers' exposure to COVID-19 infection in a New York City academic center: a prospective cohort study assessing symptoms and COVID-19 antibody testing.|pdf=|usr=008}}
 
{{tp|p=32520728|t=2020. Anesthesiologists' and intensive care providers' exposure to COVID-19 infection in a New York City academic center: a prospective cohort study assessing symptoms and COVID-19 antibody testing.|pdf=|usr=008}}
{{tp|p=32535707|t=2020. COVID-19 presenting as neutropenic fever.|pdf=|usr=008}}
+
 
{{tp|p=32506549|t=2020. COVID-19: A Global Threat to the Nervous System.|pdf=|usr=008}}
+
 
 
{{tp|p=32444415|t=2020. Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China.|pdf=|usr=008}}
 
{{tp|p=32444415|t=2020. Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China.|pdf=|usr=008}}
 
{{tp|p=32471903|t=2020. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.|pdf=|usr=008}}
 
{{tp|p=32471903|t=2020. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.|pdf=|usr=008}}
 
{{tp|p=32439956|t=2020. Management of newborns exposed to mothers with confirmed or suspected COVID-19.|pdf=|usr=008}}
 
{{tp|p=32439956|t=2020. Management of newborns exposed to mothers with confirmed or suspected COVID-19.|pdf=|usr=008}}
{{tp|p=32388880|t=2020. Guillain-Barre syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature.|pdf=|usr=008}}
+
 
 
{{tp|p=32474140|t=2020. Maternal choline and respiratory coronavirus effects on fetal brain development.|pdf=|usr=008}}
 
{{tp|p=32474140|t=2020. Maternal choline and respiratory coronavirus effects on fetal brain development.|pdf=|usr=008}}
 
{{tp|p=32434431|t=2020. Cardiovascular disease, heart failure and COVID-19.|pdf=|usr=008}}
 
{{tp|p=32434431|t=2020. Cardiovascular disease, heart failure and COVID-19.|pdf=|usr=008}}
Zeile 1.080: Zeile 1.019:
 
{{tp|p=32282964|t=2020. A Commentary on Rural-Urban Disparities in COVID-19 Testing Rates per 100,000 and Risk Factors.|pdf=|usr=008}}
 
{{tp|p=32282964|t=2020. A Commentary on Rural-Urban Disparities in COVID-19 Testing Rates per 100,000 and Risk Factors.|pdf=|usr=008}}
 
{{tp|p=32277775|t=2020. Caring for Miners During the Coronavirus Disease-2019 (COVID-19) Pandemic.|pdf=|usr=008}}
 
{{tp|p=32277775|t=2020. Caring for Miners During the Coronavirus Disease-2019 (COVID-19) Pandemic.|pdf=|usr=008}}
{{tp|p=32530597|t=2020. Happy Hypoxemia in COVID-19-A Neural Hypothesis.|pdf=|usr=008}}
+
 
 
{{tp|p=32352913|t=2020. Cesarean Section in a Pregnant Woman with COVID-19: First Case in Portugal.|pdf=|usr=008}}
 
{{tp|p=32352913|t=2020. Cesarean Section in a Pregnant Woman with COVID-19: First Case in Portugal.|pdf=|usr=008}}
 
{{tp|p=32533756|t=2020. Physiological advantages of children against COVID-19.|pdf=|usr=008}}
 
{{tp|p=32533756|t=2020. Physiological advantages of children against COVID-19.|pdf=|usr=008}}
 
{{tp|p=32533572|t=2020. COVID-19 and Down syndrome.|pdf=|usr=008}}
 
{{tp|p=32533572|t=2020. COVID-19 and Down syndrome.|pdf=|usr=008}}
{{tp|p=32527845|t=2020. Evolving Neuroimaging Findings during COVID-19.|pdf=|usr=008}}
 
{{tp|p=32527844|t=2020. Neurovascular Complications in COVID-19 Infection: Case Series.|pdf=|usr=008}}
 
{{tp|p=32527843|t=2020. Neuroimaging Findings in Patients with COVID-19.|pdf=|usr=008}}
 
{{tp|p=32527842|t=2020. Neurologic Involvement in COVID-19: Cause or Coincidence? A Neuroimaging Perspective.|pdf=|usr=008}}
 
 
{{tp|p=32239761|t=2020. COVID-19 in a designated infectious diseases hospital outside Hubei Province, China.|pdf=|usr=008}}
 
{{tp|p=32239761|t=2020. COVID-19 in a designated infectious diseases hospital outside Hubei Province, China.|pdf=|usr=008}}
 
{{tp|p=32412919|t=2020. Gender and Age Differences Reveal Risk Patterns in COVID-19 Outbreak.|pdf=|usr=008}}
 
{{tp|p=32412919|t=2020. Gender and Age Differences Reveal Risk Patterns in COVID-19 Outbreak.|pdf=|usr=008}}
{{tp|p=32412226|t=2020. A Case of COVID-19 Infection: Chief Symptom, Diarrhea.|pdf=|usr=008}}
+
 
 
{{tp|p=32531620|t=2020. Pediatric COVID-19: Systematic review of the literature.|pdf=|usr=008}}
 
{{tp|p=32531620|t=2020. Pediatric COVID-19: Systematic review of the literature.|pdf=|usr=008}}
{{tp|p=32531619|t=2020. Olfactory and gustatory dysfunctions in COVID-19. First reports of Latin-American ethnic patients.|pdf=|usr=008}}
+
 
 
{{tp|p=32530714|t=2020. Cigarette Smoking and COVID-19: A Complex Interaction.|pdf=|usr=008}}
 
{{tp|p=32530714|t=2020. Cigarette Smoking and COVID-19: A Complex Interaction.|pdf=|usr=008}}
 
{{tp|p=32530707|t=2020. Reply to: Cigarette Smoking and COVID-19: A Complex Interaction.|pdf=|usr=008}}
 
{{tp|p=32530707|t=2020. Reply to: Cigarette Smoking and COVID-19: A Complex Interaction.|pdf=|usr=008}}
{{tp|p=32524962|t=2020. Case report: COVID-19 Masquerading as an Acute Surgical Abdomen.|pdf=|usr=008}}
+
 
{{tp|p=32533891|t=2020. SARS-CoV-2 in the semen: where does it come from?|pdf=|usr=008}}
+
 
{{tp|p=32449883|t=2020. Loss of Smell and Taste in 2013 European Patients With Mild to Moderate COVID-19.|pdf=|usr=008}}
+
{{tp|p=32533727|t=2020. Report of EEG Finding on Critically Ill Patients with COVID-19.|pdf=|usr=008}}
+
{{tp|p=32468830|t=2020. Taste and Smell Dysfunction in COVID-19 Patients.|pdf=|usr=008}}
+
 
{{tp|p=32381561|t=2020. Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.|pdf=|usr=008}}
 
{{tp|p=32381561|t=2020. Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.|pdf=|usr=008}}
 
{{tp|p=32475835|t=2020. Patients with lupus with COVID-19: University of Michigan experience.|pdf=|usr=008}}
 
{{tp|p=32475835|t=2020. Patients with lupus with COVID-19: University of Michigan experience.|pdf=|usr=008}}
Zeile 1.106: Zeile 1.038:
 
{{tp|p=32475831|t=2020. Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.|pdf=|usr=008}}
 
{{tp|p=32475831|t=2020. Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.|pdf=|usr=008}}
 
{{tp|p=32471900|t=2020. Response to: Correspondence regarding research letter to the editor by Mathian et al, 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'' by Nikpour et al.|pdf=|usr=008}}
 
{{tp|p=32471900|t=2020. Response to: Correspondence regarding research letter to the editor by Mathian et al, 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'' by Nikpour et al.|pdf=|usr=008}}
{{tp|p=32471899|t=2020. Case series of acute arthritis during COVID-19 admission.|pdf=|usr=008}}
+
 
 
{{tp|p=32471898|t=2020. Correspondence regarding research letter to the editor by Mathian et al, 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'.|pdf=|usr=008}}
 
{{tp|p=32471898|t=2020. Correspondence regarding research letter to the editor by Mathian et al, 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'.|pdf=|usr=008}}
{{tp|p=32471896|t=2020. Response to: 'Case series of acute arthritis in COVID-19 admission' by Lopez-Gonzalez et al.|pdf=|usr=008}}
+
 
 
{{tp|p=32457048|t=2020. Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US 'hot spot'.|pdf=|usr=008}}
 
{{tp|p=32457048|t=2020. Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US 'hot spot'.|pdf=|usr=008}}
 
{{tp|p=32451345|t=2020. Response to: 'Are patients with systemic lupus erythematosus at increased risk for COVID-19?' by Favalli et al.|pdf=|usr=008}}
 
{{tp|p=32451345|t=2020. Response to: 'Are patients with systemic lupus erythematosus at increased risk for COVID-19?' by Favalli et al.|pdf=|usr=008}}
Zeile 1.115: Zeile 1.047:
 
{{tp|p=32467245|t=2020. Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based study.|pdf=|usr=008}}
 
{{tp|p=32467245|t=2020. Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based study.|pdf=|usr=008}}
  
{{tp|p=32401344|t=2020. The first case of acquired hemophilia A associated with SARS-CoV-2 infection.|pdf=|usr=008}}
+
 
 
{{tp|p=32415836|t=2020. Response to COVID-19 and ACEI/ARB: NOT ASSOCIATED?|pdf=|usr=008}}
 
{{tp|p=32415836|t=2020. Response to COVID-19 and ACEI/ARB: NOT ASSOCIATED?|pdf=|usr=008}}
 
{{tp|p=32415832|t=2020. COVID-19 and ACEI/ARB: NOT ASSOCIATED?|pdf=|usr=008}}
 
{{tp|p=32415832|t=2020. COVID-19 and ACEI/ARB: NOT ASSOCIATED?|pdf=|usr=008}}
{{tp|p=32479921|t=2020. Kidney Infarction in Patients With COVID-19.|pdf=|usr=008}}
+
 
{{tp|p=32405072|t=2020. SARS-CoV-2 Induces Acute and Refractory Relapse of Systemic Capillary Leak Syndrome (Clarkson's Disease).|pdf=|usr=008}}
+
 
 
{{tp|p=32460973|t=2020. Age-related difference in the rate of COVID-19 mortality in women versus men.|pdf=|usr=008}}
 
{{tp|p=32460973|t=2020. Age-related difference in the rate of COVID-19 mortality in women versus men.|pdf=|usr=008}}
 
{{tp|p=32439389|t=2020. Clinical Characteristics of 46 Pregnant Women with a SARS-CoV-2 Infection in Washington State.|pdf=|usr=008}}
 
{{tp|p=32439389|t=2020. Clinical Characteristics of 46 Pregnant Women with a SARS-CoV-2 Infection in Washington State.|pdf=|usr=008}}
Zeile 1.125: Zeile 1.057:
 
{{tp|p=32391519|t=2020. Clinical course of severe and critical COVID-19 in hospitalized pregnancies: a US cohort study.|pdf=|usr=008}}
 
{{tp|p=32391519|t=2020. Clinical course of severe and critical COVID-19 in hospitalized pregnancies: a US cohort study.|pdf=|usr=008}}
 
{{tp|p=32518902|t=2020. Coronavirus disease 2019 in pregnancy: early lessons.|pdf=|usr=008}}
 
{{tp|p=32518902|t=2020. Coronavirus disease 2019 in pregnancy: early lessons.|pdf=|usr=008}}
{{tp|p=32516656|t=2020. Clinical characteristics associated with persistent olfactory and taste alterations in COVID-19: A preliminary report on 121 patients.|pdf=|usr=008}}
 
{{tp|p=32336572|t=2020. New type of corona virus induced acute otitis media in adult.|pdf=|usr=008}}
 
{{tp|p=32307189|t=2020. Audiological profile of asymptomatic Covid-19 PCR-positive cases.|pdf=|usr=008}}
 
{{tp|p=32526530|t=2020. COVID-19 sampling from the middle ear and mastoid: A case report.|pdf=|usr=008}}
 
{{tp|p=32386897|t=2020. Comment on "Hearing loss and COVID-19: A note".|pdf=|usr=008}}
 
 
{{tp|p=32437114|t=2020. Early Rehabilitation for Critically Ill Patients With COVID-19: More Benefits Than Risks.|pdf=|usr=008}}
 
{{tp|p=32437114|t=2020. Early Rehabilitation for Critically Ill Patients With COVID-19: More Benefits Than Risks.|pdf=|usr=008}}
 
{{tp|p=32228322|t=2020. COVID-19 pandemic, coronaviruses, and diabetes mellitus.|pdf=|usr=008}}
 
{{tp|p=32228322|t=2020. COVID-19 pandemic, coronaviruses, and diabetes mellitus.|pdf=|usr=008}}
Zeile 1.143: Zeile 1.070:
 
{{tp|p=32400013|t=2020. A case of coronavirus disease 2019-infected liver transplant donor.|pdf=|usr=008}}
 
{{tp|p=32400013|t=2020. A case of coronavirus disease 2019-infected liver transplant donor.|pdf=|usr=008}}
 
{{tp|p=32314685|t=2020. Case Report: The First Case of COVID-19 in Bhutan.|pdf=|usr=008}}
 
{{tp|p=32314685|t=2020. Case Report: The First Case of COVID-19 in Bhutan.|pdf=|usr=008}}
{{tp|p=32456878|t=2020. Lesiones cutaneas en paciente con infeccion por SARS-COV-2.|pdf=|usr=008}}
 
{{tp|p=32389502|t=2020. Manifestaciones cutaneas en contexto del brote actual de enfermedad por coronavirus 2019.|pdf=|usr=008}}
 
{{tp|p=32437961|t=2020. Coagulation changes and thromboembolic risk in COVID-19 pregnant patients.|pdf=|usr=008}}
 
{{tp|p=32437586|t=2020. Understanding the COVID-19 coagulopathy spectrum.|pdf=|usr=008}}
 
{{tp|p=32436229|t=2020. Could COVID-19 have an impact on male fertility?|pdf=|usr=008}}
 
{{tp|p=32453494|t=2020. SARS-CoV-2 presence in seminal fluid: Myth or reality.|pdf=|usr=008}}
 
 
{{tp|p=32452644|t=2020. Caution in the management of SARS-CoV-2 infection in males.|pdf=|usr=008}}
 
{{tp|p=32452644|t=2020. Caution in the management of SARS-CoV-2 infection in males.|pdf=|usr=008}}
 
{{tp|p=32436355|t=2020. Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients.|pdf=|usr=008}}
 
{{tp|p=32436355|t=2020. Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients.|pdf=|usr=008}}
 
{{tp|p=32357288|t=2020. SARS-CoV-2 pandemic and repercussions for male infertility patients: A proposal for the individualized provision of andrological services.|pdf=|usr=008}}
 
{{tp|p=32357288|t=2020. SARS-CoV-2 pandemic and repercussions for male infertility patients: A proposal for the individualized provision of andrological services.|pdf=|usr=008}}
 
{{tp|p=32472773|t=2020. A COVID-19 Conundrum: Obstructive Sleep Apnea (OSA) and Non-Invasive Ventilation (NIV).|pdf=|usr=008}}
 
{{tp|p=32472773|t=2020. A COVID-19 Conundrum: Obstructive Sleep Apnea (OSA) and Non-Invasive Ventilation (NIV).|pdf=|usr=008}}
{{tp|p=32407609|t=2020. De Novo Status Epilepticus in patients with COVID-19.|pdf=|usr=008}}
 
{{tp|p=32410763|t=2020. Acute olfactory loss is specific for Covid-19 at the Emergency Department.|pdf=|usr=008}}
 
 
{{tp|p=32413342|t=2020. COVID-19 in diabetic patients: Related risks and specifics of management.|pdf=|usr=008}}
 
{{tp|p=32413342|t=2020. COVID-19 in diabetic patients: Related risks and specifics of management.|pdf=|usr=008}}
 
{{tp|p=32419766|t=2020. Assessing Differential Impacts of COVID-19 on Black Communities.|pdf=|usr=008}}
 
{{tp|p=32419766|t=2020. Assessing Differential Impacts of COVID-19 on Black Communities.|pdf=|usr=008}}
 
{{tp|p=32419765|t=2020. Understanding COVID-19 Risks and Vulnerabilities among Black Communities in America: The Lethal Force of Syndemics.|pdf=|usr=008}}
 
{{tp|p=32419765|t=2020. Understanding COVID-19 Risks and Vulnerabilities among Black Communities in America: The Lethal Force of Syndemics.|pdf=|usr=008}}
{{tp|p=32447425|t=2020. Fatal SARS-CoV-2 coinfection in course of EBV-associated lymphoproliferative disease.|pdf=|usr=008}}
+
 
{{tp|p=32425991|t=2020. The liver in times of COVID-19: What hepatologists should know.|pdf=|usr=008}}
+
 
{{tp|p=32419756|t=2020. Alteration of Consciousness as Initial Presentation in COVID-19: Observation.|pdf=|usr=008}}
+
 
{{tp|p=32419755|t=2020. COVID-19 and Epilepsy.|pdf=|usr=008}}
+
{{tp|p=32419754|t=2020. COVID-19 and Underlying Cerebrovascular Disease: Analysis on Association.|pdf=|usr=008}}
+
{{tp|p=32419753|t=2020. COVID 19: Neuromuscular Manifestations.|pdf=|usr=008}}
+
{{tp|p=32419751|t=2020. 2019-NCoV: What Every Neurologist Should Know?|pdf=|usr=008}}
+
{{tp|p=32488446|t=2020. COVID-19-associated invasive pulmonary aspergillosis.|pdf=|usr=008}}
+
 
{{tp|p=32422077|t=2020. COVID-19 and Angiotensin-Converting Enzyme Inhibitor/Angiotensin-Receptor Blocker Therapy.|pdf=|usr=008}}
 
{{tp|p=32422077|t=2020. COVID-19 and Angiotensin-Converting Enzyme Inhibitor/Angiotensin-Receptor Blocker Therapy.|pdf=|usr=008}}
 
{{tp|p=32422062|t=2020. Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.|pdf=|usr=008}}
 
{{tp|p=32422062|t=2020. Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.|pdf=|usr=008}}
{{tp|p=32422061|t=2020. Thromboembolic Findings in COVID-19 Autopsies: Pulmonary Thrombosis or Embolism?|pdf=|usr=008}}
 
{{tp|p=32422076|t=2020. Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case Series.|pdf=|usr=008}}
 
 
{{tp|p=32491919|t=2020. Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review.|pdf=|usr=008}}
 
{{tp|p=32491919|t=2020. Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review.|pdf=|usr=008}}
{{tp|p=32418288|t=2020. Steroid-Responsive Encephalitis in Coronavirus Disease 2019.|pdf=|usr=008}}
 
{{tp|p=32395831|t=2020. Rapid Dissemination of Protocols for Managing Neurology Inpatients with COVID-19.|pdf=|usr=008}}
 
 
{{tp|p=32383812|t=2020. SARS-CoV-2 and Multiple Sclerosis: Not All Immune Depleting DMTs are Equal or Bad.|pdf=|usr=008}}
 
{{tp|p=32383812|t=2020. SARS-CoV-2 and Multiple Sclerosis: Not All Immune Depleting DMTs are Equal or Bad.|pdf=|usr=008}}
{{tp|p=32527136|t=2020. Large pulmonary cavity in COVID-19 cured patient case report.|pdf=|usr=008}}
+
 
 
{{tp|p=32418848|t=2020. Early mobilization in hospitalized patients with COVID-19.|pdf=|usr=008}}
 
{{tp|p=32418848|t=2020. Early mobilization in hospitalized patients with COVID-19.|pdf=|usr=008}}
 
{{tp|p=32434818|t=2020. Comorbidities and rheumatological diseases at the time of COVID-19. Response to: 'Rheumatic diseases in intensive care unit patients with COVID-19' by Moiseev et al.|pdf=|usr=008}}
 
{{tp|p=32434818|t=2020. Comorbidities and rheumatological diseases at the time of COVID-19. Response to: 'Rheumatic diseases in intensive care unit patients with COVID-19' by Moiseev et al.|pdf=|usr=008}}
 
{{tp|p=32532753|t=2020. Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases.|pdf=|usr=008}}
 
{{tp|p=32532753|t=2020. Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases.|pdf=|usr=008}}
{{tp|p=32404678|t=2020. Gastrointestinal Complications in Critically Ill Patients With COVID-19.|pdf=|usr=008}}
+
 
{{tp|p=32489447|t=2020. Hemoptysis in COVID-19: Observation.|pdf=|usr=008}}
+
 
{{tp|p=32492443|t=2020. Right-to-left interatrial shunt in COVID-19 patients with pulmonary embolism.|pdf=|usr=008}}
+
 
 
{{tp|p=32411770|t=2020. Clinical characteristics of 60 discharged cases of 2019 novel coronavirus-infected pneumonia in Taizhou, China.|pdf=|usr=008}}
 
{{tp|p=32411770|t=2020. Clinical characteristics of 60 discharged cases of 2019 novel coronavirus-infected pneumonia in Taizhou, China.|pdf=|usr=008}}
{{tp|p=32395550|t=2020. 2019 novel coronavirus pneumonia with onset of dizziness: a case report.|pdf=|usr=008}}
+
 
 
{{tp|p=32395487|t=2020. Clinical characteristics of Coronavirus Disease 2019 and development of a prediction model for prolonged hospital length of stay.|pdf=|usr=008}}
 
{{tp|p=32395487|t=2020. Clinical characteristics of Coronavirus Disease 2019 and development of a prediction model for prolonged hospital length of stay.|pdf=|usr=008}}
 
{{tp|p=32395474|t=2020. The effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension.|pdf=|usr=008}}
 
{{tp|p=32395474|t=2020. The effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension.|pdf=|usr=008}}
{{tp|p=32474145|t=2020. COVID-19-Related Aortic Thrombosis: A Report of Four Cases.|pdf=|usr=008}}
 
{{tp|p=32473304|t=2020. Abdominal Aortic Thrombosis Complicating COVID-19 Pneumonia.|pdf=|usr=008}}
 
{{tp|p=32473303|t=2020. Inferior vena cava filter in a patient with COVID-19 pneumonia to prevent a massive pulmonary embolism.|pdf=|usr=008}}
 
{{tp|p=32440663|t=2020. Pulmonary Thromboembolism as a Potential Cause of Clinical Deterioration in COVID-19 Patients; a Commentary.|pdf=|usr=008}}
 
 
{{tp|p=32440661|t=2020. Clinical Characteristics of COVID-19 Infection in Newborns and Pediatrics: A Systematic Review.|pdf=|usr=008}}
 
{{tp|p=32440661|t=2020. Clinical Characteristics of COVID-19 Infection in Newborns and Pediatrics: A Systematic Review.|pdf=|usr=008}}
 
{{tp|p=32440660|t=2020. Analysis of Maternal Coronavirus Infections and Neonates Born to Mothers with 2019-nCoV; a Systematic Review.|pdf=|usr=008}}
 
{{tp|p=32440660|t=2020. Analysis of Maternal Coronavirus Infections and Neonates Born to Mothers with 2019-nCoV; a Systematic Review.|pdf=|usr=008}}
 
{{tp|p=32336565|t=2020. Situacion clinica de infeccion por SARS-CoV-2 en pacientes con carcinoma broncogenico: contexto actual.|pdf=|usr=008}}
 
{{tp|p=32336565|t=2020. Situacion clinica de infeccion por SARS-CoV-2 en pacientes con carcinoma broncogenico: contexto actual.|pdf=|usr=008}}
{{tp|p=32409976|t=2020. Follow-up of skin lesions during the evolution of COVID-19: a case report.|pdf=|usr=008}}
+
 
{{tp|p=32471704|t=2020. Central Nervous System Involvement in COVID-19.|pdf=|usr=008}}
+
 
 
{{tp|p=32518045|t=2020. Severe and fatal forms of COVID-19 in children.|pdf=|usr=008}}
 
{{tp|p=32518045|t=2020. Severe and fatal forms of COVID-19 in children.|pdf=|usr=008}}
{{tp|p=32517875|t=2020. Epidemia COVID-19: inverted question markdebe el oftalmologo estar alerta ante las paresias oculomotoras?|pdf=|usr=008}}
+
 
 
{{tp|p=32526068|t=2020. Perspectives of patients with rheumatic diseases in the early phase of COVID-19.|pdf=|usr=008}}
 
{{tp|p=32526068|t=2020. Perspectives of patients with rheumatic diseases in the early phase of COVID-19.|pdf=|usr=008}}
{{tp|p=32452874|t=2020. Thrombosis and coagulopathy in COVID-19 patients requiring extracorporeal membrane oxygenation.|pdf=|usr=008}}
+
 
 
{{tp|p=32304393|t=2020. Contributory Role of Positron Emission Tomography in a Left Ventricular Assist Device Recipient at the Time of COVID-19 Pandemic.|pdf=|usr=008}}
 
{{tp|p=32304393|t=2020. Contributory Role of Positron Emission Tomography in a Left Ventricular Assist Device Recipient at the Time of COVID-19 Pandemic.|pdf=|usr=008}}
{{tp|p=32513768|t=2020. COVID-19 presenting with diarrhoea and hyponatraemia.|pdf=|usr=008}}
+
 
{{tp|p=32516503|t=2020. ITP flare with mild COVID-19 infection in pregnancy: A case report.|pdf=|usr=008}}
+
 
 
{{tp|p=32526039|t=2020. Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience.|pdf=|usr=008}}
 
{{tp|p=32526039|t=2020. Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience.|pdf=|usr=008}}
{{tp|p=32535752|t=2020. Cardiovascular Implications and Therapeutic Considerations in COVID-19 Infection.|pdf=|usr=008}}
+
 
 
{{tp|p=32522306|t=2020. COVID-19 in adult patients with CHD: a matter of anatomy or comorbidities?|pdf=|usr=008}}
 
{{tp|p=32522306|t=2020. COVID-19 in adult patients with CHD: a matter of anatomy or comorbidities?|pdf=|usr=008}}
 
{{tp|p=32414805|t=2020. Prevalence of COVID-19 among patients with rheumatic diseases: the need to await results from large collaborative studies. Response to: 'COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs' by Conticini et al.|pdf=|usr=008}}
 
{{tp|p=32414805|t=2020. Prevalence of COVID-19 among patients with rheumatic diseases: the need to await results from large collaborative studies. Response to: 'COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs' by Conticini et al.|pdf=|usr=008}}
Zeile 1.213: Zeile 1.119:
 
{{tp|p=32523139|t=2020. Recomendaciones para la atencion de pacientes con insuficiencia cardiaca y COVID-19.|pdf=|usr=008}}
 
{{tp|p=32523139|t=2020. Recomendaciones para la atencion de pacientes con insuficiencia cardiaca y COVID-19.|pdf=|usr=008}}
 
{{tp|p=32531146|t=2020. Maternal transmission of SARS-COV-2 to the neonate, and possible routes for such transmission: A systematic review and critical analysis.|pdf=|usr=008}}
 
{{tp|p=32531146|t=2020. Maternal transmission of SARS-COV-2 to the neonate, and possible routes for such transmission: A systematic review and critical analysis.|pdf=|usr=008}}
{{tp|p=32526746|t=2020. Continuous Renal Replacement Therapy for a Patient with Severe COVID-19.|pdf=|usr=008}}
 
{{tp|p=32457068|t=2020. Covid-19 and acute kidney injury in hospital: summary of NICE guidelines.|pdf=|usr=008}}
 
 
{{tp|p=32220899|t=2020. Covid-19 and long term conditions: what if you have cancer, diabetes, or chronic kidney disease?|pdf=|usr=008}}
 
{{tp|p=32220899|t=2020. Covid-19 and long term conditions: what if you have cancer, diabetes, or chronic kidney disease?|pdf=|usr=008}}
 
{{tp|p=32532739|t=2020. Covid-19: People in most deprived areas of England and Wales twice as likely to die.|pdf=|usr=008}}
 
{{tp|p=32532739|t=2020. Covid-19: People in most deprived areas of England and Wales twice as likely to die.|pdf=|usr=008}}
Zeile 1.221: Zeile 1.125:
 
{{tp|p=32527732|t=2020. Ethnicity and covid-19.|pdf=|usr=008}}
 
{{tp|p=32527732|t=2020. Ethnicity and covid-19.|pdf=|usr=008}}
 
{{tp|p=32522740|t=2020. Obesity and covid-19: the role of the food industry.|pdf=|usr=008}}
 
{{tp|p=32522740|t=2020. Obesity and covid-19: the role of the food industry.|pdf=|usr=008}}
{{tp|p=32533844|t=2020. Sars-CoV-2 infection: the same virus can cause different cutaneous manifestations.|pdf=|usr=008}}
+
 
 
{{tp|p=32354809|t=2020. Managing patients with COVID-19 infections: a first-hand experience from the Wuhan Mobile Cabin Hospital.|pdf=|usr=008}}
 
{{tp|p=32354809|t=2020. Managing patients with COVID-19 infections: a first-hand experience from the Wuhan Mobile Cabin Hospital.|pdf=|usr=008}}
 
{{tp|p=32532764|t=2020. COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs.|pdf=|usr=008}}
 
{{tp|p=32532764|t=2020. COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs.|pdf=|usr=008}}
{{tp|p=32522523|t=2020. First documentation of persistent SARS-CoV-2 infection presenting with late acute severe myocarditis.|pdf=|usr=008}}
+
 
 
{{tp|p=32522556|t=2020. The impact of asthma on mortality in COVID-19 patients.|pdf=|usr=008}}
 
{{tp|p=32522556|t=2020. The impact of asthma on mortality in COVID-19 patients.|pdf=|usr=008}}
 
{{tp|p=32519912|t=2020. Effects of altered photoperiod due to COVID-19 lockdown on pregnant women and their fetuses.|pdf=|usr=008}}
 
{{tp|p=32519912|t=2020. Effects of altered photoperiod due to COVID-19 lockdown on pregnant women and their fetuses.|pdf=|usr=008}}
Zeile 1.244: Zeile 1.148:
 
{{tp|p=32409488|t=2020. Use of all cause mortality to quantify the consequences of covid-19 in Nembro, Lombardy: descriptive study.|pdf=|usr=008}}
 
{{tp|p=32409488|t=2020. Use of all cause mortality to quantify the consequences of covid-19 in Nembro, Lombardy: descriptive study.|pdf=|usr=008}}
 
{{tp|p=32513659|t=2020. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study.|pdf=|usr=008}}
 
{{tp|p=32513659|t=2020. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study.|pdf=|usr=008}}
{{tp|p=32457032|t=2020. Spontaneous pneumomediastinum in COVID-19.|pdf=|usr=008}}
+
 
{{tp|p=32423911|t=2020. Tension pneumothorax in a patient with COVID-19.|pdf=|usr=008}}
+
{{tp|p=32404376|t=2020. Hypogeusia as the initial presenting symptom of COVID-19.|pdf=|usr=008}}
+
 
{{tp|p=32385047|t=2020. Off the back burner: diverse and gender-inclusive decision-making for COVID-19 response and recovery.|pdf=|usr=008}}
 
{{tp|p=32385047|t=2020. Off the back burner: diverse and gender-inclusive decision-making for COVID-19 response and recovery.|pdf=|usr=008}}
 
{{tp|p=32532758|t=2020. Hypothesis to explain the severe form of COVID-19 in Northern Italy.|pdf=|usr=008}}
 
{{tp|p=32532758|t=2020. Hypothesis to explain the severe form of COVID-19 in Northern Italy.|pdf=|usr=008}}
 
{{tp|p=32513864|t=2020. Ethnic and racial disparities in COVID-19-related deaths: counting the trees, hiding the forest.|pdf=|usr=008}}
 
{{tp|p=32513864|t=2020. Ethnic and racial disparities in COVID-19-related deaths: counting the trees, hiding the forest.|pdf=|usr=008}}
{{tp|p=32457035|t=2020. Novelty in the gut: a systematic review and meta-analysis of the gastrointestinal manifestations of COVID-19.|pdf=|usr=008}}
 
{{tp|p=32522754|t=2020. Pneumatosis intestinalis in COVID-19.|pdf=|usr=008}}
 
 
{{tp|p=32455170|t=2020. Understanding COVID-19 in children may provide clues to protect at-risk populations.|pdf=|usr=008}}
 
{{tp|p=32455170|t=2020. Understanding COVID-19 in children may provide clues to protect at-risk populations.|pdf=|usr=008}}
 
{{tp|p=32499538|t=2020. Poor outcome in patients with acute leukemia on intensive chemotherapy and COVID-19.|pdf=|usr=008}}
 
{{tp|p=32499538|t=2020. Poor outcome in patients with acute leukemia on intensive chemotherapy and COVID-19.|pdf=|usr=008}}
 
{{tp|p=32528121|t=2020. Hematopoietic stem cell transplantation from an infected SARS-CoV2 donor sibling.|pdf=|usr=008}}
 
{{tp|p=32528121|t=2020. Hematopoietic stem cell transplantation from an infected SARS-CoV2 donor sibling.|pdf=|usr=008}}
 
{{tp|p=32483288|t=2020. Containment of a traceable COVID-19 outbreak among healthcare workers at a hematopoietic stem cell transplantation unit.|pdf=|usr=008}}
 
{{tp|p=32483288|t=2020. Containment of a traceable COVID-19 outbreak among healthcare workers at a hematopoietic stem cell transplantation unit.|pdf=|usr=008}}
{{tp|p=32530389|t=2020. SARS-CoV-2 infection of the nervous system: A review of the literature on neurological involvement in novel coronavirus disease (COVID-19).|pdf=|usr=008}}
+
 
 
{{tp|p=32534738|t=2020. Presenting symptoms of COVID-19 in children: a meta-analysis of published studies.|pdf=|usr=008}}
 
{{tp|p=32534738|t=2020. Presenting symptoms of COVID-19 in children: a meta-analysis of published studies.|pdf=|usr=008}}
 
{{tp|p=32534737|t=2020. COVID-19 and improved prevention of hospital-acquired infection.|pdf=|usr=008}}
 
{{tp|p=32534737|t=2020. COVID-19 and improved prevention of hospital-acquired infection.|pdf=|usr=008}}
Zeile 1.264: Zeile 1.164:
 
{{tp|p=32379921|t=2020. Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies.|pdf=|usr=008}}
 
{{tp|p=32379921|t=2020. Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies.|pdf=|usr=008}}
 
{{tp|p=32379902|t=2020. COVID-19 in a patient with pre-existing acute lymphoblastic leukaemia.|pdf=|usr=008}}
 
{{tp|p=32379902|t=2020. COVID-19 in a patient with pre-existing acute lymphoblastic leukaemia.|pdf=|usr=008}}
{{tp|p=32400024|t=2020. More on COVID-19 coagulopathy in Caucasian patients.|pdf=|usr=008}}
+
 
{{tp|p=32392353|t=2020. More on: 'COVID-19 coagulopathy in Caucasian patients'.|pdf=|usr=008}}
+
{{tp|p=32352162|t=2020. Author response to: Covid-19-related pancreatic injury.|pdf=|usr=008}}
+
{{tp|p=32352160|t=2020. Covid-19-related pancreatic injury.|pdf=|usr=008}}
+
{{tp|p=32479992|t=2020. Identifying causal role of COVID-19 in immunopsychiatry models.|pdf=|usr=008}}
+
 
{{tp|p=32473945|t=2020. COVID-19, hypercoagulation and what it could mean for patients with psychotic disorders.|pdf=|usr=008}}
 
{{tp|p=32473945|t=2020. COVID-19, hypercoagulation and what it could mean for patients with psychotic disorders.|pdf=|usr=008}}
 
{{tp|p=32470593|t=2020. Can COVID-19 related mental health issues be measured?|pdf=|usr=008}}
 
{{tp|p=32470593|t=2020. Can COVID-19 related mental health issues be measured?|pdf=|usr=008}}
Zeile 1.274: Zeile 1.170:
 
{{tp|p=32464156|t=2020. Depression and anxiety among adolescents during COVID-19: A cross-sectional study.|pdf=|usr=008}}
 
{{tp|p=32464156|t=2020. Depression and anxiety among adolescents during COVID-19: A cross-sectional study.|pdf=|usr=008}}
 
{{tp|p=32416290|t=2020. Immediate psychological distress in quarantined patients with COVID-19 and its association with peripheral inflammation: A mixed-method study.|pdf=|usr=008}}
 
{{tp|p=32416290|t=2020. Immediate psychological distress in quarantined patients with COVID-19 and its association with peripheral inflammation: A mixed-method study.|pdf=|usr=008}}
{{tp|p=32416289|t=2020. Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection.|pdf=|usr=008}}
+
 
{{tp|p=32425332|t=2020. Neuroleptic malignant syndrome in a COVID-19 patient.|pdf=|usr=008}}
+
 
{{tp|p=32531427|t=2020. Delirium as a presenting feature in COVID-19: neuroinvasive infection or autoimmune encephalopathy?|pdf=|usr=008}}
+
{{tp|p=32525049|t=2020. Intracerebral haemorrhage and COVID-19: Clinical characteristics from a case series.|pdf=|usr=008}}
+
{{tp|p=32497778|t=2020. A pharmacological interactome between COVID-19 patient samples and human sensory neurons reveals potential drivers of neurogenic pulmonary dysfunction.|pdf=|usr=008}}
+
{{tp|p=32497777|t=2020. The neuroinvasive potential of severe acute respiratory syndrome coronavirus 2.|pdf=|usr=008}}
+
{{tp|p=32464157|t=2020. Cutaneous hyperesthesia: A novel manifestation of COVID-19.|pdf=|usr=008}}
+
 
{{tp|p=32454138|t=2020. Lifestyle risk factors, inflammatory mechanisms, and COVID-19 hospitalization: A community-based cohort study of 387,109 adults in UK.|pdf=|usr=008}}
 
{{tp|p=32454138|t=2020. Lifestyle risk factors, inflammatory mechanisms, and COVID-19 hospitalization: A community-based cohort study of 387,109 adults in UK.|pdf=|usr=008}}
{{tp|p=32454137|t=2020. Anti-NMDA receptor encephalitis in a psychiatric Covid-19 patient: A case report.|pdf=|usr=008}}
 
{{tp|p=32445789|t=2020. Is COVID-19-related Guillain-Barre syndrome different?|pdf=|usr=008}}
 
{{tp|p=32382727|t=2020. THE IMPACT OF COVID-19 ON MENTAL HEALTH: THE INTERACTIVE ROLES OF BRAIN BIOTYPES AND HUMAN CONNECTION.|pdf=|usr=008}}
 
{{tp|p=32427134|t=2020. HOW TO DETECT AND TRACK CHRONIC NEUROLOGIC SEQUELAE OF COVID-19? USE OF AUDITORY BRAINSTEM RESPONSES AND NEUROIMAGING FOR LONG-TERM PATIENT FOLLOW-UP.|pdf=|usr=008}}
 
 
{{tp|p=32479748|t=2020. Analysis of clinical and demographic heterogeneity of patients dying from COVID-19 in Brazil versus China and Italy.|pdf=|usr=008}}
 
{{tp|p=32479748|t=2020. Analysis of clinical and demographic heterogeneity of patients dying from COVID-19 in Brazil versus China and Italy.|pdf=|usr=008}}
{{tp|p=32534982|t=2020. Incomplete and late recovery of sudden olfactory dysfunction in COVID-19.|pdf=|usr=008}}
+
 
 
{{tp|p=32405915|t=2020. Characteristics and outcomes of patients with breast cancer diagnosed with SARS-Cov-2 infection at an academic center in New York City.|pdf=|usr=008}}
 
{{tp|p=32405915|t=2020. Characteristics and outcomes of patients with breast cancer diagnosed with SARS-Cov-2 infection at an academic center in New York City.|pdf=|usr=008}}
 
{{tp|p=32271625|t=2020. Should Infants Be Separated from Mothers with COVID-19? First, Do No Harm.|pdf=|usr=008}}
 
{{tp|p=32271625|t=2020. Should Infants Be Separated from Mothers with COVID-19? First, Do No Harm.|pdf=|usr=008}}
Zeile 1.294: Zeile 1.181:
 
{{tp|p=32404451|t=2020. Coronavirus disease 2019 in children: Surprising findings in the midst of a global pandemic.|pdf=|usr=008}}
 
{{tp|p=32404451|t=2020. Coronavirus disease 2019 in children: Surprising findings in the midst of a global pandemic.|pdf=|usr=008}}
 
{{tp|p=32532719|t=2020. Symptom management and end-of-life care of residents with COVID-19 in long-term care homes.|pdf=|usr=008}}
 
{{tp|p=32532719|t=2020. Symptom management and end-of-life care of residents with COVID-19 in long-term care homes.|pdf=|usr=008}}
{{tp|p=32474111|t=2020. Echocardiographic Findings in Covid-19 Pneumonia.|pdf=|usr=008}}
+
 
 
{{tp|p=32502522|t=2020. Use of Renin-Angiotensin System Blockers During the COVID-19 Pandemic: Early Guidance and Evolving Evidence.|pdf=|usr=008}}
 
{{tp|p=32502522|t=2020. Use of Renin-Angiotensin System Blockers During the COVID-19 Pandemic: Early Guidance and Evolving Evidence.|pdf=|usr=008}}
 
{{tp|p=32494330|t=2020. Coronavirus Disease 2019 With Acute Respiratory Distress Syndrome Mimicking Heart Failure Exacerbation: Time to Rethink.|pdf=|usr=008}}
 
{{tp|p=32494330|t=2020. Coronavirus Disease 2019 With Acute Respiratory Distress Syndrome Mimicking Heart Failure Exacerbation: Time to Rethink.|pdf=|usr=008}}
 
{{tp|p=32535705|t=2020. Is Hypertension a Real Risk Factor for Poor Prognosis in the COVID-19 Pandemic?|pdf=|usr=008}}
 
{{tp|p=32535705|t=2020. Is Hypertension a Real Risk Factor for Poor Prognosis in the COVID-19 Pandemic?|pdf=|usr=008}}
{{tp|p=32472593|t=2020. Cutaneous manifestations in COVID-19: a skin rash in a child.|pdf=|usr=008}}
+
 
 
{{tp|p=32515033|t=2020. Severity and risk of COVID-19 in cancer patients: An evidence based learning.|pdf=|usr=008}}
 
{{tp|p=32515033|t=2020. Severity and risk of COVID-19 in cancer patients: An evidence based learning.|pdf=|usr=008}}
{{tp|p=32530130|t=2020. An unilateral purpuric rash in a patient with COVID-19 infection.|pdf=|usr=008}}
+
 
 
{{tp|p=32526093|t=2020. Dermatological therapies with relevance to COVID-19.|pdf=|usr=008}}
 
{{tp|p=32526093|t=2020. Dermatological therapies with relevance to COVID-19.|pdf=|usr=008}}
{{tp|p=32526073|t=2020. Novel corona virus (COVID-19) disease and ophthalmic manifestations: Clinical evidences.|pdf=|usr=008}}
+
 
{{tp|p=32520428|t=2020. Mucosal involvement in a COVID-19-positive patient: a case report.|pdf=|usr=008}}
+
 
 
{{tp|p=32517822|t=2020. Factors associated with the duration of hospitalisation among COVID-19 patients in Vietnam: A survival analysis.|pdf=|usr=008}}
 
{{tp|p=32517822|t=2020. Factors associated with the duration of hospitalisation among COVID-19 patients in Vietnam: A survival analysis.|pdf=|usr=008}}
 
{{tp|p=32526060|t=2020. What did we learn from the previous coronavirus epidemics and what can we do better: a neuroinfectiological point of view.|pdf=|usr=008}}
 
{{tp|p=32526060|t=2020. What did we learn from the previous coronavirus epidemics and what can we do better: a neuroinfectiological point of view.|pdf=|usr=008}}
 
{{tp|p=32516861|t=2020. Clinical characteristics and prognostic factors in COVID-19 patients aged >/=80 years.|pdf=|usr=008}}
 
{{tp|p=32516861|t=2020. Clinical characteristics and prognostic factors in COVID-19 patients aged >/=80 years.|pdf=|usr=008}}
{{tp|p=32516478|t=2020. Severe bleeding in a patient with Factor XIII deficiency and COVID-19.|pdf=|usr=008}}
+
 
{{tp|p=32524707|t=2020. Smell and taste disorders during COVID-19 outbreak: A cross-sectional study on 355 patients.|pdf=|usr=008}}
+
{{tp|p=32521062|t=2020. Headache as the Presenting Symptom in 2 Patients with COVID-19 and a History of Migraine: 2 Case Reports.|pdf=|usr=008}}
+
{{tp|p=32521039|t=2020. COVID-19 and Headache: A Primer for Trainees.|pdf=|usr=008}}
+
 
{{tp|p=32535689|t=2020. Challenges in Neonatal COVID-19 Infection.|pdf=|usr=008}}
 
{{tp|p=32535689|t=2020. Challenges in Neonatal COVID-19 Infection.|pdf=|usr=008}}
 
{{tp|p=32535876|t=2020. Successful management of the first reported case in Austria of COVID-19 with ARDS.|pdf=|usr=008}}
 
{{tp|p=32535876|t=2020. Successful management of the first reported case in Austria of COVID-19 with ARDS.|pdf=|usr=008}}
 
{{tp|p=32525566|t=2020. Low prevalence of IgG antibodies to SARS-CoV-2 in cancer patients with COVID-19.|pdf=|usr=008}}
 
{{tp|p=32525566|t=2020. Low prevalence of IgG antibodies to SARS-CoV-2 in cancer patients with COVID-19.|pdf=|usr=008}}
 
{{tp|p=32522559|t=2020. Covid-19 and inflammatory bowel disease: questions on incidence, severity, and impact of treatment?|pdf=|usr=008}}
 
{{tp|p=32522559|t=2020. Covid-19 and inflammatory bowel disease: questions on incidence, severity, and impact of treatment?|pdf=|usr=008}}
{{tp|p=32518103|t=2020. Guillain-Barre syndrome associated with leptomeningeal enhancement following SARS-CoV-2 infection.|pdf=|usr=008}}
+
 
 
{{tp|p=32536009|t=2020. Comment on "Psoriasis, COVID-19 and acute respiratory distress syndrome: focusing on the risk of concomitant biological treatment".|pdf=|usr=008}}
 
{{tp|p=32536009|t=2020. Comment on "Psoriasis, COVID-19 and acute respiratory distress syndrome: focusing on the risk of concomitant biological treatment".|pdf=|usr=008}}
{{tp|p=32526051|t=2020. Acute maculopapular eruption in Covid-19 patient: a case report.|pdf=|usr=008}}
+
 
 
{{tp|p=32503837|t=2020. Type 1 Diabetes and COVID-19: Preliminary Findings From a Multicenter Surveillance Study in the U.S.|pdf=|usr=008}}
 
{{tp|p=32503837|t=2020. Type 1 Diabetes and COVID-19: Preliminary Findings From a Multicenter Surveillance Study in the U.S.|pdf=|usr=008}}
 
{{tp|p=32533988|t=2020. COVID19 in South Asians/Asian Indians: Heterogeneity of data and implications for pathophysiology and research.|pdf=|usr=008}}
 
{{tp|p=32533988|t=2020. COVID19 in South Asians/Asian Indians: Heterogeneity of data and implications for pathophysiology and research.|pdf=|usr=008}}
Zeile 1.323: Zeile 1.207:
 
{{tp|p=32378797|t=2020. Epidemiology and clinical features of emergency department patients with suspected COVID-19: Initial results from the COVID-19 Emergency Department Quality Improvement Project (COVED-1).|pdf=|usr=008}}
 
{{tp|p=32378797|t=2020. Epidemiology and clinical features of emergency department patients with suspected COVID-19: Initial results from the COVID-19 Emergency Department Quality Improvement Project (COVED-1).|pdf=|usr=008}}
 
{{tp|p=32533613|t=2020. Epidemiology and clinical features of emergency department patients with suspected COVID-19: Results from the first month of the COVED Quality Improvement Project (COVED-2).|pdf=|usr=008}}
 
{{tp|p=32533613|t=2020. Epidemiology and clinical features of emergency department patients with suspected COVID-19: Results from the first month of the COVED Quality Improvement Project (COVED-2).|pdf=|usr=008}}
{{tp|p=32531024|t=2020. Fulminant COVID-19-related myocarditis in an infant.|pdf=|usr=008}}
+
 
 
{{tp|p=32531040|t=2020. Association between renin-angiotensin system inhibitors and COVID-19 complications.|pdf=|usr=008}}
 
{{tp|p=32531040|t=2020. Association between renin-angiotensin system inhibitors and COVID-19 complications.|pdf=|usr=008}}
{{tp|p=32535894|t=2020. Bloodstream infections in critically ill patients with COVID-19.|pdf=|usr=008}}
+
 
 
{{tp|p=32535885|t=2020. High mortality in COVID-19 patients with mild respiratory disease.|pdf=|usr=008}}
 
{{tp|p=32535885|t=2020. High mortality in COVID-19 patients with mild respiratory disease.|pdf=|usr=008}}
 
{{tp|p=32531806|t=2020. Obesity, adipokines and COVID-19.|pdf=|usr=008}}
 
{{tp|p=32531806|t=2020. Obesity, adipokines and COVID-19.|pdf=|usr=008}}
 
{{tp|p=32522810|t=2020. Fighting on two fronts: drug-drug interactions in people living with HIV infected with SARS-CoV-2.|pdf=|usr=008}}
 
{{tp|p=32522810|t=2020. Fighting on two fronts: drug-drug interactions in people living with HIV infected with SARS-CoV-2.|pdf=|usr=008}}
{{tp|p=32533876|t=2020. Guillain-Barre syndrome after SARS-CoV-2 infection.|pdf=|usr=008}}
+
 
{{tp|p=32531083|t=2020. Guillain-Barre syndrome in a patient with antibodies against SARS-COV-2.|pdf=|usr=008}}
+
{{tp|p=32301349|t=2020. Cost-effectiveness of rivaroxaban plus aspirin (dual pathway inhibition) for prevention of ischaemic events in patients with cardiovascular disease: on top optimisation of secondary prevention medication in the context of COVID-19 pandemia.|pdf=|usr=008}}
+
 
{{tp|p=32525813|t=2020. Renin-angiotensin system and SARS-CoV-2 interaction: underlying mechanisms and potential clinical implications.|pdf=|usr=008}}
 
{{tp|p=32525813|t=2020. Renin-angiotensin system and SARS-CoV-2 interaction: underlying mechanisms and potential clinical implications.|pdf=|usr=008}}
 
{{tp|p=32535573|t=2020. COVID-19 IN DIABETES PATIENTS IN UKRAINE: LESSONS FOR DOCTORS AND PATIENTS.|pdf=|usr=008}}
 
{{tp|p=32535573|t=2020. COVID-19 IN DIABETES PATIENTS IN UKRAINE: LESSONS FOR DOCTORS AND PATIENTS.|pdf=|usr=008}}
Zeile 1.338: Zeile 1.220:
 
{{tp|p=32530392|t=2020. The prevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG antibodies in intensive care unit (ICU) healthcare personnel (HCP) and its implications-a single-center, prospective, pilot study.|pdf=|usr=008}}
 
{{tp|p=32530392|t=2020. The prevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG antibodies in intensive care unit (ICU) healthcare personnel (HCP) and its implications-a single-center, prospective, pilot study.|pdf=|usr=008}}
 
{{tp|p=32517835|t=2020. Delayed Recognition of Community Transmission of COVID-19 Resulting in Healthcare Worker Infections.|pdf=|usr=008}}
 
{{tp|p=32517835|t=2020. Delayed Recognition of Community Transmission of COVID-19 Resulting in Healthcare Worker Infections.|pdf=|usr=008}}
{{tp|p=32516107|t=2020. Pleural Effusion as a Sign of Coronavirus Disease 2019 (COVID-19) Pneumonia: A Case Report.|pdf=|usr=008}}
+
 
{{tp|p=32530326|t=2020. Does coronavirus affect the audio-vestibular system? A rapid systematic review.|pdf=|usr=008}}
+
 
  
 
{{tp|p=32393351|t=2020. Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19.|pdf=|usr=008}}
 
{{tp|p=32393351|t=2020. Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19.|pdf=|usr=008}}
 
{{tp|p=32527257|t=2020. Impact of diabetes mellitus on clinical outcomes in patients affected by Covid-19.|pdf=|usr=008}}
 
{{tp|p=32527257|t=2020. Impact of diabetes mellitus on clinical outcomes in patients affected by Covid-19.|pdf=|usr=008}}
{{tp|p=32420106|t=2020. An 'asymptomatic' driver with COVID-19: atypical suspected myocarditis by SARS-CoV-2.|pdf=|usr=008}}
+
 
{{tp|p=32468143|t=2020. Heparin-Related Major Bleeding in Covid-19-Positive Patient: Perspective from the Outbreak.|pdf=|usr=008}}
+
 
{{tp|p=32419077|t=2020. Spontaneous Bleedings in COVID-19 Patients: An Emerging Complication.|pdf=|usr=008}}
+
 
{{tp|p=32423791|t=2020. COVID-19 (SARS-Cov-2) and the heart - An ominous association.|pdf=|usr=008}}
+
{{tp|p=32426575|t=2020. Clot in Transit on Transesophageal Echocardiography in a Prone Patient with COVID-19 Acute Respiratory Distress Syndrome.|pdf=|usr=008}}
+
 
{{tp|p=32426242|t=2020. Novel coronavirus-related acute respiratory distress syndrome in a patient with twin pregnancy: A case report.|pdf=|usr=008}}
 
{{tp|p=32426242|t=2020. Novel coronavirus-related acute respiratory distress syndrome in a patient with twin pregnancy: A case report.|pdf=|usr=008}}
 
{{tp|p=32523874|t=2020. Multidisciplinary team management and cesarean delivery for a Jordanian woman infected with SARS-COV-2: A case report.|pdf=|usr=008}}
 
{{tp|p=32523874|t=2020. Multidisciplinary team management and cesarean delivery for a Jordanian woman infected with SARS-COV-2: A case report.|pdf=|usr=008}}
Zeile 1.364: Zeile 1.244:
 
{{tp|p=32393409|t=2020. Does intranasal naloxone administration increase the risk of 2019 coronavirus disease transmission?|pdf=|usr=008}}
 
{{tp|p=32393409|t=2020. Does intranasal naloxone administration increase the risk of 2019 coronavirus disease transmission?|pdf=|usr=008}}
 
{{tp|p=32473151|t=2020. Laboratory abnormalities in children with mild and severe coronavirus disease 2019 (COVID-19): A pooled analysis and review.|pdf=|usr=008}}
 
{{tp|p=32473151|t=2020. Laboratory abnormalities in children with mild and severe coronavirus disease 2019 (COVID-19): A pooled analysis and review.|pdf=|usr=008}}
{{tp|p=32533585|t=2020. COVID-19 and the heart: An update for clinicians.|pdf=|usr=008}}
+
 
{{tp|p=32417209|t=2020. Thrombocytopenia and coagulation disorders due to COVID 19 infection with concomitant cardiovascular diseases requiring anti-platelet and anticoagulant therapy, which strategy?|pdf=|usr=008}}
+
 
 
{{tp|p=32405079|t=2020. Dynamic changes in routine blood parameters of a severe COVID-19 case.|pdf=|usr=008}}
 
{{tp|p=32405079|t=2020. Dynamic changes in routine blood parameters of a severe COVID-19 case.|pdf=|usr=008}}
{{tp|p=32385858|t=2020. Erythema multiforme-like eruption in patients with COVID-19 infection: clinical and histological findings.|pdf=|usr=008}}
 
{{tp|p=32384180|t=2020. Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital.|pdf=|usr=008}}
 
{{tp|p=32407564|t=2020. Cutaneous manifestations in COVID-19: familial cluster of urticarial rash.|pdf=|usr=008}}
 
{{tp|p=32356578|t=2020. Comment on 'Two cases of COVID-19 presenting with a clinical picture resembling chilblains: first report from the Middle East': pernio unrelated to COVID-19.|pdf=|usr=008}}
 
 
{{tp|p=32404011|t=2020. Clinical characteristics of coronavirus disease 2019 (COVID-19) patients with hypertension on renin-angiotensin system inhibitors.|pdf=|usr=008}}
 
{{tp|p=32404011|t=2020. Clinical characteristics of coronavirus disease 2019 (COVID-19) patients with hypertension on renin-angiotensin system inhibitors.|pdf=|usr=008}}
 
{{tp|p=32462378|t=2020. Clinical features of hemodialysis patients with COVID-19: a single-center retrospective study on 32 patients.|pdf=|usr=008}}
 
{{tp|p=32462378|t=2020. Clinical features of hemodialysis patients with COVID-19: a single-center retrospective study on 32 patients.|pdf=|usr=008}}
{{tp|p=32406140|t=2020. The ocular surface, coronaviruses and COVID-19.|pdf=|usr=008}}
 
{{tp|p=32396988|t=2020. COVID-19, sweat, tears... and myopia?|pdf=|usr=008}}
 
 
{{tp|p=32434304|t=2020. Does the Clinical Spectrum of Coronavirus Disease 2019 (COVID-19) Show Regional Differences?|pdf=|usr=008}}
 
{{tp|p=32434304|t=2020. Does the Clinical Spectrum of Coronavirus Disease 2019 (COVID-19) Show Regional Differences?|pdf=|usr=008}}
{{tp|p=32485300|t=2020. Pneumatosis Intestinalis in COVID-19.|pdf=|usr=008}}
 
{{tp|p=32480008|t=2020. ENDOSCOPIC FINDINGS IN PATIENTS INFECTED WITH 2019 NOVEL CORONAVIRUS IN LOMBARDY, ITALY.|pdf=|usr=008}}
 
{{tp|p=32425707|t=2020. COVID-19 related liver injury: call for international consensus.|pdf=|usr=008}}
 
 
{{tp|p=32425706|t=2020. We Know Liver Biochemistries Are Elevated in COVID-19, But Should We Be Concerned?|pdf=|usr=008}}
 
{{tp|p=32425706|t=2020. We Know Liver Biochemistries Are Elevated in COVID-19, But Should We Be Concerned?|pdf=|usr=008}}
{{tp|p=32425705|t=2020. Pooled Prevalence of Diarrhea among COVID-19 Patients.|pdf=|usr=008}}
+
 
 
{{tp|p=32407784|t=2020. Cardiac and Muscle Injury Might Partially Contribute to Elevated Aminotransferases in COVID-19 Patients.|pdf=|usr=008}}
 
{{tp|p=32407784|t=2020. Cardiac and Muscle Injury Might Partially Contribute to Elevated Aminotransferases in COVID-19 Patients.|pdf=|usr=008}}
 
{{tp|p=32407783|t=2020. Clinical Characteristics of COVID-19 in Patients With Liver Injury.|pdf=|usr=008}}
 
{{tp|p=32407783|t=2020. Clinical Characteristics of COVID-19 in Patients With Liver Injury.|pdf=|usr=008}}
{{tp|p=32437870|t=2020. Covid-19 digestive system involvement and clinical outcomes in a large academic hospital in Milan, Italy.|pdf=|usr=008}}
 
{{tp|p=32535231|t=2020. Putative Mechanisms of diarrhea in COVID-19.|pdf=|usr=008}}
 
{{tp|p=32534042|t=2020. Detection of SARS-CoV-2 in Fecal Samples from Patients with Asymptomatic and Mild COVID-19 in Korea.|pdf=|usr=008}}
 
{{tp|p=32497637|t=2020. Analysis of Gastrointestinal and Hepatic Manifestations of SARS-CoV-2 Infection in 892 patients in Queens, NY.|pdf=|usr=008}}
 
 
{{tp|p=32425338|t=2020. Extrapulmonary manifestations of COVID-19: Radiologic and clinical overview.|pdf=|usr=008}}
 
{{tp|p=32425338|t=2020. Extrapulmonary manifestations of COVID-19: Radiologic and clinical overview.|pdf=|usr=008}}
{{tp|p=32445671|t=2020. Can Ticagrelor be used to prevent sepsis-induced coagulopathy in COVID-19?|pdf=|usr=008}}
+
 
 
{{tp|p=32535188|t=2020. Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy.|pdf=|usr=008}}
 
{{tp|p=32535188|t=2020. Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy.|pdf=|usr=008}}
 
{{tp|p=32382755|t=2020. Association of higher body mass index (BMI) with severe coronavirus disease 2019 (COVID-19) in younger patients.|pdf=|usr=008}}
 
{{tp|p=32382755|t=2020. Association of higher body mass index (BMI) with severe coronavirus disease 2019 (COVID-19) in younger patients.|pdf=|usr=008}}
 
{{tp|p=32382748|t=2020. Lessons from COVID-19 in children: Key hypotheses to guide preventative and therapeutic strategies.|pdf=|usr=008}}
 
{{tp|p=32382748|t=2020. Lessons from COVID-19 in children: Key hypotheses to guide preventative and therapeutic strategies.|pdf=|usr=008}}
 
{{tp|p=32409825|t=2020. Analysis of the infection status of the health care workers in Wuhan during the COVID-19 outbreak: A cross-sectional study.|pdf=|usr=008}}
 
{{tp|p=32409825|t=2020. Analysis of the infection status of the health care workers in Wuhan during the COVID-19 outbreak: A cross-sectional study.|pdf=|usr=008}}
{{tp|p=32407467|t=2020. Clinical features and outcomes of HIV patients with coronavirus disease 2019.|pdf=|usr=008}}
+
 
 
{{tp|p=32407459|t=2020. Risk Factors of Severe Disease and Efficacy of Treatment in Patients Infected with COVID-19: A Systematic Review, Meta-Analysis and Meta-Regression Analysis.|pdf=|usr=008}}
 
{{tp|p=32407459|t=2020. Risk Factors of Severe Disease and Efficacy of Treatment in Patients Infected with COVID-19: A Systematic Review, Meta-Analysis and Meta-Regression Analysis.|pdf=|usr=008}}
 
{{tp|p=32392337|t=2020. SARS-CoV-2 (COVID-19): What do we know about children? A systematic review.|pdf=|usr=008}}
 
{{tp|p=32392337|t=2020. SARS-CoV-2 (COVID-19): What do we know about children? A systematic review.|pdf=|usr=008}}
 
{{tp|p=32392330|t=2020. The Effects of Pregnancy on Women with COVID-19: Maternal and Infant Outcomes.|pdf=|usr=008}}
 
{{tp|p=32392330|t=2020. The Effects of Pregnancy on Women with COVID-19: Maternal and Infant Outcomes.|pdf=|usr=008}}
 
{{tp|p=32527714|t=2020. Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab.|pdf=|usr=008}}
 
{{tp|p=32527714|t=2020. Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab.|pdf=|usr=008}}
{{tp|p=32447049|t=2020. Anosmia in COVID-19 patients.|pdf=|usr=008}}
+
 
 
{{tp|p=32526275|t=2020. Risk factors for disease progression in mild to moderate COVID-19 patients- a multi-center observational study.|pdf=|usr=008}}
 
{{tp|p=32526275|t=2020. Risk factors for disease progression in mild to moderate COVID-19 patients- a multi-center observational study.|pdf=|usr=008}}
{{tp|p=32502645|t=2020. New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection.|pdf=|usr=008}}
+
 
 
{{tp|p=32502644|t=2020. Excretion of SARS-CoV-2 in human breast milk.|pdf=|usr=008}}
 
{{tp|p=32502644|t=2020. Excretion of SARS-CoV-2 in human breast milk.|pdf=|usr=008}}
 
{{tp|p=32535147|t=2020. Ibuprofen use and clinical outcomes in COVID-19 patients.|pdf=|usr=008}}
 
{{tp|p=32535147|t=2020. Ibuprofen use and clinical outcomes in COVID-19 patients.|pdf=|usr=008}}
 
{{tp|p=32535148|t=2020. Low risk for SARS-CoV2 symptomatic infection and early complications in pediatric patients during the ongoing CoVID19 epidemics in Lombardy.|pdf=|usr=008}}
 
{{tp|p=32535148|t=2020. Low risk for SARS-CoV2 symptomatic infection and early complications in pediatric patients during the ongoing CoVID19 epidemics in Lombardy.|pdf=|usr=008}}
{{tp|p=32422545|t=2020. Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review.|pdf=|usr=008}}
 
{{tp|p=32405258|t=2020. Non-lesional status epilepticus in a patient with coronavirus disease 2019.|pdf=|usr=008}}
 
{{tp|p=32422529|t=2020. Post SARS-CoV-2 Guillain-Barre syndrome.|pdf=|usr=008}}
 
 
{{tp|p=32324898|t=2020. Incidence of Adverse Drug Reactions in COVID-19 Patients in China: An Active Monitoring Study by Hospital Pharmacovigilance System.|pdf=|usr=008}}
 
{{tp|p=32324898|t=2020. Incidence of Adverse Drug Reactions in COVID-19 Patients in China: An Active Monitoring Study by Hospital Pharmacovigilance System.|pdf=|usr=008}}
{{tp|p=32430631|t=2020. Acute myocardial infarction due to coronary stent thrombosis in a symptomatic COVID-19 patient.|pdf=|usr=008}}
+
 
{{tp|p=32482542|t=2020. Atypical presentations of coronavirus disease 2019 in a patient with acute obstructive suppurative cholangitis.|pdf=|usr=008}}
+
 
 
{{tp|p=32471656|t=2020. Is SARS-CoV-2 associated with liver dysfunction in COVID-19 patients?|pdf=|usr=008}}
 
{{tp|p=32471656|t=2020. Is SARS-CoV-2 associated with liver dysfunction in COVID-19 patients?|pdf=|usr=008}}
 
{{tp|p=32418852|t=2020. The liver injury and gastrointestinal symptoms in patients with Coronavirus Disease 19: A systematic review and meta-analysis.|pdf=|usr=008}}
 
{{tp|p=32418852|t=2020. The liver injury and gastrointestinal symptoms in patients with Coronavirus Disease 19: A systematic review and meta-analysis.|pdf=|usr=008}}
 
{{tp|p=32474884|t=2020. Are patients with rheumatologic diseases on chronic immunosuppressive therapy at lower risk of developing severe symptoms when infected with COVID-19?|pdf=|usr=008}}
 
{{tp|p=32474884|t=2020. Are patients with rheumatologic diseases on chronic immunosuppressive therapy at lower risk of developing severe symptoms when infected with COVID-19?|pdf=|usr=008}}
{{tp|p=32530063|t=2020. Herpes zoster in COVID-19-positive patients.|pdf=|usr=008}}
+
 
 
{{tp|p=32515168|t=2020. Clonal haematopoiesis and COVID-19: A possible deadly liaison.|pdf=|usr=008}}
 
{{tp|p=32515168|t=2020. Clonal haematopoiesis and COVID-19: A possible deadly liaison.|pdf=|usr=008}}
{{tp|p=32531120|t=2020. Histological findings in chilblain-lupus like COVID lesions: in search of an answer to understand their etiology.|pdf=|usr=008}}
+
 
{{tp|p=32526040|t=2020. The broad spectrum of dermatological manifestations in COVID-19. Clinical and histopathological features learned from a series of 34 cases.|pdf=|usr=008}}
+
 
{{tp|p=32525251|t=2020. Urticaria (angioedema) and COVID- 19 infection.|pdf=|usr=008}}
+
{{tp|p=32525578|t=2020. When do you say it's SARS-CoV-2-associated diarrhea?|pdf=|usr=008}}
+
{{tp|p=32529774|t=2020. High Frequency of Antiphospholipid Antibodies in Critically-ill COVID-19 Patients: a Link with Hypercoagulability?|pdf=|usr=008}}
+
 
{{tp|p=32516844|t=2020. Comment on Han et al: Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China.|pdf=|usr=008}}
 
{{tp|p=32516844|t=2020. Comment on Han et al: Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China.|pdf=|usr=008}}
 
{{tp|p=32515500|t=2020. Clinical and epidemiological characteristics of 320 deceased Covid-19 patients in an Italian Province: a retrospective observational study.|pdf=|usr=008}}
 
{{tp|p=32515500|t=2020. Clinical and epidemiological characteristics of 320 deceased Covid-19 patients in an Italian Province: a retrospective observational study.|pdf=|usr=008}}
 
{{tp|p=32530534|t=2020. Dyspnea: the vanished warning symptom of COVID-19 pneumonia.|pdf=|usr=008}}
 
{{tp|p=32530534|t=2020. Dyspnea: the vanished warning symptom of COVID-19 pneumonia.|pdf=|usr=008}}
{{tp|p=32530522|t=2020. SARS-CoV-2 was found in the bile juice from a patient with severe COVID-19.|pdf=|usr=008}}
+
 
 
{{tp|p=32530509|t=2020. Association of cardiac biomarkers and comorbidities with increased mortality, severity, and cardiac injury in COVID-19 patients: A meta-regression and Decision tree analysis.|pdf=|usr=008}}
 
{{tp|p=32530509|t=2020. Association of cardiac biomarkers and comorbidities with increased mortality, severity, and cardiac injury in COVID-19 patients: A meta-regression and Decision tree analysis.|pdf=|usr=008}}
 
{{tp|p=32530499|t=2020. The epidemiology and clinical characteristics of co-infection of SARS-CoV-2 and influenza viruses in patients during COVID-19 outbreak.|pdf=|usr=008}}
 
{{tp|p=32530499|t=2020. The epidemiology and clinical characteristics of co-infection of SARS-CoV-2 and influenza viruses in patients during COVID-19 outbreak.|pdf=|usr=008}}
Zeile 1.429: Zeile 1.290:
 
{{tp|p=32525575|t=2020. The possible impairment of respiratory-related neural loops may be associated with the silent pneumonia induced by SARS-CoV-2.|pdf=|usr=008}}
 
{{tp|p=32525575|t=2020. The possible impairment of respiratory-related neural loops may be associated with the silent pneumonia induced by SARS-CoV-2.|pdf=|usr=008}}
 
{{tp|p=32525558|t=2020. New IgM seroconversion and positive RT-PCR test after exposure to the virus in recovered COVID-19 patient.|pdf=|usr=008}}
 
{{tp|p=32525558|t=2020. New IgM seroconversion and positive RT-PCR test after exposure to the virus in recovered COVID-19 patient.|pdf=|usr=008}}
{{tp|p=32519763|t=2020. The characteristics of two patients coinfected with SARS-CoV-2 and HIV in Wuhan, China.|pdf=|usr=008}}
+
 
 
{{tp|p=32519760|t=2020. Diagnosis of COVID-19 pneumonia despite missing detection of viral nucleic acid and initially inconspicuous radiologic findings.|pdf=|usr=008}}
 
{{tp|p=32519760|t=2020. Diagnosis of COVID-19 pneumonia despite missing detection of viral nucleic acid and initially inconspicuous radiologic findings.|pdf=|usr=008}}
{{tp|p=32525467|t=2020. EXPRESS: COVID-19 and Acute Ischemic Stroke- A Case Series from Dubai, UAE.|pdf=|usr=008}}
+
 
 
{{tp|p=32310017|t=2020. COVID-19 and stroke-A global World Stroke Organization perspective.|pdf=|usr=008}}
 
{{tp|p=32310017|t=2020. COVID-19 and stroke-A global World Stroke Organization perspective.|pdf=|usr=008}}
 
{{tp|p=32522462|t=2020. Association of asthma and its genetic predisposition with the risk of severe COVID-19.|pdf=|usr=008}}
 
{{tp|p=32522462|t=2020. Association of asthma and its genetic predisposition with the risk of severe COVID-19.|pdf=|usr=008}}
Zeile 1.437: Zeile 1.298:
 
{{tp|p=32519921|t=2020. COVID-19 in a severe eosinophilic asthmatic receiving benralizumab - a case study.|pdf=|usr=008}}
 
{{tp|p=32519921|t=2020. COVID-19 in a severe eosinophilic asthmatic receiving benralizumab - a case study.|pdf=|usr=008}}
 
{{tp|p=32527675|t=2020. SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients.|pdf=|usr=008}}
 
{{tp|p=32527675|t=2020. SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients.|pdf=|usr=008}}
{{tp|p=32531174|t=2020. New Insights for the Pathogenesis of COVID-19-Related Dysgeusia.|pdf=|usr=008}}
+
 
{{tp|p=32535979|t=2020. The red half moon nail sign: a novel manifestation of Coronavirus infection.|pdf=|usr=008}}
+
 
{{tp|p=32535943|t=2020. SARS-CoV-2, skin lesions and the need of a multidisciplinary approach.|pdf=|usr=008}}
+
{{tp|p=32534473|t=2020. "COVID-19-related acute genital ulcers".|pdf=|usr=008}}
+
{{tp|p=32534469|t=2020. Cutaneous manifestations of hospitalized COVID-19 patients: A report of six cases with clinicopathologic features and viral RNA in situ hybridization.|pdf=|usr=008}}
+
{{tp|p=32533899|t=2020. Major cluster of pediatric " true " primary chilblains during the COVID-19 pandemic: a consequence of lifestyle changes due to lockdown.|pdf=|usr=008}}
+
{{tp|p=32531860|t=2020. Papular-Purpuric Exanthem in a COVID-19 Patient: Clinical and Dermoscopic Description.|pdf=|usr=008}}
+
{{tp|p=32531121|t=2020. Two cases of cutaneous eruptions due to CoVID-19 infection in Singapore: New insights into the spectrum of clinical presentation and histopathology.|pdf=|usr=008}}
+
{{tp|p=32531119|t=2020. A generalized purpuric eruption with histopathologic features of leucocytoclastic vasculitis in a patient severely ill with COVID-19.|pdf=|usr=008}}
+
{{tp|p=32525726|t=2020. Thoracoscopic Bullectomy for Persistent Air Leak in a 14-Year-Old Child with COVID-19 Bilateral Pulmonary Disease.|pdf=|usr=008}}
+
 
{{tp|p=32434403|t=2020. Pregnancy affected by SARS-CoV-2 infection: a flash report from Michigan.|pdf=|usr=008}}
 
{{tp|p=32434403|t=2020. Pregnancy affected by SARS-CoV-2 infection: a flash report from Michigan.|pdf=|usr=008}}
 
{{tp|p=32429786|t=2020. COVID-19 pneumonia and pregnancy; a systematic review and meta-analysis.|pdf=|usr=008}}
 
{{tp|p=32429786|t=2020. COVID-19 pneumonia and pregnancy; a systematic review and meta-analysis.|pdf=|usr=008}}
 
{{tp|p=32419544|t=2020. COVID 19 in neonates.|pdf=|usr=008}}
 
{{tp|p=32419544|t=2020. COVID 19 in neonates.|pdf=|usr=008}}
{{tp|p=32510261|t=2020. Is there any possible link between COVID-19 and human infertility?|pdf=|usr=008}}
+
 
 
{{tp|p=32533777|t=2020. Clinical Characteristics of COVID-19 in patients with pre-existing ILD: A retrospective study in a single center in Wuhan, China.|pdf=|usr=008}}
 
{{tp|p=32533777|t=2020. Clinical Characteristics of COVID-19 in patients with pre-existing ILD: A retrospective study in a single center in Wuhan, China.|pdf=|usr=008}}
{{tp|p=32530531|t=2020. Are co-infections with COVID-19 and Influenza low or underreported? An observational study examining current published literature including three new unpublished cases.|pdf=|usr=008}}
 
  
{{tp|p=32500226|t=2020. Antiphospholipid antibodies in patient with acute lower member ischemia and pulmonary thromboembolism as a result of infection by SARS-CoV2.|pdf=|usr=008}}
+
 
{{tp|p=32458242|t=2020. Can COVID-19 cause myalgia with a completely different mechanism? A hypothesis.|pdf=|usr=008}}
+
 
 +
 
 
{{tp|p=32406001|t=2020. COVID-19 with rheumatic diseases: a report of 5 cases.|pdf=|usr=008}}
 
{{tp|p=32406001|t=2020. COVID-19 with rheumatic diseases: a report of 5 cases.|pdf=|usr=008}}
 
{{tp|p=32447647|t=2020. Electronic nicotine delivery systems (ECs) and COVID-19: the perfect storm for young consumers.|pdf=|usr=008}}
 
{{tp|p=32447647|t=2020. Electronic nicotine delivery systems (ECs) and COVID-19: the perfect storm for young consumers.|pdf=|usr=008}}
Zeile 1.463: Zeile 1.316:
 
{{tp|p=32428112|t=2020. Expert recommendations for the care of newborns of mothers with COVID-19.|pdf=|usr=008}}
 
{{tp|p=32428112|t=2020. Expert recommendations for the care of newborns of mothers with COVID-19.|pdf=|usr=008}}
 
{{tp|p=32428111|t=2020. Why is SARS-CoV-2 infection milder among children?|pdf=|usr=008}}
 
{{tp|p=32428111|t=2020. Why is SARS-CoV-2 infection milder among children?|pdf=|usr=008}}
{{tp|p=32428084|t=2020. Fonoaudiologia, amamentacao e COVID-19: informacoes aos fonoaudiologos.|pdf=|usr=008}}
 
{{tp|p=32422426|t=2020. Importance of SARs-Cov-2 anosmia: From phenomenology to neurobiology.|pdf=|usr=008}}
 
{{tp|p=32456695|t=2020. Clinical analysis of sinus bradycardia in patients with severe COVID-19 pneumonia.|pdf=|usr=008}}
 
{{tp|p=32456648|t=2020. Two consecutive myocardial tissue insults for inpatients with COVID-19.|pdf=|usr=008}}
 
{{tp|p=32423461|t=2020. Cardiovascular phenotypes in ventilated patients with COVID-19 acute respiratory distress syndrome.|pdf=|usr=008}}
 
 
{{tp|p=32410714|t=2020. Patients with COVID-19 in 19 ICUs in Wuhan, China: a cross-sectional study.|pdf=|usr=008}}
 
{{tp|p=32410714|t=2020. Patients with COVID-19 in 19 ICUs in Wuhan, China: a cross-sectional study.|pdf=|usr=008}}
 
{{tp|p=32513232|t=2020. Non-febrile COVID-19 patients were common and often became critically ill: a retrospective multicenter cohort study.|pdf=|usr=008}}
 
{{tp|p=32513232|t=2020. Non-febrile COVID-19 patients were common and often became critically ill: a retrospective multicenter cohort study.|pdf=|usr=008}}
 
{{tp|p=32498689|t=2020. Mortality rates of patients with COVID-19 in the intensive care unit: a systematic review of the emerging literature.|pdf=|usr=008}}
 
{{tp|p=32498689|t=2020. Mortality rates of patients with COVID-19 in the intensive care unit: a systematic review of the emerging literature.|pdf=|usr=008}}
{{tp|p=32487231|t=2020. Severe pulmonary embolism in COVID-19 patients: a call for increased awareness.|pdf=|usr=008}}
 
{{tp|p=32487122|t=2020. Thrombotic and hemorrhagic events in critically ill COVID-19 patients: a French monocenter retrospective study.|pdf=|usr=008}}
 
{{tp|p=32527297|t=2020. Severe Covid-19 disease: rather AVDS than ARDS?|pdf=|usr=008}}
 
{{tp|p=32527286|t=2020. COVID-19: opening a new paradigm in thromboprophylaxis for critically ill patients?|pdf=|usr=008}}
 
{{tp|p=32522226|t=2020. Low molecular weight heparins in COVID-19 patients: beware of augmented renal clearance!|pdf=|usr=008}}
 
 
{{tp|p=32426751|t=2020. The Clinical Presentation and Immunology of Viral Pneumonia and Implications for Management of Coronavirus Disease 2019.|pdf=|usr=008}}
 
{{tp|p=32426751|t=2020. The Clinical Presentation and Immunology of Viral Pneumonia and Implications for Management of Coronavirus Disease 2019.|pdf=|usr=008}}
{{tp|p=32426749|t=2020. Neurologic Manifestations of Severe Respiratory Viral Contagions.|pdf=|usr=008}}
+
 
{{tp|p=32467443|t=2020. Coagulopathy of Coronavirus Disease 2019.|pdf=|usr=008}}
+
 
 
{{tp|p=32452888|t=2020. ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019.|pdf=|usr=008}}
 
{{tp|p=32452888|t=2020. ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019.|pdf=|usr=008}}
 
{{tp|p=32371611|t=2020. Acute Physiology and Chronic Health Evaluation II Score as a Predictor of Hospital Mortality in Patients of Coronavirus Disease 2019.|pdf=|usr=008}}
 
{{tp|p=32371611|t=2020. Acute Physiology and Chronic Health Evaluation II Score as a Predictor of Hospital Mortality in Patients of Coronavirus Disease 2019.|pdf=|usr=008}}
 
{{tp|p=32528774|t=2020. Coronavirus Disease 2019 (COVID-19) in a Renal Transplant Patient.|pdf=|usr=008}}
 
{{tp|p=32528774|t=2020. Coronavirus Disease 2019 (COVID-19) in a Renal Transplant Patient.|pdf=|usr=008}}
{{tp|p=32528770|t=2020. A Review of Cardiac Complications in Coronavirus Disease 2019.|pdf=|usr=008}}
 
{{tp|p=32528760|t=2020. Cardiac Manifestations of Coronavirus Disease 2019 (COVID-19): A Comprehensive Review.|pdf=|usr=008}}
 
 
{{tp|p=32391234|t=2020. A Hemodialysis Patient with Severe COVID-19 Pneumonia.|pdf=|usr=008}}
 
{{tp|p=32391234|t=2020. A Hemodialysis Patient with Severe COVID-19 Pneumonia.|pdf=|usr=008}}
 
{{tp|p=32489751|t=2020. Managing Acute Portal Hypertensive Gastropathy Bleed During the Time of COVID-19 Pandemic: Novelty or Necessity?|pdf=|usr=008}}
 
{{tp|p=32489751|t=2020. Managing Acute Portal Hypertensive Gastropathy Bleed During the Time of COVID-19 Pandemic: Novelty or Necessity?|pdf=|usr=008}}
{{tp|p=32499974|t=2020. Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy, MRI Brain and Cerebrospinal Fluid Findings: Case 2.|pdf=|usr=008}}
+
 
{{tp|p=32455090|t=2020. Two False Negative Test Results in a Symptomatic Patient with a Confirmed Case of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Suspected Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN).|pdf=|usr=008}}
+
 
{{tp|p=32455089|t=2020. A Review of Neurological Complications of COVID-19.|pdf=|usr=008}}
+
 
 
{{tp|p=32432015|t=2020. Neonatal Coronavirus 2019 (COVID-19) Infection: A Case Report and Review of Literature.|pdf=|usr=008}}
 
{{tp|p=32432015|t=2020. Neonatal Coronavirus 2019 (COVID-19) Infection: A Case Report and Review of Literature.|pdf=|usr=008}}
{{tp|p=32426200|t=2020. Encephalopathy as the Sentinel Sign of a Cortical Stroke in a Patient Infected With Coronavirus Disease-19 (COVID-19).|pdf=|usr=008}}
+
 
 
{{tp|p=32411566|t=2020. Nifedipine and Amlodipine Are Associated With Improved Mortality and Decreased Risk for Intubation and Mechanical Ventilation in Elderly Patients Hospitalized for COVID-19.|pdf=|usr=008}}
 
{{tp|p=32411566|t=2020. Nifedipine and Amlodipine Are Associated With Improved Mortality and Decreased Risk for Intubation and Mechanical Ventilation in Elderly Patients Hospitalized for COVID-19.|pdf=|usr=008}}
{{tp|p=32494532|t=2020. Anosmia and Ageusia as the Only Indicators of Coronavirus Disease 2019 (COVID-19).|pdf=|usr=008}}
+
 
 
{{tp|p=32528785|t=2020. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Mimicking as Pulmonary Tuberculosis in an Inmate.|pdf=|usr=008}}
 
{{tp|p=32528785|t=2020. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Mimicking as Pulmonary Tuberculosis in an Inmate.|pdf=|usr=008}}
{{tp|p=32528783|t=2020. Neurological and Psychological Effects of Coronavirus (COVID-19): An Overview of the Current Era Pandemic.|pdf=|usr=008}}
+
 
{{tp|p=32509485|t=2020. Coronavirus Disease 2019 (COVID-19) Infection Associated With Antiphospholipid Antibodies and Four-Extremity Deep Vein thrombosis in a Previously Healthy Female.|pdf=|usr=008}}
+
 
 
{{tp|p=32399342|t=2020. A Case of a COVID-19-positive Patient.|pdf=|usr=008}}
 
{{tp|p=32399342|t=2020. A Case of a COVID-19-positive Patient.|pdf=|usr=008}}
{{tp|p=32489743|t=2020. COVID-19 Pandemic: A Neurological Perspective.|pdf=|usr=008}}
+
 
{{tp|p=32489724|t=2020. Basal Ganglia Involvement and Altered Mental Status: A Unique Neurological Manifestation of Coronavirus Disease 2019.|pdf=|usr=008}}
+
 
 
{{tp|p=32483507|t=2020. Coronavirus Disease 2019 (COVID-19) Can Masquerade as Acute Postoperative Periprosthetic Joint Infection.|pdf=|usr=008}}
 
{{tp|p=32483507|t=2020. Coronavirus Disease 2019 (COVID-19) Can Masquerade as Acute Postoperative Periprosthetic Joint Infection.|pdf=|usr=008}}
{{tp|p=32483497|t=2020. Novel Coronavirus Disease 2019 and Subarachnoid Hemorrhage: A Case Report.|pdf=|usr=008}}
+
 
 
{{tp|p=32467810|t=2020. Coronavirus Disease 2019 (COVID-19) in Cancer Patients.|pdf=|usr=008}}
 
{{tp|p=32467810|t=2020. Coronavirus Disease 2019 (COVID-19) in Cancer Patients.|pdf=|usr=008}}
{{tp|p=32467792|t=2020. Bradycardia, Renal Failure, Atrioventricular Nodal Blockade, Shock, and Hyperkalemia (BRASH) Syndrome as a Presentation of Coronavirus Disease 2019.|pdf=|usr=008}}
+
 
{{tp|p=32415481|t=2020. 2019-Novel Coronavirus-Related Acute Cardiac Injury Cannot Be Ignored.|pdf=|usr=008}}
+
{{tp|p=32529517|t=2020. Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment.|pdf=|usr=008}}
+
{{tp|p=31471666|t=2019. Rivaroxaban and Aspirin in Peripheral Vascular Disease: a Review of Implementation Strategies and Management of Common Clinical Scenarios.|pdf=|usr=008}}
+
 
{{tp|p=32382587|t=2020. Cardiac Troponin-I may be a predictor of complications and mortality in COVID-19 patients.|pdf=|usr=008}}
 
{{tp|p=32382587|t=2020. Cardiac Troponin-I may be a predictor of complications and mortality in COVID-19 patients.|pdf=|usr=008}}
{{tp|p=32385869|t=2020. Coronavirus Disease-2019 with Dermatologic Manifestations and Implications: An Unfolding Conundrum.|pdf=|usr=008}}
 
{{tp|p=32385938|t=2020. A dermatologist's perspective of the COVID-19 outbreak.|pdf=|usr=008}}
 
 
{{tp|p=32385891|t=2020. Systemic immunobiological, immunosuppressant, and oncologic agents for the treatment of dermatologic diseases during the SARS-CoV-2 (COVID-19) pandemic emergency: A quick review for a quick consultation.|pdf=|usr=008}}
 
{{tp|p=32385891|t=2020. Systemic immunobiological, immunosuppressant, and oncologic agents for the treatment of dermatologic diseases during the SARS-CoV-2 (COVID-19) pandemic emergency: A quick review for a quick consultation.|pdf=|usr=008}}
{{tp|p=32383234|t=2020. Cutaneous manifestations of the Coronavirus Disease 2019 (COVID-19): A brief review.|pdf=|usr=008}}
+
 
 
{{tp|p=32378293|t=2020. Update on COVID-19 Effects in Dermatology Specialty.|pdf=|usr=008}}
 
{{tp|p=32378293|t=2020. Update on COVID-19 Effects in Dermatology Specialty.|pdf=|usr=008}}
{{tp|p=32447801|t=2020. Herpes zoster might be an indicator for latent COVID 19 infection.|pdf=|usr=008}}
+
 
{{tp|p=32445283|t=2020. Atypical erythema nodosum in a patient with COVID-19 pneumonia.|pdf=|usr=008}}
+
{{tp|p=32445279|t=2020. Diagnostic and prognostic values of cutaneous manifestations in COVID-19.|pdf=|usr=008}}
+
{{tp|p=32424851|t=2020. Therapy for probable COVID-19 associated erythema pernio-like lesions in pediatric age. Case report.|pdf=|usr=008}}
+
{{tp|p=32412681|t=2020. Appearance of skin rash in pediatric patients with COVID-19: Three case presentations.|pdf=|usr=008}}
+
 
{{tp|p=32406114|t=2020. Psychological effects of COVID-19 on parenting and maternal-fetal mental health.|pdf=|usr=008}}
 
{{tp|p=32406114|t=2020. Psychological effects of COVID-19 on parenting and maternal-fetal mental health.|pdf=|usr=008}}
{{tp|p=32401411|t=2020. A case of COVID-19 pneumonia presenting with acute urticaria.|pdf=|usr=008}}
 
{{tp|p=32390279|t=2020. Cutaneous signs in COVID-19 patients: A review.|pdf=|usr=008}}
 
 
{{tp|p=32468230|t=2020. Novel Coronavirus Disease (COVID-19) and Biologic Therapy for Psoriasis: Successful Recovery in Two Patients After Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).|pdf=|usr=008}}
 
{{tp|p=32468230|t=2020. Novel Coronavirus Disease (COVID-19) and Biologic Therapy for Psoriasis: Successful Recovery in Two Patients After Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).|pdf=|usr=008}}
 
{{tp|p=32425701|t=2020. Cigarette Smoke Exposure and Inflammatory Signaling Increase the Expression of the SARS-CoV-2 Receptor ACE2 in the Respiratory Tract.|pdf=|usr=008}}
 
{{tp|p=32425701|t=2020. Cigarette Smoke Exposure and Inflammatory Signaling Increase the Expression of the SARS-CoV-2 Receptor ACE2 in the Respiratory Tract.|pdf=|usr=008}}
Zeile 1.544: Zeile 1.374:
 
{{tp|p=32446801|t=2020. SARS-CoV-2 and diabetes: New challenges for the disease.|pdf=|usr=008}}
 
{{tp|p=32446801|t=2020. SARS-CoV-2 and diabetes: New challenges for the disease.|pdf=|usr=008}}
 
{{tp|p=32446798|t=2020. Characteristics and outcomes of COVID-19 positive patients with diabetes managed as outpatients.|pdf=|usr=008}}
 
{{tp|p=32446798|t=2020. Characteristics and outcomes of COVID-19 positive patients with diabetes managed as outpatients.|pdf=|usr=008}}
{{tp|p=32442555|t=2020. Type 1 diabetes triggered by covid-19 pandemic: A potential outbreak?|pdf=|usr=008}}
+
 
{{tp|p=32526092|t=2020. Thromboprophylaxis in a patient with COVID-19 and severe hemophilia A on emicizumab prophylaxis.|pdf=|usr=008}}
+
{{tp|p=32526058|t=2020. Response to 'all these D-dimers in COVID-19'.|pdf=|usr=008}}
+
 
{{tp|p=32524609|t=2020. COVID-19 in Australian health care workers: early experience of the Royal Melbourne Hospital emphasises the importance of community acquisition.|pdf=|usr=008}}
 
{{tp|p=32524609|t=2020. COVID-19 in Australian health care workers: early experience of the Royal Melbourne Hospital emphasises the importance of community acquisition.|pdf=|usr=008}}
 
{{tp|p=32519352|t=2020. The possible protective role of alpha-synuclein against the SARS-CoV-2 infections in patients with Parkinson's disease.|pdf=|usr=008}}
 
{{tp|p=32519352|t=2020. The possible protective role of alpha-synuclein against the SARS-CoV-2 infections in patients with Parkinson's disease.|pdf=|usr=008}}
 
{{tp|p=32515393|t=2020. Long term complications and rehabilitation of COVID-19 patients.|pdf=|usr=008}}
 
{{tp|p=32515393|t=2020. Long term complications and rehabilitation of COVID-19 patients.|pdf=|usr=008}}
 
{{tp|p=32515389|t=2020. COVID-19 in children: Epidemiology, presentation, diagnosis and management.|pdf=|usr=008}}
 
{{tp|p=32515389|t=2020. COVID-19 in children: Epidemiology, presentation, diagnosis and management.|pdf=|usr=008}}
{{tp|p=32515382|t=2020. Cardiovigilance in COVID 19.|pdf=|usr=008}}
+
 
{{tp|p=32515381|t=2020. The digestive system and the COVID-19.|pdf=|usr=008}}
+
 
{{tp|p=32515380|t=2020. Endocrine vigilance in COVID-19.|pdf=|usr=008}}
+
{{tp|p=32515379|t=2020. Neurological manifestations of COVID-19.|pdf=|usr=008}}
+
 
{{tp|p=32515378|t=2020. Clinical features, diagnosis and management of COVID-19 patients in the outdoor setting.|pdf=|usr=008}}
 
{{tp|p=32515378|t=2020. Clinical features, diagnosis and management of COVID-19 patients in the outdoor setting.|pdf=|usr=008}}
 
{{tp|p=32329797|t=2020. Characteristics of Hospitalized Adults With COVID-19 in an Integrated Health Care System in California.|pdf=|usr=008}}
 
{{tp|p=32329797|t=2020. Characteristics of Hospitalized Adults With COVID-19 in an Integrated Health Care System in California.|pdf=|usr=008}}
 
{{tp|p=32530453|t=2020. Factors Associated With Surgical Mortality and Complications Among Patients With and Without Coronavirus Disease 2019 (COVID-19) in Italy.|pdf=|usr=008}}
 
{{tp|p=32530453|t=2020. Factors Associated With Surgical Mortality and Complications Among Patients With and Without Coronavirus Disease 2019 (COVID-19) in Italy.|pdf=|usr=008}}
 
{{tp|p=32302270|t=2020. Managing COVID-19 in Patients With Cancer: A Double Blow for Oncologists.|pdf=|usr=008}}
 
{{tp|p=32302270|t=2020. Managing COVID-19 in Patients With Cancer: A Double Blow for Oncologists.|pdf=|usr=008}}
{{tp|p=32515699|t=2020. [The Agreed Experts' Position of the Eurasian Association of Therapists on Some new Mechanisms of COVID-19 Pathways: Focus on Hemostasis, Hemotransfusion Issues and Blood gas Exchange].|pdf=|usr=008}}
+
 
{{tp|p=32515698|t=2020. [Recommendations of the Eurasian Arrhythmology Association (EURA) for the diagnosis and treatment of patients with arrhythmias and conduction disorders during the COVID-19 pandemic].|pdf=|usr=008}}
+
 
{{tp|p=32521557|t=2020. Riechstorungen bei COVID-19 - aktueller Wissensstand.|pdf=|usr=008}}
+
 
{{tp|p=32534336|t=2020. COVID-19 & Periodontitis: The cytokine connection.|pdf=|usr=008}}
+
{{tp|p=32531536|t=2020. Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy?|pdf=|usr=008}}
+
 
{{tp|p=32531754|t=2020. Covid-19 in a patient with multiple sclerosis treated with natalizumab: May the blockade of integrins have a protective role?|pdf=|usr=008}}
 
{{tp|p=32531754|t=2020. Covid-19 in a patient with multiple sclerosis treated with natalizumab: May the blockade of integrins have a protective role?|pdf=|usr=008}}
{{tp|p=32535934|t=2020. COVID-19 associated myositis with severe proximal and bulbar weakness.|pdf=|usr=008}}
+
 
  
 
{{tp|p=32360400|t=2020. Hyperglycemia and the worse prognosis of COVID-19. Why a fast blood glucose control should be mandatory.|pdf=|usr=008}}
 
{{tp|p=32360400|t=2020. Hyperglycemia and the worse prognosis of COVID-19. Why a fast blood glucose control should be mandatory.|pdf=|usr=008}}
Zeile 1.573: Zeile 1.397:
 
{{tp|p=32416121|t=2020. Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients.|pdf=|usr=008}}
 
{{tp|p=32416121|t=2020. Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients.|pdf=|usr=008}}
 
{{tp|p=32407746|t=2020. Prevalence of diabetes mellitus in 2019 novel coronavirus: A meta-analysis.|pdf=|usr=008}}
 
{{tp|p=32407746|t=2020. Prevalence of diabetes mellitus in 2019 novel coronavirus: A meta-analysis.|pdf=|usr=008}}
{{tp|p=32339533|t=2020. Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus.|pdf=|usr=008}}
+
 
 
{{tp|p=32278764|t=2020. COVID-19 and diabetes: Knowledge in progress.|pdf=|usr=008}}
 
{{tp|p=32278764|t=2020. COVID-19 and diabetes: Knowledge in progress.|pdf=|usr=008}}
 
{{tp|p=32179126|t=2020. Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed.|pdf=|usr=008}}
 
{{tp|p=32179126|t=2020. Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed.|pdf=|usr=008}}
 
{{tp|p=32472191|t=2020. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study.|pdf=|usr=008}}
 
{{tp|p=32472191|t=2020. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study.|pdf=|usr=008}}
 
{{tp|p=32405783|t=2020. Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature.|pdf=|usr=008}}
 
{{tp|p=32405783|t=2020. Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature.|pdf=|usr=008}}
{{tp|p=32447742|t=2020. Clinical Insights into the Gastrointestinal Manifestations of COVID-19.|pdf=|usr=008}}
 
{{tp|p=32487506|t=2020. Systematic analysis of acute liver injury during SARS-CoV-2 infection.|pdf=|usr=008}}
 
{{tp|p=32532607|t=2020. Intestinal ischemia in the COVID-19 era.|pdf=|usr=008}}
 
 
{{tp|p=32473875|t=2020. Intellectual and developmental disability and COVID-19 case-fatality trends: TriNetX analysis.|pdf=|usr=008}}
 
{{tp|p=32473875|t=2020. Intellectual and developmental disability and COVID-19 case-fatality trends: TriNetX analysis.|pdf=|usr=008}}
 
{{tp|p=32529474|t=2020. Does Ibuprofen Worsen COVID-19?|pdf=|usr=008}}
 
{{tp|p=32529474|t=2020. Does Ibuprofen Worsen COVID-19?|pdf=|usr=008}}
 
{{tp|p=32527380|t=2020. SARS-CoV-2 in the Employees of a Large University Hospital.|pdf=|usr=008}}
 
{{tp|p=32527380|t=2020. SARS-CoV-2 in the Employees of a Large University Hospital.|pdf=|usr=008}}
 
{{tp|p=32519943|t=2020. Hospital Admission in Children and Adolescents With COVID-19.|pdf=|usr=008}}
 
{{tp|p=32519943|t=2020. Hospital Admission in Children and Adolescents With COVID-19.|pdf=|usr=008}}
{{tp|p=32530413|t=2020. Pulmonary Artery Embolism in COVID-19 Despite Thrombosis Prophylaxis.|pdf=|usr=008}}
+
 
{{tp|p=32468193|t=2020. Postintubation Dysphagia During COVID-19 Outbreak-Contemporary Review.|pdf=|usr=008}}
+
{{tp|p=32533346|t=2020. Oropharyngeal Dysphagia and Aspiration Pneumonia Following Coronavirus Disease 2019: A Case Report.|pdf=|usr=008}}
+
 
{{tp|p=32499091|t=2020. (Mis-)understanding COVID-19 and digit ratio: Methodological and statistical issues in Manning and Fink (2020).|pdf=|usr=008}}
 
{{tp|p=32499091|t=2020. (Mis-)understanding COVID-19 and digit ratio: Methodological and statistical issues in Manning and Fink (2020).|pdf=|usr=008}}
 
{{tp|p=32419720|t=2020. Understanding COVID-19: Digit ratio (2D:4D) and sex differences in national case fatality rates.|pdf=|usr=008}}
 
{{tp|p=32419720|t=2020. Understanding COVID-19: Digit ratio (2D:4D) and sex differences in national case fatality rates.|pdf=|usr=008}}
{{tp|p=32474399|t=2020. Infectivity of human coronavirus in the brain.|pdf=|usr=008}}
+
 
 
{{tp|p=32535547|t=2020. Merits and culprits of immunotherapies for neurological diseases in times of COVID-19.|pdf=|usr=008}}
 
{{tp|p=32535547|t=2020. Merits and culprits of immunotherapies for neurological diseases in times of COVID-19.|pdf=|usr=008}}
 
{{tp|p=32407284|t=2020. Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March-April 2020.|pdf=|usr=008}}
 
{{tp|p=32407284|t=2020. Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March-April 2020.|pdf=|usr=008}}
{{tp|p=32396506|t=2020. COVID-19 and Acute Pulmonary Embolism in Postpartum Patient.|pdf=|usr=008}}
+
 
{{tp|p=32396504|t=2020. Abdominal Visceral Infarction in 3 Patients with COVID-19.|pdf=|usr=008}}
+
 
 
{{tp|p=32497001|t=2020. Viral RNA Load in Mildly Symptomatic and Asymptomatic Children with COVID-19, Seoul.|pdf=|usr=008}}
 
{{tp|p=32497001|t=2020. Viral RNA Load in Mildly Symptomatic and Asymptomatic Children with COVID-19, Seoul.|pdf=|usr=008}}
{{tp|p=32491984|t=2020. Parotitis-Like Symptoms Associated with COVID-19, France, March-April 2020.|pdf=|usr=008}}
+
 
 
{{tp|p=32521222|t=2020. Clusters of Coronavirus Disease in Communities, Japan, January-April 2020.|pdf=|usr=008}}
 
{{tp|p=32521222|t=2020. Clusters of Coronavirus Disease in Communities, Japan, January-April 2020.|pdf=|usr=008}}
 
{{tp|p=32390285|t=2020. SARS-CoV-2 testing and outcomes in the first 30 days after the first case of COVID-19 at an Australian children's hospital.|pdf=|usr=008}}
 
{{tp|p=32390285|t=2020. SARS-CoV-2 testing and outcomes in the first 30 days after the first case of COVID-19 at an Australian children's hospital.|pdf=|usr=008}}
 
{{tp|p=32515651|t=2020. Clinical characteristics of foreign-imported COVID-19 cases in Shanghai, China.|pdf=|usr=008}}
 
{{tp|p=32515651|t=2020. Clinical characteristics of foreign-imported COVID-19 cases in Shanghai, China.|pdf=|usr=008}}
 
{{tp|p=32449100|t=2020. Incidentally discovered COVID-19 in low-suspicion patients-a threat to front line health care workers.|pdf=|usr=008}}
 
{{tp|p=32449100|t=2020. Incidentally discovered COVID-19 in low-suspicion patients-a threat to front line health care workers.|pdf=|usr=008}}
{{tp|p=32524296|t=2020. Pneumomediastinum and spontaneous pneumothorax as an extrapulmonary complication of COVID-19 disease.|pdf=|usr=008}}
+
 
{{tp|p=32488837|t=2020. Possible long-term endocrine-metabolic complications in COVID-19: lesson from the SARS model.|pdf=|usr=008}}
+
 
 
{{tp|p=32475769|t=2020. Consecuencias de la COVID-19 sobre las personas con diabetes.|pdf=|usr=008}}
 
{{tp|p=32475769|t=2020. Consecuencias de la COVID-19 sobre las personas con diabetes.|pdf=|usr=008}}
 
{{tp|p=32425489|t=2020. RECOMENDACIONES Y MANEJO PRACTICO DE LA GESTANTE CON COVID-19: SCOPING REVIEW.|pdf=|usr=008}}
 
{{tp|p=32425489|t=2020. RECOMENDACIONES Y MANEJO PRACTICO DE LA GESTANTE CON COVID-19: SCOPING REVIEW.|pdf=|usr=008}}
Zeile 1.610: Zeile 1.429:
 
{{tp|p=32460927|t=2020. Association of hypertension with the severity and fatality of SARS-CoV-2 infection: A meta-analysis.|pdf=|usr=008}}
 
{{tp|p=32460927|t=2020. Association of hypertension with the severity and fatality of SARS-CoV-2 infection: A meta-analysis.|pdf=|usr=008}}
 
{{tp|p=32430084|t=2020. Outbreak of COVID-19 in a family, Wenzhou, China.|pdf=|usr=008}}
 
{{tp|p=32430084|t=2020. Outbreak of COVID-19 in a family, Wenzhou, China.|pdf=|usr=008}}
{{tp|p=32304092|t=2020. New onset acute symptomatic seizure and risk factors in coronavirus disease 2019: A retrospective multicenter study.|pdf=|usr=008}}
+
 
{{tp|p=32523963|t=2020. Pulmonary embolism: yet another cause of hypoxaemic respiratory failure in COVID-19.|pdf=|usr=008}}
+
 
 
{{tp|p=32488522|t=2020. Risk of neuropsychiatric disorders in offspring of COVID-19-infected pregnant women and nutritional intervention.|pdf=|usr=008}}
 
{{tp|p=32488522|t=2020. Risk of neuropsychiatric disorders in offspring of COVID-19-infected pregnant women and nutritional intervention.|pdf=|usr=008}}
{{tp|p=32405639|t=2020. At the heart of COVID-19.|pdf=|usr=008}}
+
 
 
{{tp|p=32388565|t=2020. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors.|pdf=|usr=008}}
 
{{tp|p=32388565|t=2020. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors.|pdf=|usr=008}}
 
{{tp|p=32388547|t=2020. Plasma angiotensin-converting enzyme 2: novel biomarker in heart failure with implications for COVID-19.|pdf=|usr=008}}
 
{{tp|p=32388547|t=2020. Plasma angiotensin-converting enzyme 2: novel biomarker in heart failure with implications for COVID-19.|pdf=|usr=008}}
 
{{tp|p=32383763|t=2020. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy.|pdf=|usr=008}}
 
{{tp|p=32383763|t=2020. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy.|pdf=|usr=008}}
 
{{tp|p=32383758|t=2020. SARS-CoV-2 receptor ACE2 expression in the human heart: cause of a post-pandemic wave of heart failure?|pdf=|usr=008}}
 
{{tp|p=32383758|t=2020. SARS-CoV-2 receptor ACE2 expression in the human heart: cause of a post-pandemic wave of heart failure?|pdf=|usr=008}}
{{tp|p=32396627|t=2020. Successful percutaneous thrombectomy in a patient with COVID-19 pneumonia and acute pulmonary embolism supported by extracorporeal membrane oxygenation.|pdf=|usr=008}}
+
 
{{tp|p=32391885|t=2020. SARS-CoV-2, a novel virus with an unusual cardiac feature: inverted takotsubo syndrome.|pdf=|usr=008}}
+
 
{{tp|p=32391877|t=2020. Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019.|pdf=|usr=008}}
+
 
{{tp|p=32412641|t=2020. Unusual presentation of acute coronary syndrome in a patient with SARS-CoV-2 infection.|pdf=|usr=008}}
+
{{tp|p=32395765|t=2020. A case of Takotsubo cardiomyopathy with COVID 19.|pdf=|usr=008}}
+
{{tp|p=32391912|t=2020. The role of cardiovascular imaging for myocardial injury in hospitalized COVID-19 patients.|pdf=|usr=008}}
+
{{tp|p=32383737|t=2020. The tug-of-war between coagulopathy and anticoagulant agents in patients with COVID-19.|pdf=|usr=008}}
+
{{tp|p=32523933|t=2020. Diaphragmatic Rupture and Gastric Perforation in a Patient with COVID-19 Pneumonia.|pdf=|usr=008}}
+
 
{{tp|p=32523932|t=2020. Should the Management of Embolic Stroke in the Elderly Be Changed if They Also Have COVID-19?|pdf=|usr=008}}
 
{{tp|p=32523932|t=2020. Should the Management of Embolic Stroke in the Elderly Be Changed if They Also Have COVID-19?|pdf=|usr=008}}
 
{{tp|p=32523931|t=2020. Fatal Ischaemic Stroke During COVID-19 and Acute Lung Injury.|pdf=|usr=008}}
 
{{tp|p=32523931|t=2020. Fatal Ischaemic Stroke During COVID-19 and Acute Lung Injury.|pdf=|usr=008}}
{{tp|p=32523929|t=2020. Respiratory Distress in SARS-CoV-2 without Lung Damage: Phrenic Paralysis Should Be Considered in COVID-19 Infection.|pdf=|usr=008}}
+
 
{{tp|p=32523928|t=2020. D-dimer and C-reactive Protein Blood Levels Over Time Used to Predict Pulmonary Embolism in Two COVID-19 Patients.|pdf=|usr=008}}
+
 
{{tp|p=32523927|t=2020. COVID-19 Presenting as Acute Limb Ischaemia.|pdf=|usr=008}}
+
 
{{tp|p=32523926|t=2020. Stress Cardiomyopathy in COVID-19 Disease.|pdf=|usr=008}}
+
{{tp|p=32523925|t=2020. Acalculous Acute Pancreatitis in a COVID-19 Patient.|pdf=|usr=008}}
+
 
{{tp|p=32523924|t=2020. Long-term Positivity to SARS-CoV-2: A Clinical Case of COVID-19 with Persistent Evidence of Infection.|pdf=|usr=008}}
 
{{tp|p=32523924|t=2020. Long-term Positivity to SARS-CoV-2: A Clinical Case of COVID-19 with Persistent Evidence of Infection.|pdf=|usr=008}}
{{tp|p=32523923|t=2020. Pericardial Fluid in a COVID-19 Patient: Is It Exudate or Transudate?|pdf=|usr=008}}
+
 
{{tp|p=32523922|t=2020. Thrombocytopenia in the Course of COVID-19 Infection.|pdf=|usr=008}}
+
 
{{tp|p=32523921|t=2020. Acute Pericarditis and Cardiac Tamponade in a Patient with COVID-19: A Therapeutic Challenge.|pdf=|usr=008}}
+
 
{{tp|p=32523920|t=2020. COVID-19 and Pulmonary Embolism: Not a Coincidence.|pdf=|usr=008}}
+
 
{{tp|p=32399457|t=2020. Cerebral Venous Sinus Thrombosis as a Presentation of COVID-19.|pdf=|usr=008}}
+
 
{{tp|p=32399456|t=2020. Arterial Mesenteric Thrombosis as a Complication of SARS-CoV-2 Infection.|pdf=|usr=008}}
+
 
{{tp|p=32399454|t=2020. Transient ST Segment Elevation in Two Patients with COVID-19 and a Normal Transthoracic Echocardiogram.|pdf=|usr=008}}
+
{{tp|p=32399453|t=2020. Takotsubo Syndrome Associated with COVID-19.|pdf=|usr=008}}
+
{{tp|p=32399452|t=2020. Co-infection with Influenza A and COVID-19.|pdf=|usr=008}}
+
{{tp|p=32399451|t=2020. A Case of Coinfection with SARS-COV-2 and Cytomegalovirus in the Era of COVID-19.|pdf=|usr=008}}
+
{{tp|p=32399449|t=2020. Deep Vein Thrombosis and Pulmonary Embolism: Two Complications of COVID-19 Pneumonia?|pdf=|usr=008}}
+
 
{{tp|p=32383239|t=2020. Diabetes or endocrinopathy admitted in the COVID-19 ward.|pdf=|usr=008}}
 
{{tp|p=32383239|t=2020. Diabetes or endocrinopathy admitted in the COVID-19 ward.|pdf=|usr=008}}
{{tp|p=32415992|t=2020. Emerging cardiological issues during the COVID-19 pandemic.|pdf=|usr=008}}
+
 
{{tp|p=32406522|t=2020. COVID-19: focus on the lungs but do not forget the gastrointestinal tract.|pdf=|usr=008}}
+
 
 
{{tp|p=32307717|t=2020. COVID-19 diagnosis does not rule out other concomitant diseases.|pdf=|usr=008}}
 
{{tp|p=32307717|t=2020. COVID-19 diagnosis does not rule out other concomitant diseases.|pdf=|usr=008}}
 
{{tp|p=32404898|t=2020. Diabetes and COVID-19: evidence, current status and unanswered research questions.|pdf=|usr=008}}
 
{{tp|p=32404898|t=2020. Diabetes and COVID-19: evidence, current status and unanswered research questions.|pdf=|usr=008}}
 
{{tp|p=32379084|t=2020. Daily pool testing of nasopharyngeal self-obtained swaps of healthcare professionals with definite COVID-19 exposition.|pdf=|usr=008}}
 
{{tp|p=32379084|t=2020. Daily pool testing of nasopharyngeal self-obtained swaps of healthcare professionals with definite COVID-19 exposition.|pdf=|usr=008}}
 
{{tp|p=32424571|t=2020. Burden and prevalence of prognostic factors for severe COVID-19 in Sweden.|pdf=|usr=008}}
 
{{tp|p=32424571|t=2020. Burden and prevalence of prognostic factors for severe COVID-19 in Sweden.|pdf=|usr=008}}
{{tp|p=32530585|t=2020. New-Onset Diabetes in Covid-19.|pdf=|usr=008}}
+
 
 
{{tp|p=32530584|t=2020. Natural History of Asymptomatic SARS-CoV-2 Infection.|pdf=|usr=008}}
 
{{tp|p=32530584|t=2020. Natural History of Asymptomatic SARS-CoV-2 Infection.|pdf=|usr=008}}
 
{{tp|p=32516853|t=2020. Publication of COVID-19 case reports: are we hurrying?|pdf=|usr=008}}
 
{{tp|p=32516853|t=2020. Publication of COVID-19 case reports: are we hurrying?|pdf=|usr=008}}
{{tp|p=32524689|t=2020. Overlapping findings or oral manifestations in new SARS-CoV-2 infection?|pdf=|usr=008}}
+
 
{{tp|p=32524663|t=2020. Oral lesions of herpes zoster in COVID-19 patients or truly associated to the disease?|pdf=|usr=008}}
+
 
 
{{tp|p=32521564|t=2020. Viral enanthema in oral mucosa: a possible diagnostic challenge in the COVID-19 pandemic.|pdf=|usr=008}}
 
{{tp|p=32521564|t=2020. Viral enanthema in oral mucosa: a possible diagnostic challenge in the COVID-19 pandemic.|pdf=|usr=008}}
{{tp|p=32521067|t=2020. Oral manifestations in COVID-19 patients.|pdf=|usr=008}}
+
 
 
{{tp|p=32515518|t=2020. Postnatal SARS-CoV-2 Infection and Immunological Reaction: A Prospective Family Cohort Study.|pdf=|usr=008}}
 
{{tp|p=32515518|t=2020. Postnatal SARS-CoV-2 Infection and Immunological Reaction: A Prospective Family Cohort Study.|pdf=|usr=008}}
{{tp|p=32524630|t=2020. Rash as a presenting complaint in a child with COVID-19.|pdf=|usr=008}}
+
 
 
{{tp|p=32519809|t=2020. What we know so far about Coronavirus Disease 2019 in children: A meta-analysis of 551 laboratory-confirmed cases.|pdf=|usr=008}}
 
{{tp|p=32519809|t=2020. What we know so far about Coronavirus Disease 2019 in children: A meta-analysis of 551 laboratory-confirmed cases.|pdf=|usr=008}}
{{tp|p=32527756|t=2020. Endocrine changes in SARS-CoV-2 patients and lessons from SARS-CoV.|pdf=|usr=008}}
+
 
 
{{tp|p=32529643|t=2020. Mechanisms and evidence of vertical transmission of infections in pregnancy including SARS-CoV-2.|pdf=|usr=008}}
 
{{tp|p=32529643|t=2020. Mechanisms and evidence of vertical transmission of infections in pregnancy including SARS-CoV-2.|pdf=|usr=008}}
 
{{tp|p=32434211|t=2020. Viral and host factors related to the clinical outcome of COVID-19.|pdf=|usr=008}}
 
{{tp|p=32434211|t=2020. Viral and host factors related to the clinical outcome of COVID-19.|pdf=|usr=008}}
Zeile 1.668: Zeile 1.475:
 
{{tp|p=32516273|t=2020. Rates of Maternal and Perinatal Mortality and Vertical Transmission in Pregnancies Complicated by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Co-V-2) Infection: A Systematic Review.|pdf=|usr=008}}
 
{{tp|p=32516273|t=2020. Rates of Maternal and Perinatal Mortality and Vertical Transmission in Pregnancies Complicated by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Co-V-2) Infection: A Systematic Review.|pdf=|usr=008}}
 
{{tp|p=32428215|t=2020. SARS-COV-2 pandemic: the significance of underlying conditions.|pdf=|usr=008}}
 
{{tp|p=32428215|t=2020. SARS-COV-2 pandemic: the significance of underlying conditions.|pdf=|usr=008}}
{{tp|p=32463341|t=2020. COVID-19 and Eye Problems.|pdf=|usr=008}}
 
{{tp|p=32513065|t=2020. Persistent Smell Loss Following Undetectable SARS-CoV-2.|pdf=|usr=008}}
 
{{tp|p=32513055|t=2020. Comment on "The Prevalence of Olfactory and Gustatory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis".|pdf=|usr=008}}
 
 
{{tp|p=32513036|t=2020. Disparate Nasopharyngeal and Tracheal COVID-19 Diagnostic Test Results in a Patient With a Total Laryngectomy.|pdf=|usr=008}}
 
{{tp|p=32513036|t=2020. Disparate Nasopharyngeal and Tracheal COVID-19 Diagnostic Test Results in a Patient With a Total Laryngectomy.|pdf=|usr=008}}
 
{{tp|p=32520362|t=2020. What Are the Newest Effects of COVID-19 in Children?|pdf=|usr=008}}
 
{{tp|p=32520362|t=2020. What Are the Newest Effects of COVID-19 in Children?|pdf=|usr=008}}
{{tp|p=32533607|t=2020. Chilblains in children in the time of Covid-19: new evidence with serology assay.|pdf=|usr=008}}
+
 
{{tp|p=32516281|t=2020. ANOSMIA AND AGEUSIA: NOT AN UNCOMMON PRESENTATION OF COVID-19 INFECTION IN CHILDREN AND ADOLESCENTS.|pdf=|usr=008}}
+
 
 
{{tp|p=32525645|t=2020. Comparison of the Clinical Features of SARS-CoV-2, Other Coronavirus and Influenza Infections in Infants Less Than 1-Year-Old.|pdf=|usr=008}}
 
{{tp|p=32525645|t=2020. Comparison of the Clinical Features of SARS-CoV-2, Other Coronavirus and Influenza Infections in Infants Less Than 1-Year-Old.|pdf=|usr=008}}
 
{{tp|p=32525644|t=2020. Three Hypotheses About Children COVID19.|pdf=|usr=008}}
 
{{tp|p=32525644|t=2020. Three Hypotheses About Children COVID19.|pdf=|usr=008}}
Zeile 1.685: Zeile 1.489:
 
{{tp|p=32192856|t=2020. Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19).|pdf=|usr=008}}
 
{{tp|p=32192856|t=2020. Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19).|pdf=|usr=008}}
 
{{tp|p=32532661|t=2020. Management and outcomes of post-acute COVID-19 patients in Northern Italy.|pdf=|usr=008}}
 
{{tp|p=32532661|t=2020. Management and outcomes of post-acute COVID-19 patients in Northern Italy.|pdf=|usr=008}}
{{tp|p=32383343|t=2020. Two patients with acute meningoencephalitis concomitant with SARS-CoV-2 infection.|pdf=|usr=008}}
+
 
{{tp|p=32396710|t=2020. COVID-19 and neurodegeneration: what can we learn from the past?|pdf=|usr=008}}
+
 
 
{{tp|p=32493595|t=2020. Delayed umbilical cord clamping and breastfeeding after childbirth in mothers affected by COVID 19: Recommended or not?|pdf=|usr=008}}
 
{{tp|p=32493595|t=2020. Delayed umbilical cord clamping and breastfeeding after childbirth in mothers affected by COVID 19: Recommended or not?|pdf=|usr=008}}
 
{{tp|p=32456886|t=2020. Is termination of early pregnancy indicated in women with COVID-19?|pdf=|usr=008}}
 
{{tp|p=32456886|t=2020. Is termination of early pregnancy indicated in women with COVID-19?|pdf=|usr=008}}
Zeile 1.694: Zeile 1.498:
 
{{tp|p=32405137|t=2020. Prone positioning and high-flow oxygen improved respiratory function in a 25-week pregnant woman with COVID-19.|pdf=|usr=008}}
 
{{tp|p=32405137|t=2020. Prone positioning and high-flow oxygen improved respiratory function in a 25-week pregnant woman with COVID-19.|pdf=|usr=008}}
 
{{tp|p=32439245|t=2020. Vaginal delivery in a woman infected with SARS-CoV-2 - The first case reported in Portugal.|pdf=|usr=008}}
 
{{tp|p=32439245|t=2020. Vaginal delivery in a woman infected with SARS-CoV-2 - The first case reported in Portugal.|pdf=|usr=008}}
{{tp|p=32474800|t=2020. Children's heart and COVID-19: Up-to-date evidence in the form of a systematic review.|pdf=|usr=008}}
+
 
 
{{tp|p=32424745|t=2020. SARS-COV-2 infection in children and newborns: a systematic review.|pdf=|usr=008}}
 
{{tp|p=32424745|t=2020. SARS-COV-2 infection in children and newborns: a systematic review.|pdf=|usr=008}}
 
{{tp|p=32495147|t=2020. Characteristic of COVID-19 infection in pediatric patients: early findings from two Italian Pediatric Research Networks.|pdf=|usr=008}}
 
{{tp|p=32495147|t=2020. Characteristic of COVID-19 infection in pediatric patients: early findings from two Italian Pediatric Research Networks.|pdf=|usr=008}}
 
{{tp|p=32495145|t=2020. COVID-19 in children: patiently and critically evaluate the scientific evidence.|pdf=|usr=008}}
 
{{tp|p=32495145|t=2020. COVID-19 in children: patiently and critically evaluate the scientific evidence.|pdf=|usr=008}}
 
{{tp|p=32391719|t=2020. Cardiovascular disease and COVID-19: les liaisons dangereuses.|pdf=|usr=008}}
 
{{tp|p=32391719|t=2020. Cardiovascular disease and COVID-19: les liaisons dangereuses.|pdf=|usr=008}}
{{tp|p=32526743|t=2020. COVID-19-Related Stroke: Barking up the Wrong Tree?|pdf=|usr=008}}
+
 
 
{{tp|p=32385648|t=2020. Clinical and radiological changes of hospitalised patients with COVID-19 pneumonia from disease onset to acute exacerbation: a multicentre paired cohort study.|pdf=|usr=008}}
 
{{tp|p=32385648|t=2020. Clinical and radiological changes of hospitalised patients with COVID-19 pneumonia from disease onset to acute exacerbation: a multicentre paired cohort study.|pdf=|usr=008}}
{{tp|p=32457198|t=2020. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases.|pdf=|usr=008}}
+
 
 
{{tp|p=32430431|t=2020. Smoking, ACE-2, and COVID-19: Ongoing Controversies.|pdf=|usr=008}}
 
{{tp|p=32430431|t=2020. Smoking, ACE-2, and COVID-19: Ongoing Controversies.|pdf=|usr=008}}
 
{{tp|p=32430427|t=2020. COVID-19 and vaping: risk for increased susceptibility to SARS-CoV-2 infection?|pdf=|usr=008}}
 
{{tp|p=32430427|t=2020. COVID-19 and vaping: risk for increased susceptibility to SARS-CoV-2 infection?|pdf=|usr=008}}
{{tp|p=32398297|t=2020. Pulmonary embolism in patients with Covid-19 pneumonia.|pdf=|usr=008}}
+
 
{{tp|p=32398294|t=2020. Venous thromboembolism in SARS-CoV-2 patients: only a problem in ventilated ICU patients, or is there more to it?|pdf=|usr=008}}
+
{{tp|p=32482787|t=2020. Clinical characteristics of COVID-19 and active tuberculosis co-infection in an Italian reference hospital.|pdf=|usr=008}}
+
 
{{tp|p=32398296|t=2020. Arterial hypertension and the risk of severity and mortality of COVID-19.|pdf=|usr=008}}
 
{{tp|p=32398296|t=2020. Arterial hypertension and the risk of severity and mortality of COVID-19.|pdf=|usr=008}}
 
{{tp|p=32381497|t=2020. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge.|pdf=|usr=008}}
 
{{tp|p=32381497|t=2020. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge.|pdf=|usr=008}}
Zeile 1.720: Zeile 1.522:
 
{{tp|p=32519618|t=2020. Incidence and Immunologic Analysis of Coronavirus Disease (COVID-19) in Hemodialysis Patients:A Single-Center Experience.|pdf=|usr=008}}
 
{{tp|p=32519618|t=2020. Incidence and Immunologic Analysis of Coronavirus Disease (COVID-19) in Hemodialysis Patients:A Single-Center Experience.|pdf=|usr=008}}
 
{{tp|p=32519617|t=2020. Coronavirus Disease (COVID-19) in Kidney and Liver Transplant Patients: A Single-Center Experience.|pdf=|usr=008}}
 
{{tp|p=32519617|t=2020. Coronavirus Disease (COVID-19) in Kidney and Liver Transplant Patients: A Single-Center Experience.|pdf=|usr=008}}
{{tp|p=32424329|t=2020. Detection of severe acute respiratory syndrome Coronavirus-2 in the tears of patients with Coronavirus disease 2019.|pdf=|usr=008}}
+
 
{{tp|p=32424327|t=2020. Coronavirus disease 2019 (SARS-CoV-2) and colonization of ocular tissues and secretions: a systematic review.|pdf=|usr=008}}
+
{{tp|p=32398850|t=2020. Care for critically Ill patients with COVID-19: don't forget the eyes.|pdf=|usr=008}}
+
{{tp|p=32489244|t=2020. Microthrombotic Complications of COVID-19 Are Likely Due to Embolism of Circulating Endothelial Derived Ultralarge Von Willebrand Factor (eULVWF) Decorated-Platelet Strings.|pdf=|usr=008}}
+
 
{{tp|p=32482250|t=2020. Prior and novel coronaviruses, Coronavirus Disease 2019 (COVID-19), and human reproduction: what is known?|pdf=|usr=008}}
 
{{tp|p=32482250|t=2020. Prior and novel coronaviruses, Coronavirus Disease 2019 (COVID-19), and human reproduction: what is known?|pdf=|usr=008}}
 
{{tp|p=32535599|t=2020. Coronavirus Disease 2019 in Pregnancy: A Clinical Management Protocol and Considerations for Practice.|pdf=|usr=008}}
 
{{tp|p=32535599|t=2020. Coronavirus Disease 2019 in Pregnancy: A Clinical Management Protocol and Considerations for Practice.|pdf=|usr=008}}
{{tp|p=32401577|t=2020. Fatal Eosinophilic Myocarditis in a Healthy 17-Year-Old Male with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2c).|pdf=|usr=008}}
+
 
 
{{tp|p=32391384|t=2020. COVID and the Renin-Angiotensin System: Are Hypertension or Its Treatments Deleterious?|pdf=|usr=008}}
 
{{tp|p=32391384|t=2020. COVID and the Renin-Angiotensin System: Are Hypertension or Its Treatments Deleterious?|pdf=|usr=008}}
 
{{tp|p=32405974|t=2020. Organ function support in patients with coronavirus disease 2019: Tongji experience.|pdf=|usr=008}}
 
{{tp|p=32405974|t=2020. Organ function support in patients with coronavirus disease 2019: Tongji experience.|pdf=|usr=008}}
Zeile 1.733: Zeile 1.532:
 
{{tp|p=32426362|t=2020. Covid-19: A Dynamic Analysis of Fatality Risk in Italy.|pdf=|usr=008}}
 
{{tp|p=32426362|t=2020. Covid-19: A Dynamic Analysis of Fatality Risk in Italy.|pdf=|usr=008}}
 
{{tp|p=32391367|t=2020. The Malnutritional Status of the Host as a Virulence Factor for New Coronavirus SARS-CoV-2.|pdf=|usr=008}}
 
{{tp|p=32391367|t=2020. The Malnutritional Status of the Host as a Virulence Factor for New Coronavirus SARS-CoV-2.|pdf=|usr=008}}
{{tp|p=32390931|t=2020. A Case of Coronavirus Disease 2019 With Concomitant Acute Cerebral Infarction and Deep Vein Thrombosis.|pdf=|usr=008}}
+
 
 
{{tp|p=32426311|t=2020. Novel Coronavirus Disease 2019 Infection in Children: The Dark Side of a Worldwide Outbreak.|pdf=|usr=008}}
 
{{tp|p=32426311|t=2020. Novel Coronavirus Disease 2019 Infection in Children: The Dark Side of a Worldwide Outbreak.|pdf=|usr=008}}
 
{{tp|p=32411652|t=2020. Gender Differences in Patients With COVID-19: Focus on Severity and Mortality.|pdf=|usr=008}}
 
{{tp|p=32411652|t=2020. Gender Differences in Patients With COVID-19: Focus on Severity and Mortality.|pdf=|usr=008}}
Zeile 1.743: Zeile 1.542:
 
{{tp|p=32442561|t=2020. COVID-19 in Liver Transplant Recipients: An Initial Experience from the U.S. Epicenter.|pdf=|usr=008}}
 
{{tp|p=32442561|t=2020. COVID-19 in Liver Transplant Recipients: An Initial Experience from the U.S. Epicenter.|pdf=|usr=008}}
 
{{tp|p=32425229|t=2020. Focusing on gastrointestinal symptoms in COVID-19 is far from enough.|pdf=|usr=008}}
 
{{tp|p=32425229|t=2020. Focusing on gastrointestinal symptoms in COVID-19 is far from enough.|pdf=|usr=008}}
{{tp|p=32422209|t=2020. Are Gastrointestinal Symptoms Specific for COVID-19 Infection? A Prospective Case-Control Study from the United States.|pdf=|usr=008}}
+
 
 
{{tp|p=32422208|t=2020. Associations between Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blocker Use, Gastrointestinal Symptoms, and Mortality among Patients with COVID-19.|pdf=|usr=008}}
 
{{tp|p=32422208|t=2020. Associations between Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blocker Use, Gastrointestinal Symptoms, and Mortality among Patients with COVID-19.|pdf=|usr=008}}
{{tp|p=32407808|t=2020. AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19.|pdf=|usr=008}}
+
 
 
{{tp|p=32407807|t=2020. Could Patients With Inflammatory Bowel Disease Treated with Immunomodulators or Biologics Be at Lower Risk for Severe Forms of Covid-19?|pdf=|usr=008}}
 
{{tp|p=32407807|t=2020. Could Patients With Inflammatory Bowel Disease Treated with Immunomodulators or Biologics Be at Lower Risk for Severe Forms of Covid-19?|pdf=|usr=008}}
{{tp|p=32497545|t=2020. Emerging phenotype of SARS-CoV2 associated pancreatitis.|pdf=|usr=008}}
+
 
{{tp|p=32470824|t=2020. Delirium in COVID-19: A case series and exploration of potential mechanisms for central nervous system involvement.|pdf=|usr=008}}
+
 
{{tp|p=32451846|t=2020. Does SARS-CoV-2 infection cause chronic neurological complications?|pdf=|usr=008}}
+
 
{{tp|p=32430627|t=2020. COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches.|pdf=|usr=008}}
+
 
{{tp|p=32409587|t=2020. GI symptoms as early signs of COVID-19 in hospitalised Italian patients.|pdf=|usr=008}}
+
 
 
{{tp|p=32534808|t=2020. Cancer patients affected by COVID-19: Experience from Milan, Lombardy.|pdf=|usr=008}}
 
{{tp|p=32534808|t=2020. Cancer patients affected by COVID-19: Experience from Milan, Lombardy.|pdf=|usr=008}}
 
{{tp|p=32527955|t=2020. COVID-19 in patients with sickle cell disease - a case series from a UK Tertiary Hospital.|pdf=|usr=008}}
 
{{tp|p=32527955|t=2020. COVID-19 in patients with sickle cell disease - a case series from a UK Tertiary Hospital.|pdf=|usr=008}}
{{tp|p=32357379|t=2020. Validation of a self-administered olfactory and gustatory test for the remotely evaluation of COVID-19 patients in home quarantine.|pdf=|usr=008}}
+
 
 
{{tp|p=32338805|t=2020. Tobacco use and vaping in the COVID-19 era.|pdf=|usr=008}}
 
{{tp|p=32338805|t=2020. Tobacco use and vaping in the COVID-19 era.|pdf=|usr=008}}
{{tp|p=32515675|t=2020. Neurological Involvement of COVID-19 Patients: Making the Most of MRI.|pdf=|usr=008}}
+
 
 
{{tp|p=32531138|t=2020. Clinical course and treatment efficacy of COVID-19 near Hubei Province, China: a multicentre, retrospective study.|pdf=|usr=008}}
 
{{tp|p=32531138|t=2020. Clinical course and treatment efficacy of COVID-19 near Hubei Province, China: a multicentre, retrospective study.|pdf=|usr=008}}
 
{{tp|p=32515076|t=2020. COVID-19 in pancreas transplant recipients.|pdf=|usr=008}}
 
{{tp|p=32515076|t=2020. COVID-19 in pancreas transplant recipients.|pdf=|usr=008}}
 
{{tp|p=32521074|t=2020. COVID-19 in Lung Transplant Recipients.|pdf=|usr=008}}
 
{{tp|p=32521074|t=2020. COVID-19 in Lung Transplant Recipients.|pdf=|usr=008}}
{{tp|p=32533768|t=2020. Time scale for resolution of olfactory dysfunction in COVID-19.|pdf=|usr=008}}
+
 
{{tp|p=32527804|t=2020. COVID-19 and flu, a perfect storm.|pdf=|usr=008}}
+
 
 
{{tp|p=32533615|t=2020. Incidental COVID-19 in a Heart-Kidney Transplant Recipient with Malnutrition and Recurrent Infections: Implications for the SARS-CoV-2 Immune Response.|pdf=|usr=008}}
 
{{tp|p=32533615|t=2020. Incidental COVID-19 in a Heart-Kidney Transplant Recipient with Malnutrition and Recurrent Infections: Implications for the SARS-CoV-2 Immune Response.|pdf=|usr=008}}
{{tp|p=32530411|t=2020. Pulmonary Embolism in Covid-19. Coagulation Parameters, Close Monitoring to Prevent?|pdf=|usr=008}}
+
 
 
{{tp|p=32530409|t=2020. Rethinking the First COVID-19 Death in Turkey.|pdf=|usr=008}}
 
{{tp|p=32530409|t=2020. Rethinking the First COVID-19 Death in Turkey.|pdf=|usr=008}}
 
{{tp|p=32530408|t=2020. Acute Respiratory Failure in COVID-19 Pneumoniae: The Best Interface for an Optimal Management. A South Italian Experience.|pdf=|usr=008}}
 
{{tp|p=32530408|t=2020. Acute Respiratory Failure in COVID-19 Pneumoniae: The Best Interface for an Optimal Management. A South Italian Experience.|pdf=|usr=008}}
{{tp|p=32515336|t=2020. [Forhojet D-dimer og karakteristiske billeddiagnostiske fund hos patient med COVID-19].|pdf=|usr=008}}
 
{{tp|p=32515339|t=2020. [Venous thromboembolism in patients with COVID-19].|pdf=|usr=008}}
 
 
{{tp|p=32522535|t=2020. Clinical features of discharged COVID-19 patients with an extended SARS-CoV-2 RNA positive signal in respiratory samples.|pdf=|usr=008}}
 
{{tp|p=32522535|t=2020. Clinical features of discharged COVID-19 patients with an extended SARS-CoV-2 RNA positive signal in respiratory samples.|pdf=|usr=008}}
 
{{tp|p=32391676|t=2020. [Follow-up testing of viral nucleic acid in discharged patients with moderate type of COVID-19].|pdf=|usr=008}}
 
{{tp|p=32391676|t=2020. [Follow-up testing of viral nucleic acid in discharged patients with moderate type of COVID-19].|pdf=|usr=008}}
Zeile 1.783: Zeile 1.580:
 
{{tp|p=32294812|t=2020. [Diagnosis and treatment of disease 2019 novel coronavirus infection suitable for Military support Hubei medical team].|pdf=|usr=008}}
 
{{tp|p=32294812|t=2020. [Diagnosis and treatment of disease 2019 novel coronavirus infection suitable for Military support Hubei medical team].|pdf=|usr=008}}
 
{{tp|p=32527345|t=2020. [Clinical analysis of 23 patients with coronavirus disease 2019 in Xinyang City of Henan Province].|pdf=|usr=008}}
 
{{tp|p=32527345|t=2020. [Clinical analysis of 23 patients with coronavirus disease 2019 in Xinyang City of Henan Province].|pdf=|usr=008}}
{{tp|p=32527343|t=2020. [Analysis of gastrointestinal symptoms in 80 patients with coronavirus disease 2019].|pdf=|usr=008}}
+
 
{{tp|p=32527342|t=2020. [Clinical characteristics and risk factors of acute kidney injury in coronavirus disease 2019].|pdf=|usr=008}}
+
 
 
{{tp|p=32527341|t=2020. [Analysis of the clinical characteristics and early warning model construction of severe/critical coronavirus disease 2019 patients].|pdf=|usr=008}}
 
{{tp|p=32527341|t=2020. [Analysis of the clinical characteristics and early warning model construction of severe/critical coronavirus disease 2019 patients].|pdf=|usr=008}}
 
{{tp|p=32527340|t=2020. [Nationwide survey on clinical treatment of coronavirus disease 2019 in 9 provinces and municipalities].|pdf=|usr=008}}
 
{{tp|p=32527340|t=2020. [Nationwide survey on clinical treatment of coronavirus disease 2019 in 9 provinces and municipalities].|pdf=|usr=008}}
 
{{tp|p=32394688|t=2020. [Chronic granulocytic leukemia with COVID-19 pneumonia: a case report].|pdf=|usr=008}}
 
{{tp|p=32394688|t=2020. [Chronic granulocytic leukemia with COVID-19 pneumonia: a case report].|pdf=|usr=008}}
 
{{tp|p=32149486|t=2020. [COVID-19 with post-chemotherapy agranulocytosis in childhood acute leukemia: a case report].|pdf=|usr=008}}
 
{{tp|p=32149486|t=2020. [COVID-19 with post-chemotherapy agranulocytosis in childhood acute leukemia: a case report].|pdf=|usr=008}}
{{tp|p=32283878|t=2020. [Whether conjunctival congestion in patients infected with 2019 novel coronavirus is definitely related the novel coronavirus?]|pdf=|usr=008}}
+
 
 
{{tp|p=32157848|t=2020. [Practice and Reflection on the Battle against COVID-19 by Guangdong Medical Aid Team in the city of Honghu].|pdf=|usr=008}}
 
{{tp|p=32157848|t=2020. [Practice and Reflection on the Battle against COVID-19 by Guangdong Medical Aid Team in the city of Honghu].|pdf=|usr=008}}
 
{{tp|p=32388946|t=2020. [Screening and management of asymptomatic infection of 2019-novel coronavirus].|pdf=|usr=008}}
 
{{tp|p=32388946|t=2020. [Screening and management of asymptomatic infection of 2019-novel coronavirus].|pdf=|usr=008}}
  
 
{{tp|p=32064855|t=2020. [Analysis of the first cluster of cases in a family of novel coronavirus pneumonia in Gansu Province].|pdf=|usr=008}}
 
{{tp|p=32064855|t=2020. [Analysis of the first cluster of cases in a family of novel coronavirus pneumonia in Gansu Province].|pdf=|usr=008}}
{{tp|p=32389782|t=2020. Acute kidney injury in hospitalized patients with coronavirus disease 2019 (COVID-19): A meta-analysis.|pdf=|usr=008}}
+
 
 
{{tp|p=32474034|t=2020. Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient.|pdf=|usr=008}}
 
{{tp|p=32474034|t=2020. Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient.|pdf=|usr=008}}
 
{{tp|p=32474047|t=2020. Drinking no-links to the severity of COVID-19: a systematic review and meta-analysis.|pdf=|usr=008}}
 
{{tp|p=32474047|t=2020. Drinking no-links to the severity of COVID-19: a systematic review and meta-analysis.|pdf=|usr=008}}
{{tp|p=32474045|t=2020. Co-infection of SARS-CoV-2 and Influenza virus in Early Stage of the COVID-19 Epidemic in Wuhan, China.|pdf=|usr=008}}
 
{{tp|p=32474044|t=2020. COVID-19 Patients with Recent Influenza A/B Infection: A Retrospective Study.|pdf=|usr=008}}
 
 
{{tp|p=32474043|t=2020. Estimation of Renin-Angiotensin-Aldosterone-System (RAAS)-Inhibitor effect on COVID-19 outcome: A Meta-analysis.|pdf=|usr=008}}
 
{{tp|p=32474043|t=2020. Estimation of Renin-Angiotensin-Aldosterone-System (RAAS)-Inhibitor effect on COVID-19 outcome: A Meta-analysis.|pdf=|usr=008}}
 
{{tp|p=32474042|t=2020. Fatality rate of COVID-19 in patients with malignancies: a sytematic review and meta-analysis.|pdf=|usr=008}}
 
{{tp|p=32474042|t=2020. Fatality rate of COVID-19 in patients with malignancies: a sytematic review and meta-analysis.|pdf=|usr=008}}
 
{{tp|p=32474041|t=2020. Cancer in intensive care unit patients with COVID-19.|pdf=|usr=008}}
 
{{tp|p=32474041|t=2020. Cancer in intensive care unit patients with COVID-19.|pdf=|usr=008}}
{{tp|p=32474035|t=2020. COVID-19 and the Eye.|pdf=|usr=008}}
+
 
 
{{tp|p=32474033|t=2020. Markers of liver injury and clinical outcomes in COVID-19 patients: A systematic review and meta-analysis.|pdf=|usr=008}}
 
{{tp|p=32474033|t=2020. Markers of liver injury and clinical outcomes in COVID-19 patients: A systematic review and meta-analysis.|pdf=|usr=008}}
 
{{tp|p=32474032|t=2020. COVID-19 patients with hypertension have more severity condition, and ACEI/ARB treatment have no infulence on the clinical severity and outcome.|pdf=|usr=008}}
 
{{tp|p=32474032|t=2020. COVID-19 patients with hypertension have more severity condition, and ACEI/ARB treatment have no infulence on the clinical severity and outcome.|pdf=|usr=008}}
 
{{tp|p=32473236|t=2020. Ethnicity profiles of COVID-19 admissions and outcomes.|pdf=|usr=008}}
 
{{tp|p=32473236|t=2020. Ethnicity profiles of COVID-19 admissions and outcomes.|pdf=|usr=008}}
{{tp|p=32473235|t=2020. Co-infections in people with COVID-19: a systematic review and meta-analysis.|pdf=|usr=008}}
+
 
 
{{tp|p=32473231|t=2020. Cardiovascular disease as a risk factor of disease progression in COVID-19: The corrected effect size and forest plot.|pdf=|usr=008}}
 
{{tp|p=32473231|t=2020. Cardiovascular disease as a risk factor of disease progression in COVID-19: The corrected effect size and forest plot.|pdf=|usr=008}}
 
{{tp|p=32445728|t=2020. Asymptomatic infection and atypical manifestations of COVID-19: Comparison of viral shedding duration.|pdf=|usr=008}}
 
{{tp|p=32445728|t=2020. Asymptomatic infection and atypical manifestations of COVID-19: Comparison of viral shedding duration.|pdf=|usr=008}}
{{tp|p=32445724|t=2020. Different patterns of Influenza A and B detected during early stages of COVID-19 in a university hospital in Sao Paulo, Brazil.|pdf=|usr=008}}
+
 
 
{{tp|p=32416124|t=2020. Cardiac troponins predict mortality in patients with COVID-19: A meta-analysis of adjusted risk estimates.|pdf=|usr=008}}
 
{{tp|p=32416124|t=2020. Cardiac troponins predict mortality in patients with COVID-19: A meta-analysis of adjusted risk estimates.|pdf=|usr=008}}
 
{{tp|p=32425274|t=2020. Effects of age and sex on recovery from COVID-19: Analysis of 5769 Israeli patients.|pdf=|usr=008}}
 
{{tp|p=32425274|t=2020. Effects of age and sex on recovery from COVID-19: Analysis of 5769 Israeli patients.|pdf=|usr=008}}
Zeile 1.817: Zeile 1.612:
 
{{tp|p=32407757|t=2020. Age but not sex may explain the negative effect of arterial hypertension and diabetes on COVID-19 prognosis.|pdf=|usr=008}}
 
{{tp|p=32407757|t=2020. Age but not sex may explain the negative effect of arterial hypertension and diabetes on COVID-19 prognosis.|pdf=|usr=008}}
 
{{tp|p=32502509|t=2020. The association between severe or death COVID-19 and autoimmune disease: a systematic review and meta-analysis.|pdf=|usr=008}}
 
{{tp|p=32502509|t=2020. The association between severe or death COVID-19 and autoimmune disease: a systematic review and meta-analysis.|pdf=|usr=008}}
{{tp|p=32535156|t=2020. Detection of SARS-CoV-2 RNA in fecal specimens of patients with confirmed COVID-19: A meta-analysis.|pdf=|usr=008}}
+
 
 
{{tp|p=32283155|t=2020. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis.|pdf=|usr=008}}
 
{{tp|p=32283155|t=2020. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis.|pdf=|usr=008}}
 
{{tp|p=32142929|t=2020. Corona Virus Disease 2019, a growing threat to children?|pdf=|usr=008}}
 
{{tp|p=32142929|t=2020. Corona Virus Disease 2019, a growing threat to children?|pdf=|usr=008}}
{{tp|p=32283149|t=2020. Dynamics of faecal SARS-CoV-2 in infected children during the convalescent phase.|pdf=|usr=008}}
+
 
 
{{tp|p=32112886|t=2020. Characteristics of COVID-19 infection in Beijing.|pdf=|usr=008}}
 
{{tp|p=32112886|t=2020. Characteristics of COVID-19 infection in Beijing.|pdf=|usr=008}}
 
{{tp|p=32525829|t=2020. Different outcome of COVID-19 in members of a family.|pdf=|usr=008}}
 
{{tp|p=32525829|t=2020. Different outcome of COVID-19 in members of a family.|pdf=|usr=008}}
Zeile 1.827: Zeile 1.622:
 
{{tp|p=32405329|t=2020. COVID-19 transmission and blood transfusion: A case report.|pdf=|usr=008}}
 
{{tp|p=32405329|t=2020. COVID-19 transmission and blood transfusion: A case report.|pdf=|usr=008}}
 
{{tp|p=32534945|t=2020. Clinical characteristics of COVID-19 in Saudi Arabia: A national retrospective study.|pdf=|usr=008}}
 
{{tp|p=32534945|t=2020. Clinical characteristics of COVID-19 in Saudi Arabia: A national retrospective study.|pdf=|usr=008}}
{{tp|p=32475804|t=2020. Spontaneous pneumothorax and subcutaneous emphysema in COVID-19 patient: Case report.|pdf=|usr=008}}
+
 
 
{{tp|p=32528233|t=2020. SARS-CoV-2 COVID-19 susceptibility and lung inflammatory storm by smoking and vaping.|pdf=|usr=008}}
 
{{tp|p=32528233|t=2020. SARS-CoV-2 COVID-19 susceptibility and lung inflammatory storm by smoking and vaping.|pdf=|usr=008}}
 
{{tp|p=32489403|t=2020. COVID-19: An update from England's high consequence infectious diseases intensive care unit leads.|pdf=|usr=008}}
 
{{tp|p=32489403|t=2020. COVID-19: An update from England's high consequence infectious diseases intensive care unit leads.|pdf=|usr=008}}
 
{{tp|p=32494896|t=2020. COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies.|pdf=|usr=008}}
 
{{tp|p=32494896|t=2020. COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies.|pdf=|usr=008}}
 
{{tp|p=32525402|t=2020. Atypical Presentation of Novel Coronavirus Disease 2019 in a Peritoneal Dialysis Patient.|pdf=|usr=008}}
 
{{tp|p=32525402|t=2020. Atypical Presentation of Novel Coronavirus Disease 2019 in a Peritoneal Dialysis Patient.|pdf=|usr=008}}
{{tp|p=32522037|t=2020. A Case Series of Patients Coinfected With Influenza and COVID-19.|pdf=|usr=008}}
+
 
{{tp|p=32493147|t=2020. The Coincidence of 2 Epidemics, Coccidioidomycosis and SARS-CoV-2: A Case Report.|pdf=|usr=008}}
+
 
{{tp|p=32493073|t=2020. COVID-19 Presented With Deep Vein Thrombosis: An Unusual Presenting.|pdf=|usr=008}}
+
 
 
{{tp|p=32449328|t=2020. Seventy-two Hours, Targeting Time from First COVID-19 Symptom Onset to Hospitalization.|pdf=|usr=008}}
 
{{tp|p=32449328|t=2020. Seventy-two Hours, Targeting Time from First COVID-19 Symptom Onset to Hospitalization.|pdf=|usr=008}}
{{tp|p=32383370|t=2020. Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients.|pdf=|usr=008}}
 
{{tp|p=32476306|t=2020. Olfactory and Gustatory Dysfunction in a COVID-19 Patient with Ankylosing Spondylitis Treated with Etanercept: Case Report.|pdf=|usr=008}}
 
{{tp|p=32383776|t=2020. Patient Follow-up after Discharge after COVID-19 Pneumonia: Considerations for Infectious Control.|pdf=|usr=008}}
 
{{tp|p=32383264|t=2020. Comment on "Central Nervous System Involvement by Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2)".|pdf=|usr=008}}
 
{{tp|p=32383174|t=2020. High prevalence of olfactory and taste disorder during SARS-CoV-2 infection in outpatients.|pdf=|usr=008}}
 
 
{{tp|p=32383171|t=2020. Asymptomatic cases with SARS-CoV-2 infection.|pdf=|usr=008}}
 
{{tp|p=32383171|t=2020. Asymptomatic cases with SARS-CoV-2 infection.|pdf=|usr=008}}
{{tp|p=32437002|t=2020. Is the brain a reservoir organ for SARS-CoV2?|pdf=|usr=008}}
+
 
{{tp|p=32410338|t=2020. Co-infection with COVID-19 and influenza A virus in two died patients with acute respiratory syndrome, Bojnurd, Iran.|pdf=|usr=008}}
+
{{tp|p=32410319|t=2020. Coronavirus Disease 2019 and Viral Hepatitis coinfection: Provide guidelines for integrated screening and treatment.|pdf=|usr=008}}
+
 
{{tp|p=32410245|t=2020. The clinical characteristic of eight patients of COVID-19 with positive RT-PCR test after discharge.|pdf=|usr=008}}
 
{{tp|p=32410245|t=2020. The clinical characteristic of eight patients of COVID-19 with positive RT-PCR test after discharge.|pdf=|usr=008}}
{{tp|p=32410241|t=2020. Skin involvement in SARS-CoV-2 infection: Case series.|pdf=|usr=008}}
+
 
 
{{tp|p=32401361|t=2020. Clinical characteristics of rehospitalized patients with COVID-19 in China.|pdf=|usr=008}}
 
{{tp|p=32401361|t=2020. Clinical characteristics of rehospitalized patients with COVID-19 in China.|pdf=|usr=008}}
{{tp|p=32401359|t=2020. Recovery from COVID-19 in two patients with coexisted HIV infection.|pdf=|usr=008}}
+
 
{{tp|p=32401352|t=2020. Update on the neurology of COVID-19.|pdf=|usr=008}}
+
 
{{tp|p=32396239|t=2020. The impact of laryngopharyngeal reflux disease on 95 hospitalized patients with COVID-19 in Wuhan, China: A retrospective study.|pdf=|usr=008}}
+
 
 
{{tp|p=32293710|t=2020. Hyperglycemia, hydroxychloroquine, and the COVID-19 pandemic.|pdf=|usr=008}}
 
{{tp|p=32293710|t=2020. Hyperglycemia, hydroxychloroquine, and the COVID-19 pandemic.|pdf=|usr=008}}
{{tp|p=32266995|t=2020. Reply to Comments on 'Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China'.|pdf=|usr=008}}
 
{{tp|p=32242946|t=2020. Comments on "coinfection of SARS-CoV-2 and HIV in a patient in Wuhan city, China".|pdf=|usr=008}}
 
 
{{tp|p=32343428|t=2020. Three Taiwan's domestic family cluster infections of coronavirus disease 2019.|pdf=|usr=008}}
 
{{tp|p=32343428|t=2020. Three Taiwan's domestic family cluster infections of coronavirus disease 2019.|pdf=|usr=008}}
 
{{tp|p=32330313|t=2020. Asymptomatic COVID-19 infection in late pregnancy indicated no vertical transmission.|pdf=|usr=008}}
 
{{tp|p=32330313|t=2020. Asymptomatic COVID-19 infection in late pregnancy indicated no vertical transmission.|pdf=|usr=008}}
 
{{tp|p=32320084|t=2020. Response to Char's comment: Comment on Li et al.: COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis.|pdf=|usr=008}}
 
{{tp|p=32320084|t=2020. Response to Char's comment: Comment on Li et al.: COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis.|pdf=|usr=008}}
 
{{tp|p=32281653|t=2020. Reply to: "Reporting of all cardiac medications and their outcome in COVID-19".|pdf=|usr=008}}
 
{{tp|p=32281653|t=2020. Reply to: "Reporting of all cardiac medications and their outcome in COVID-19".|pdf=|usr=008}}
{{tp|p=32275082|t=2020. Conjunctiva is not a preferred gateway of entry for SARS-CoV-2 to infect respiratory tract.|pdf=|usr=008}}
+
 
 
{{tp|p=32275072|t=2020. Vaginal delivery report of a healthy neonate born to a convalescent mother with COVID--19.|pdf=|usr=008}}
 
{{tp|p=32275072|t=2020. Vaginal delivery report of a healthy neonate born to a convalescent mother with COVID--19.|pdf=|usr=008}}
{{tp|p=32482367|t=2020. Fungal antigenemia in patients with severe Coronavirus disease 2019 (COVID-19): The facts and challenges.|pdf=|usr=008}}
 
{{tp|p=32482366|t=2020. Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?|pdf=|usr=008}}
 
 
{{tp|p=32475799|t=2020. A case of COVID-19 with long duration of viral shedding.|pdf=|usr=008}}
 
{{tp|p=32475799|t=2020. A case of COVID-19 with long duration of viral shedding.|pdf=|usr=008}}
 
{{tp|p=32527700|t=2020. First COVID-19 mortality case in Taiwan with bacterial co-infection by national surveillance of critically ill patients with influenza-negative pneumonia.|pdf=|usr=008}}
 
{{tp|p=32527700|t=2020. First COVID-19 mortality case in Taiwan with bacterial co-infection by national surveillance of critically ill patients with influenza-negative pneumonia.|pdf=|usr=008}}
{{tp|p=32526224|t=2020. Cardiac injuries in coronavirus disease 2019 (COVID-19).|pdf=|usr=008}}
+
 
{{tp|p=32529462|t=2020. May the Central Nervous System Be Fogged by the Cytokine Storm in COVID-19?: an Appraisal.|pdf=|usr=008}}
+
{{tp|p=32447746|t=2020. SARS-CoV-2 Infection Leads to Neurological Dysfunction.|pdf=|usr=008}}
+
{{tp|p=32474657|t=2020. COVID-19-associated acute disseminated encephalomyelitis (ADEM).|pdf=|usr=008}}
+
 
{{tp|p=32494855|t=2020. Mild COVID-19 symptoms despite treatment with teriflunomide and high-dose methylprednisolone due to multiple sclerosis relapse.|pdf=|usr=008}}
 
{{tp|p=32494855|t=2020. Mild COVID-19 symptoms despite treatment with teriflunomide and high-dose methylprednisolone due to multiple sclerosis relapse.|pdf=|usr=008}}
{{tp|p=32462348|t=2020. Onset of Covid-19 with impaired consciousness and ataxia: a case report.|pdf=|usr=008}}
 
{{tp|p=32458198|t=2020. Acute transverse myelitis after COVID-19 pneumonia.|pdf=|usr=008}}
 
{{tp|p=32458197|t=2020. Neurological manifestations of COVID-19: a review of what we know so far.|pdf=|usr=008}}
 
{{tp|p=32458195|t=2020. Miller-Fisher-like syndrome related to SARS-CoV-2 infection (COVID 19).|pdf=|usr=008}}
 
{{tp|p=32458194|t=2020. Non-epileptic seizures in autonomic dysfunction as the initial symptom of COVID-19.|pdf=|usr=008}}
 
{{tp|p=32458193|t=2020. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms.|pdf=|usr=008}}
 
{{tp|p=32458192|t=2020. Post-infectious Guillain-Barre syndrome related to SARS-CoV-2 infection: a case report.|pdf=|usr=008}}
 
{{tp|p=32451613|t=2020. Quantitative evaluation of olfactory dysfunction in hospitalized patients with Coronavirus [2] (COVID-19).|pdf=|usr=008}}
 
{{tp|p=32436105|t=2020. Stroke in patients with SARS-CoV-2 infection: case series.|pdf=|usr=008}}
 
{{tp|p=32430572|t=2020. Guillain-Barre syndrome in the COVID-19 era: just an occasional cluster?|pdf=|usr=008}}
 
{{tp|p=32399694|t=2020. Acute polyradiculoneuritis with locked-in syndrome in a patient with Covid-19.|pdf=|usr=008}}
 
 
{{tp|p=32494856|t=2020. COVID-19 in teriflunomide-treated patients with multiple sclerosis.|pdf=|usr=008}}
 
{{tp|p=32494856|t=2020. COVID-19 in teriflunomide-treated patients with multiple sclerosis.|pdf=|usr=008}}
{{tp|p=32494854|t=2020. A review of pathophysiology and neuropsychiatric manifestations of COVID-19.|pdf=|usr=008}}
+
 
{{tp|p=32533323|t=2020. Bilateral carotid artery dissection in a SARS-CoV-2 infected patient: causality or coincidence?|pdf=|usr=008}}
+
{{tp|p=32533322|t=2020. Mixed central and peripheral nervous system disorders in severe SARS-CoV-2 infection.|pdf=|usr=008}}
+
{{tp|p=32533321|t=2020. Isolated post SARS-CoV-2 diplopia.|pdf=|usr=008}}
+
{{tp|p=32529577|t=2020. COVID-19 encephalopathy: detection of antibodies against SARS-CoV-2 in CSF.|pdf=|usr=008}}
+
{{tp|p=32529575|t=2020. Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis.|pdf=|usr=008}}
+
{{tp|p=32494853|t=2020. Neurological complications of COVID-19: a preliminary review.|pdf=|usr=008}}
+
{{tp|p=32436101|t=2020. Neurological manifestations associated with COVID-19: a review and a call for action.|pdf=|usr=008}}
+
{{tp|p=32531579|t=2020. Serotonin syndrome in two COVID-19 patients treated with lopinavir/ritonavir.|pdf=|usr=008}}
+
{{tp|p=32480073|t=2020. COVID-19-associated delayed posthypoxic necrotizing leukoencephalopathy.|pdf=|usr=008}}
+
{{tp|p=32474220|t=2020. COVID-19-associated mild encephalitis/encephalopathy with a reversible splenial lesion.|pdf=|usr=008}}
+
{{tp|p=32532449|t=2020. Part I. SARS-CoV-2 triggered 'PANIC' attack in severe COVID-19.|pdf=|usr=008}}
+
{{tp|p=32474362|t=2020. Posterior reversible encephalopathy syndrome (PRES) as a neurological association in severe Covid-19.|pdf=|usr=008}}
+
{{tp|p=32447193|t=2020. COVID-19 related neuroimaging findings: A signal of thromboembolic complications and a strong prognostic marker of poor patient outcome.|pdf=|usr=008}}
+
{{tp|p=32444286|t=2020. Brain imaging findings in COVID-19: What do we know so far?|pdf=|usr=008}}
+
{{tp|p=32417159|t=2020. Neuroradiological features in COVID-19 patients: First evidence in a complex scenario.|pdf=|usr=008}}
+
{{tp|p=32437707|t=2020. Cerebral venous thrombosis associated with COVID-19 infection: Causality or coincidence?|pdf=|usr=008}}
+
{{tp|p=32424616|t=2020. A special symptom of olfactory dysfunction in coronavirus disease 2019: report of three cases.|pdf=|usr=008}}
+
{{tp|p=32418055|t=2020. COVID-19 virus may have neuroinvasive potential and cause neurological complications: a perspective review.|pdf=|usr=008}}
+
{{tp|p=32529516|t=2020. Miller Fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2.|pdf=|usr=008}}
+
{{tp|p=32447630|t=2020. COVID-19 and the nervous system.|pdf=|usr=008}}
+
{{tp|p=32423471|t=2020. Musculoskeletal symptoms in SARS-CoV-2 (COVID-19) patients.|pdf=|usr=008}}
+
 
{{tp|p=32405091|t=2020. Severe COVID-19 in Children and Young Adults in the Washington, DC Metropolitan Region.|pdf=|usr=008}}
 
{{tp|p=32405091|t=2020. Severe COVID-19 in Children and Young Adults in the Washington, DC Metropolitan Region.|pdf=|usr=008}}
 
{{tp|p=32407719|t=2020. Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 (COVID-19) at a Tertiary Care Medical Center in New York City.|pdf=|usr=008}}
 
{{tp|p=32407719|t=2020. Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 (COVID-19) at a Tertiary Care Medical Center in New York City.|pdf=|usr=008}}
Zeile 1.930: Zeile 1.679:
 
{{tp|p=32369615|t=2020. Favourable outcome of coronavirus disease 2019 in a 1-year-old girl with acute myeloid leukaemia and severe treatment-induced immunosuppression |pdf=|usr=}}
 
{{tp|p=32369615|t=2020. Favourable outcome of coronavirus disease 2019 in a 1-year-old girl with acute myeloid leukaemia and severe treatment-induced immunosuppression |pdf=|usr=}}
 
{{tp|p=32266501|t=ä. Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19 |pdf=|usr=}}
 
{{tp|p=32266501|t=ä. Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19 |pdf=|usr=}}
{{tp|p=32352633|t=2020. Insights for increased risk of failed fibrinolytic therapy and stent thrombosis associated with COVID-19 in ST-segment elevation myocardial infarction patients |pdf=|usr=}}
+
 
{{tp|p=32339025|t=2020. Why Fibrinolytic Therapy for STEMI in The COVID-19 Pandemic is Not Your New Best  Friend |pdf=|usr=}}
+
 
 
*[https://www.boston25news.com/news/health/high-blood-pressure-drugs-cleared-covid/UC5LTCKKKVDETBWKJDZ2P776XY/ ACEI/AT1RA not risky ?]
 
*[https://www.boston25news.com/news/health/high-blood-pressure-drugs-cleared-covid/UC5LTCKKKVDETBWKJDZ2P776XY/ ACEI/AT1RA not risky ?]
  
 
{{tp|p=32320270|t=2020. Obesity a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms |pdf=|usr=}}
 
{{tp|p=32320270|t=2020. Obesity a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms |pdf=|usr=}}
 
{{tp|p=32259878|t=ä. A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID?19: Will cases of psoriasis increase after COVID?19 pandemic?|pdf=|usr=}}
 
{{tp|p=32259878|t=ä. A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID?19: Will cases of psoriasis increase after COVID?19 pandemic?|pdf=|usr=}}
{{tp|p=32369240|t=2020. Cutaneous manifestations of a 21st century worldwide fungal epidemic possibly complicating the COVID-19 pandemic to jointly menace mankind |pdf=|usr=}}
+
 
 
{{tp|p=32367558|t=2020. Dermatological diseases presented before COVID-19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID-19?|pdf=|usr=}}
 
{{tp|p=32367558|t=2020. Dermatological diseases presented before COVID-19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID-19?|pdf=|usr=}}
  
Zeile 1.942: Zeile 1.691:
  
 
{{tp|p=32347572|t=2020. Outcome of Parkinson s Disease Patients Affected by COVID-19 |pdf=|usr=}}
 
{{tp|p=32347572|t=2020. Outcome of Parkinson s Disease Patients Affected by COVID-19 |pdf=|usr=}}
 
{{tp|p=32529284|t=2020. Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection.|pdf=|usr=008}}
 
{{tp|p=32462329|t=2020. Autoimmune thrombotic thrombocytopenic purpura (TTP) associated with COVID-19.|pdf=|usr=008}}
 
{{tp|p=32500224|t=2020. Severe exacerbation of immune thrombocytopenia and COVID-19: the favorable response to corticosteroid-based therapy-a case report.|pdf=|usr=008}}
 
{{tp|p=32529285|t=2020. SARS-CoV-2 infection in children with febrile neutropenia.|pdf=|usr=008}}
 
  
 
{{tp|p=32360210|t=2020. Letter to the Editor: Fasting plasma glucose associated with mortality rate in T2DM patients with COVID-19 infection |pdf=|usr=}}
 
{{tp|p=32360210|t=2020. Letter to the Editor: Fasting plasma glucose associated with mortality rate in T2DM patients with COVID-19 infection |pdf=|usr=}}

Version vom 29. Juni 2020, 12:15 Uhr

coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.

which risk factors make covid worse/better/no effect

RSP - identifying risk factors


which characteristics has covid in a diseased patient with underlying disorder/state

RSP - Pregnancy, Neonatology

RSP - Liver disease

RSP - Diabetes, Obesity

RSP - Kidney disease

RSP - any transplantation

RSP - any on biologicals

RSP - On RAS drugs

RSP - On NSAIDs

RSP - Smoking

RSP - Pulmonary disease

RSP - Cystic fibrosis

RSP - Cardiovascular disease

RSP - Cancer solid

RSP - Cancer hematology

RSP - Hematology other

RSP - HIV

RSP - DIS Children

RSP - DIS Elderly

RSP - DIS Male

RSP - DIS Race

===007=== rsp and secondary d




32486196 2020. Cerebrovascular and Neurological Dysfunction under the Threat of COVID-19: Is There a Comorbid Role for Smoking and Vaping?
32455539 2020. Smoking-Mediated Upregulation of the Androgen Pathway Leads to Increased SARS-CoV-2 Susceptibility.
32423094 2020. COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?


32472662 2020. COVID-19 and diabetes: Is there enough evidence?



32443899 2020. Early Predictors of Clinical Deterioration in a Cohort of 239 Patients Hospitalized for Covid-19 Infection in Lombardy, Italy.



32498262 2020. Outcomes of COVID-19 among Patients on In-Center Hemodialysis: An Experience from the Epicenter in South Korea.
32498230 2020. Acute Coronary Syndromes and Covid-19: Exploring the Uncertainties.
32496205 2020. Why African Americans Are a Potential Target for COVID-19 Infection in the United States.
32449782 2020. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis.
32271393 2020. Medical Rehabilitation in Pandemics: Towards a New Perspective.
32482654 2020. Dr. Favalli, et al reply.



32475104 2020. Coronavirus Disease 2019 Presenting as Conjunctivitis.
32314329 2020. ACE-2 och coronavirus - en fraga om balans och dynamik?
32471831 2020. Reply to Siniorakis et al., "COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure".
32444383 2020. COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure.
32467553 2020. Smoking amidst the COVID-19 Pandemic - the invisible threat?


32442932 2020. Experiencia COVID-19 en un sanatorio privado de Buenos Aires durante el primer mes de la pandemia: 26 casos.
32481381 2020. A case report with COVID-19 during perioperative period of lobectomy.


32384516 2020. Novel coronavirus 2019 (COVID-19): A case report and review of treatments.
32502054 2020. A 3-month-old child with COVID-19: A case report.
32502034 2020. The epidemiological characteristics of 2019 novel coronavirus diseases (COVID-19) in Jingmen, Hubei, China.


32408731 2020. Covid-19 infection in kidney transplant recipients: endocrine and metabolic issues.
32380802 2020. Cardiovascular system and COVID-19: perspectives from a developing country.
32449614 2020. Gender differences in patients with COVID-19: a narrative review.
32447949 2020. Extrapolation of mortality in COVID-19: Exploring the role of age, sex, co-morbidities and health-care related occupation.
32432433 2020. Severity of COVID-19: The importance of being hypertensive.



32457226 2020. COVID-19 in MS: Initial observations from the Pacific Northwest.
32414755 2020. COVID-19 and MS disease-modifying therapies.



32503140 2020. Human T leukaemia Type 1 and COVID-19.
32384078 2020. Clinical findings of patients with coronavirus disease 2019 in Jiangsu province, China: A retrospective, multi-center study.
32497090 2020. Maternal and neonatal outcomes associated with COVID-19 infection: A systematic review.
32420710 2020. Clinical characteristics and short-term outcomes of patients with coronavirus disease 2019: a retrospective single-center experience of a designated hospital in Poland.
32385979 2020. Diagnosis and recovery from severe acute respiratory syndrome coronavirus 2 infection is challenging in kidney patients: tests are an issue.
32491298 2020. Gender differences in the frequency of gastrointestinal symptoms and olfactory or taste disorders among 1,942 non-hospitalized patients with COVID-19.


32458823 2020. Infeccion por coronavirus Covid-19 y lactancia materna: una revision exploratoria.


32491116 2020. A brief-review of the risk factors for covid-19 severity.
32491091 2020. Adults at high-risk of severe coronavirus disease-2019 (Covid-19) in Brazil.
32491053 2020. Diabetes and covid-19: more than the sum of two morbidities.
32507709 2020. Sindrome de DRESS simulando enfermedad por coronavirus 2019-NcoV.
32512263 2020. COVID-19 in rheumatic disease patients on immunosuppressive agents.
32460453 2020. COVID-19 in Singapore - a case series from primary care.
32466735 2020. Clinical Characteristics and Outcomes of COVID-19 Patients With a History of Stroke in Wuhan, China.
32460390 2020. Covid-19 in solid organ transplant recipients: A single center experience.
32429038 2020. Prognosis of COVID-19 in Patients with Liver and Kidney Diseases: An Early Systematic Review and Meta-Analysis.
32395790 2020. COVID-19 and Cardiovascular diseases. Scoping review study.
32395788 2020. Features of patients with 2019 novel coronavirus admitted in a pneumology department: The first retrospective Tunisian case series.
32395787 2020. First case of imported and confirmed COVID-19 in Tunisia.
32394689 2020. COVID-19, Renin-angiotensin System and Hematopoiesis.
32490641 2020. Characteristics of the initial patients hospitalized for COVID-19: a single-center report.
32430957 2020. Effects of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcomes: a systematic review.


32456286 2020. Antiviral Effects of Hydroxychloroquine and Type I Interferon on In Vitro Fatal Feline Coronavirus Infection.
32403242 2020. Prognostic Value of Cardiovascular Biomarkers in COVID-19: A Review.


32493200 2020. Prevention of COVID-19 infection in the medical population: a possible help from anosmia?.



32396143 2020. Clinical and laboratory findings from patients with COVID-19 pneumonia in Babol North of Iran: a retrospective cohort study.
32435811 2020. COVID-19 Infection May Cause Clozapine Intoxication: Case Report and Discussion.


32512586 2020. Confronting COVID-19: Issues in Hemophilia and Congenital Bleeding Disorders.
32510876 2020. Differences in Clinical Characteristics of Covid-19 in Hispanic/Latino Population.
32510771 2020. COVID-19 In Lung Transplant Recipients: A Case Series From Milan, Italy.


32500942 2020. Outcome of COVID-19 in liver transplant recipients: A preliminary report from Northwestern Italy.
32500922 2020. Failed antibody response in a renal transplant recipient with SARS-CoV-2 infected.
32500666 2020. Coronavirus Disease 2019 in an Orthotopic Liver Transplant Recipient Living with Human Immunodeficiency Virus.
32492485 2020. Comparison of clinical and epidemiological characteristics of asymptomatic and symptomatic SARS-CoV-2 infection: A multi-center study in Sichuan Province, China.
32400381 2020. [De forste kliniske data fra RASi-behandlede indlagte patienter med COVID-19 kommer nu, og vi skal ikke aendre medicinering].




32223839 2020. [Epidemiology and clinical features of highly pathogenic human coronavirus infection in children].
32065520 2020. [First case of neonate infected with novel coronavirus pneumonia in China].
32294814 2020. [Recommendations for respiratory rehabilitation of coronavirus disease 2019 in adult].



32496259 2020. COVID-19-Hospitalized Patients in Karnataka: Survival and Stay Characteristics.
32393678 2020. COVID-19: Important Issues for Pediatricians.
32412915 2020. Managing Children with Renal Diseases during COVID-19 Pandemic.
32487797 2020. The seXY side of COVID-19: what is behind female protection?
32487793 2020. Severe respiratory failure in an immunocompetent host with invasive pulmonary aspergillosis and H1N1 influenza.
32487789 2020. Risk factors for mortality in patients with Coronavirus Disease 2019 (COVID-19) in Bolivia: An analysis of the first 107 confirmed cases.


32449528 2020. Effects of COVID-19 on Parkinson's Disease Clinical Features: A Community-Based Case-Control Study.
32470210 2020. Obesity is associated with worse outcomes in COVID-19: Analysis of Early Data From New York City.
32463562 2020. Possible Role of Adipose Tissue and Endocannabinoid System in COVID-19 Pathogenesis: Can Rimonabant Return?
32463545 2020. Obesity and COVID-19: an Italian snapshot.
32445512 2020. Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.
32445496 2020. Body Mass Index, Weight Discrimination, and Psychological, Behavioral, and Interpersonal Responses to the Coronavirus Pandemic.
32428380 2020. Increased ACE2 Expression in the Bronchial Epithelium of COPD Patients who are Overweight.
32505551 2020. Oral submucous fibrosis and COVID-19: Perspective on comorbidity.


32469426 2020. African American children are at higher risk of COVID-19 infection.
32437077 2020. Clinical characteristics of COVID-19 in children: Are they similar to those of SARS?
32501190 2020. Angiotensin converting enzyme 2 (ACE2) and COVID-19: using antihypertensive medications, pharmacogenetic considerations.
32461198 2020. COVID-19, hypertension and cardiovascular diseases: Should we change the therapy?
32505834 2020. Would ACEIs/ARBs be beneficial for COVID-19 patients without hypertension?



32463446 2020. Familial cluster of SARS-CoV-2 infection associated with a railway journey.
32250460 2020. Impact of the COVID-19 Pandemic on Parkinson's Disease and Movement Disorders.
32484584 2020. COVID-19 in Parkinson's Disease Patients Living in Lombardy, Italy.
32479103 2020. Special report: Prevalence of selected underlying health conditions among active component Army service members with coronavirus disease 2019, 11 February-6 April 2020.
32467603 2020. Resistance of children to Covid-19. How?
32463329 2020. Alemtuzumab in multiple sclerosis during the COVID-19 pandemic: A mild uncomplicated infection despite intense immunosuppression.
32391998 2020. De eerste 29 COVID-19-patienten in de kliniek.
32391997 2020. De eerste honderd opgenomen COVID-19-patienten in het Elisabeth-Tweesteden Ziekenhuis.


32498065 2020. Neonates Hospitalized with Community-Acquired SARS-CoV-2 in a Colorado Neonatal Intensive Care Unit.
32237206 2020. Obesity and its Implications for COVID-19 Mortality.
32384387 2020. A Postpartum Death Due to Coronavirus Disease 2019 (COVID-19) in the United States.
32384385 2020. Acute Respiratory Distress Syndrome in a Preterm Pregnant Patient With Coronavirus Disease 2019 (COVID-19).
32459701 2020. Symptoms and Critical Illness Among Obstetric Patients With Coronavirus Disease 2019 (COVID-19) Infection.
32433453 2020. Clinical Findings and Disease Severity in Hospitalized Pregnant Women With Coronavirus Disease 2019 (COVID-19).
32433451 2020. Lymphopenia and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Hospitalized Obstetric Patients.
32496337 2020. Prevalence and Severity of Coronavirus Disease 2019 (COVID-19) Illness in Symptomatic Pregnant and Postpartum Women Stratified by Hispanic Ethnicity.


32482123 2020. SARS-CoV-2 Infection in Health Care Workers: Cross-sectional Analysis of an Otolaryngology Unit.


32413201 2020. Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak.




32404786 2020. Clinical Analysis of 25 Novel Coronavirus Infections in Children.


32398569 2020. COVID-19 in Children, Pregnancy and Neonates: A Review of Epidemiologic and Clinical Features.



32404791 2020. COVID-19 in the Pediatric Population Admitted to a Tertiary Referral Hospital in Northern Italy: Preliminary Clinical Data.
32404780 2020. First Case of Coronavirus Disease 2019 in Childhood Leukemia in China.
32384398 2020. COVID-19 in Neonates and Infants: Progression and Recovery.
32384397 2020. Children Hospitalized With Severe COVID-19 in Wuhan.


32492251 2020. Clinical manifestations of children with COVID-19: A systematic review.
32483934 2020. Overview: The history and pediatric perspectives of severe acute respiratory syndromes: Novel or just like SARS.
32392382 2020. COVID-19: A message of hope from a young girl with severe cystic fibrosis.


32409480 2020. Caring for Newborns Born to Mothers with COVID-19: More Questions than Answers.
32404431 2020. A Case Series of the 2019 Novel Coronavirus (SARS-CoV-2) in Three Febrile Infants in New York.


32419564 2020. Consideration of prevention and management of long-term consequences of post-acute respiratory distress syndrome in patients with COVID-19.
32449876 2020. COVID-19: an unprecedented pandemia with a potential arrhythmic undertone.
32434874 2020. Elevated N-terminal pro-brain natriuretic peptide is associated with increased mortality in patients with COVID-19: systematic review and meta-analysis.
32338566 2020. Experiences and Insights from the Early US COVID-19 Epicenter: A Rapid Assessment Procedure Informed Clinical Ethnography Case Series.
32286091 2020. Mental health burden for the public affected by the COVID-19 outbreak in China: Who will be the high-risk group?
32442308 2020. The Clinical Features and Outcomes of Discharged Coronavirus Disease 2019 PatientsA Prospective Cohort Study.



32374550 2020. Covid-19: la troublante decouverte des possibles vertus de la nicotine.
32374540 2020. Prise en charge de l'asthme et de la BPCO en situation de pandemie de COVID-19.
32374539 2020. Pandemie de COVID-19 : aspects cardiologiques.
32462846 2020. COVID-19: differences de symptomatologie entre la Chine et l'Europe.
32462841 2020. Obesite et risque de COVID-19 severe.
32432429 2020. COVID-19: elements de connaissances concernant les enfants.
32401442 2020. Les bloqueurs du systeme renine-angiotensine-aldosterone en temps de pandemie Covid-19 : amis ou ennemis ?
32496707 2020. La rehabilitation: indispensable pour les survivants d'un COVID-19 severe.



32348050 2020. Prise en charge des patients avec maladies digestives et hepatiques durant la pandemie COVID-19.
32348048 2020. COVID-19 : impact pediatrique.




32458742 2020. Nurse infected with Covid-19 from a provisional dengue patient.



32467096 2020. Clinicopathological characteristics of 8697 patients with COVID-19 in China: meta-analysis.


32474561 2020. Clinical Characteristics of Elderly Patients with COVID-19 in Hunan Province, China: A Multicenter, Retrospective Study.
32482915 2020. Expression of Receptors for SARS-CoV-2 in the Gut of Patients with Inflammatory Bowel Disease.
32436996 2020. The value of clinical parameters in predicting the severity of COVID-19.


32418216 2020. Children with coronavirus disease 2019: A review of demographic, clinical, laboratory, and imaging features in pediatric patients.
32510106 2020. Clinical Presentation of COVID19 in Dementia Patients.
32418199 2020. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).


32459046 2020. Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID-19.
32492092 2020. Epidemiology, Clinical Features, and Disease Severity in Patients With Coronavirus Disease 2019 (COVID-19) in a Children's Hospital in New York City, New York.
32505466 2020. Cyclosporine as preferred calcineurin inhibitor in renal allograft recipients with COVID-19 infection.



32505846 2020. The use of ibuprofen to treat fever in COVID-19: A possible indirect association with worse outcome?
32512494 2020. Could nutritional and functional status serve as prognostic factors for COVID-19 in the elderly?
32441063 2020. Coronavirus disease 2019 (COVID-19): angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and cardiovascular disease.


32472989 2020. Relationship between ACE-inhibitors, ARBs and SARS-CoV-2 infection: where are we?
32508078 2020. SARS-CoV-2 infection in pregnant women: are there long-term effects in offspring's brain development?
32480326 2020. Are type 1 interferons treatment in Multiple Sclerosis as a potential therapy against COVID-19?
32480327 2020. Benign course of COVID-19 in a multiple sclerosis patient treated with Ocrelizumab.
32460086 2020. B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran.



32497334 2020. A missing link between SARS-CoV-2 and the eye?: ACE2 expression on the ocular surface.


32497297 2020. Gendered effects on inflammation reaction and outcome of COVID-19 patients in Wuhan.
32497290 2020. Epidemiological evidence for association between higher influenza vaccine uptake in the elderly and lower COVID-19 deaths in Italy.


32508329 2020. COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome.
32500549 2020. Clinical update on COVID-19 in pregnancy: A review article.
32423324 2020. Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab.


32390643 2020. COVID-19 and Parkinson's Disease: Are We Dealing with Short-term Impacts or Something Worse?
32441753 2020. Clinical and Epidemiological Features of a Family Cluster of Symptomatic and Asymptomatic SARS-CoV-2 Infection.
32441743 2020. A Case Report of Neonatal Acute Respiratory Failure Due to SARS-CoV-2.
32504532 2020. Coronavirus Disease 2019 in Children Cared for at Texas Children's Hospital: Initial Clinical Characteristics and Outcomes.
32479632 2020. Characteristics of Hospitalized Pediatric COVID-19 Cases - Chicago, Illinois, March - April 2020.
32401228 2020. Are Covid-19-positive mothers dangerous for their term and well newborn babies? Is there an answer?
32404798 2020. Long-term Pulmonary Consequences of Coronavirus Disease 2019 (COVID-19): What We Know and What to Expect.


32348627 2020. Hereditary Haemorrhagic Telangiectasia: a disease not to be forgotten during the COVID-19 pandemic.


32432681 2020. Nasal ACE2 Levels and COVID-19 in Children.
32391864 2020. COVID-19 and Racial/Ethnic Disparities.
32215579 2020. Can SARS-CoV-2 Infection Be Acquired In Utero?: More Definitive Evidence Is Needed.
32511673 2020. Association Between Mode of Delivery Among Pregnant Women With COVID-19 and Maternal and Neonatal Outcomes in Spain.
32250408 2020. Critical Illness in Patients With COVID-19: Mounting an Effective Clinical and Research Response.
32293639 2020. COVID-19 and African Americans.


32401283 2020. Low-Income Children and Coronavirus Disease 2019 (COVID-19) in the US.
32392288 2020. Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units.
32511066 2020. Effect of Cancer on Clinical Outcomes of Patients With COVID-19: A Meta-Analysis of Patient Data.
32369410 2020. Management of Febrile Neutropenia Associated With SARS-CoV-2 Infection in a Patient With Cancer.
32394850 2020. [Role of age, comorbidity and renin- angiotensin-aldosterone system in COVID-19. Effects of ACE inhibitors and angiotensin receptor blockers].


32471013 2020. Low prevalence and disease severity of COVID-19 in post liver transplant recipients - a single centre experience.
32495496 2020. Abnormal liver tests in patients hospitalized with Coronavirus disease 2019: should we worry?
32502316 2020. COVID-19 Infection in Early Post-Operative Period after Liver Transplantation.
32485314 2020. Persistent SARS-CoV-2 infection and the risk for cancer.
32512287 2020. Evaluation of COVID-19 infection in patients with Neuromyelitis optica spectrum disorder (NMOSD): A report from Iran.


32320565 2020. First Case of Covid-19 in the United States. Reply.
32320563 2020. First Case of Covid-19 in the United States.
32320562 2020. First Case of Covid-19 in the United States.
32320561 2020. First Case of Covid-19 in the United States.
32320560 2020. First Case of Covid-19 in the United States.
32320559 2020. First Case of Covid-19 in the United States.
32220206 2020. Clinical Characteristics of Covid-19 in China. Reply.
32220205 2020. Clinical Characteristics of Covid-19 in China.
32220204 2020. Clinical Characteristics of Covid-19 in China.
32220203 2020. Clinical Characteristics of Covid-19 in China.
32220202 2020. Clinical Characteristics of Covid-19 in China.


32427431 2020. Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19. Reply.
32427430 2020. Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19.
32427429 2020. Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19.
32427428 2020. Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19.
32329974 2020. Mild or Moderate Covid-19.
32427903 2020. How to address the coronavirus's outsized toll on people of colour.


32265541 2020. Why measles deaths are surging - and coronavirus could make it worse.
32395965 2020. Een man met dyspneu na een COVID-19-pneumonie.


32403153 2020. COVID-19-assoziierte Pneumonie trotz persistierend negativen PCR-Tests aus oropharyngealen Abstrichen.
32449179 2020. Mortality in Older Patients with COVID-19.
32441771 2020. COVID-SAFER: Deprescribing Guidance for Hydroxychloroquine Drug Interactions in Older Adults.
32445276 2020. Prosthetic aortic valve endocarditis complicated by COVID-19 and hemorrhage.
32452050 2020. The outlook for diagnostic purposes of the 2019-novel coronavirus disease.
32459882 2020. Comment on "Is the type of diabetes treatment relevant to outcome of COVID-19?"


32455485 2020. The COVID-19 outbreak in dermatologic surgery: resetting clinical priorities.
32455475 2020. COVID-19 in a melanoma patient under treatment with checkpoint-inhibition.
32426877 2020. Metastatic melanoma treatment with checkpoint inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit.


32436622 2020. Metabolic associated fatty liver disease increases coronavirus disease 2019 disease severity in nondiabetic patients.
32512022 2020. Early administered antibiotics do not impact mortality in critically ill patients with COVID-19.
32512021 2020. Anormal pulmonary function and residual CT abnormalities in rehabilitating COVID-19 patients after discharge.
32504736 2020. Tumor biomarkers predict clinical outcome of COVID-19 patients.
32458565 2020. Mortality of people with intellectual disabilities during the 2017/2018 influenza epidemic in the Netherlands: potential implications for the COVID-19 pandemic.
32459372 2020. COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy?
32500773 2020. COVID-19 and Acute Lupus Pneumonitis: Diagnostic and Treatment Dilemma.
32470212 2020. Letter to the Editor: Are severe COVID-19 patients more susceptible to conjunctivitis?


32470186 2020. Correlation between the variables collected at admission and progression to severe cases during hospitalization among patients with COVID-19 in Chongqing.
32470174 2020. Higher prevalence of asymptomatic or mild COVID-19 in children, claims and clues.
32470167 2020. Early risk factors of the exacerbation of Coronavirus disease 2019 pneumonia.





32441816 2020. Systematic analysis of ACE2 and TMPRSS2 expression in salivary glands reveals underlying transmission mechanism caused by SARS-CoV-2.
32441789 2020. Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis.



32437017 2020. Epidemiological and clinical characteristics of discharged patients infected with SARS-CoV-2 on the Qinghai plateau.
32437016 2020. Obesity predisposes to the risk of higher mortality in young COVID-19 patients.



32436998 2020. Lack of viral transmission to preterm newborn from a COVID-19 positive breastfeeding mother at 11 days postpartum.


32505438 2020. The Association Between Symptom Onset and Length of Hospital Stay in 2019 Novel Coronavirus Pneumonia Cases Without Epidemiological Trace.
32505908 2020. Immunologic characterization of a immunosuppressed multiple sclerosis patient that recovered from SARS-CoV-2 infection.
32385130 2020. Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan, China.
32467113 2020. Presentation and Outcomes of Patients with ESKD and COVID-19.
32484893 2020. Elevated Cardiac Troponin I Is Associated with Poor Outcomes in COVID-19 Patients at an Academic Medical Center in Midwestern USA.



32510598 2020. Single-cell RNA analysis on ACE2 expression provides insights into SARS-CoV-2 potential entry into the bloodstream and heart injury.
32433344 2020. Judicious Use of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Diabetes on Coronavirus-19 Pandemic.


32502117 2020. Coronavirus disease 2019 in children: Current status.
32474598 2020. Predicting mortality due to SARS-CoV-2: A mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico.


32488958 2020. Analysis of clinical features and outcomes of 161 patients with severe and critical COVID-19: A multicenter descriptive study.
32488888 2020. Elevated serum aspartate aminotransferase level identifies patients with coronavirus disease 2019 and predicts the length of hospital stay.
32479133 2020. TMPRSS2 and ACE2 Coexpression in SARS-CoV-2 Salivary Glands Infection.
32406283 2020. A survey of psoriasis patients on biologics during COVID-19: a single centre experience.
32363967 2020. A challenging case of psoriasis flare-up after COVID-19 infection.
32433220 2020. When life is put on hold, how do we hold on to life? - Challenges and Opportunities in Developmental and Behavioral Pediatrics during COVID-19.
32394639 2020. COVID-19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity?
32389027 2020. Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States.
32506937 2020. Why Do People With Diabetes Have a High Risk for Severe COVID-19 Disease?-A Dental Hypothesis and Possible Prevention Strategy.



32506122 2020. Clinical Characteristics of Hospitalized Individuals Dying with COVID-19 by Age Group in Italy.
32490807 2020. Clinical Progress Note: Point-of-Care Ultrasound Applications in COVID-19.
32502097 2020. Angiotensin-converting enzyme inhibitors, angiotensin II type 1 receptor blockers and risk of COVID 19: information from Bartter's and Gitelman's syndromes patients.
32502096 2020. Are COVID-19 patients with hypertension at higher risk in China?



32504741 2020. Does type of immunosupression influence the course of Covid-19 infection?
32490559 2020. Supporting individuals with intellectual and developmental disability during the first 100 days of the COVID-19 outbreak in the USA.
32462792 2020. Sex-based dimorphism in the SARS-CoV2 virulence.
32452046 2020. Racial disparities in COVID-19 deaths reveal harsh truths about structural inequality in America.
32498135 2020. Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States.


32498581 2020. Relationship between pregnancy and coronavirus: what we know.
32223477 2020. Pregnant women in the exposure to COVID-19 infection outbreak: the unseen risk factors and preventive healthcare patterns.
32369209 2020. Clinical characteristics and outcomes of cancer patients with COVID-19.



32492209 2020. Determining Host Factors Contributing to Disease Severity in a Family Cluster of 29 Hospitalized SARS-CoV-2 Patients: Could Genetic Factors Be Relevant in the Clinical Course of COVID-19?.




32314808 2020. Comment on Li et al: COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis.
32335609 2020. Clinical Profile of Cases of COVID-19 in Far Western Province of Nepal.




32409438 2020. Treating acute anxiety in patients with COVID-19.
32409436 2020. Patients with interstitial lung disease and pulmonary sarcoidosis are at high risk for severe illness related to COVID-19.
32409434 2020. Renin-angiotensin system inhibitors in COVID-19.
32393596 2020. COVID-19 and pulmonary hypertension.



32452350 2020. Understanding immune effects of oestrogens to explain the reduced morbidity and mortality in female versus male COVID-19 patients. Comparisons with autoimmunity and vaccination.
32461326 2020. Baseline characteristics and outcomes of patients with COVID-19 admitted to intensive care units in Vancouver, Canada: a case series.


32409520 2020. Probable congenital SARS-CoV-2 infection in a neonate born to a woman with active SARS-CoV-2 infection.


32456720 2020. COVID-19 infections among HCWs exposed to a patient with a delayed diagnosis of COVID-19.



32449224 2020. Analysis of the clinical characteristics, drug treatments and prognoses of 136 patients with coronavirus disease 2019.



32242895 2020. Experiences and lesson strategies for cardiology from the COVID-19 outbreak in Wuhan, China, by 'on the scene' cardiologists.
32498078 2020. Renin-angiotensin system inhibitors in the COVID-19 pandemic: consequences of antihypertensive drugs.
32423251 2020. Comparison of cardiovascular metabolic characteristics and impact on COVID-19 and MERS.
32423249 2020. Physical activity/inactivity and COVID-19.
32397803 2020. Les liaisons dangereuses and the danger of deductions: The interplay between cardiovascular disease and COVID-19.
32475157 2020. Exercise in the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) era: A Question and Answer session with the experts Endorsed by the section of Sports Cardiology & Exercise of the European Association of Preventive Cardiology (EAPC).
32270698 2020. Physical inactivity and cardiovascular disease at the time of coronavirus disease 2019 (COVID-19).
32233671 2020. Have a heart during the COVID-19 crisis: Making the case for cardiac rehabilitation in the face of an ongoing pandemic.
32495914 2020. No infectious risk of COVID-19 patients with long-term fecal 2019-nCoV nucleic acid positive.


32495849 2020. Gender differences in COVID-19 infection. The estrogen effect on upper and lower airways. Can it help to figure out a treatment?
32441761 2020. COVID-19 and QT interval prolongation: more than just drug toxicity?
32441223 2020. COVID-19 and obesity: links and risks.
32511033 2020. COVID-19 and diabetes mellitus: implications for prognosis and clinical management.



32420884 2020. Pathologies cardiovasculaires et Covid-19 : particularites chez les personnes agees.
32434831 2020. Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study.


32414813 2020. Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores.
32493828 2020. Prevalence, risk factors and clinical outcomes of COVID-19 in patients with a history of pancreatitis in Northern California.
32431118 2020. [CURRENT KNOWLEDGE ON COVID-19 IN CHILDREN - CAUTIOUS OPTIMISM].
32437224 2020. Disparities In Outcomes Among COVID-19 Patients In A Large Health Care System In California.
32461330 2020. Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis.
32461328 2020. Getting to the heart of the matter of COVID-19.
32451360 2020. Cardiovascular disease and COVID-19: implications for prevention, surveillance and treatment.


32364920 2020. A Case of Postoperative Covid-19 Infection After Cardiac Surgery: Lessons Learned.


32415860 2020. Liver Biochemistries in Hospitalized Patients With COVID-19.
32512611 2020. Endocrine Conditions and COVID-19.


32456489 2020. Complications and outcomes of SARS-CoV-2 in pregnancy: where and what is the evidence?
32383626 2020. RAAs inhibitors and outcome in patients with SARS-CoV-2 pneumonia. A case series study.
32383624 2020. Controversial Relationship between Renin-Angiotensin System Inhibitors and Severity of COVID-19: Announcing a Large Multicentre Case-Control Study in Italy.
32458694 2020. Decreased Mortality of COVID-19 with Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients with Hypertension: A Meta-Analysis.
32493070 2020. Comparative impacts of angiotensin converting enzyme inhibitors versus angiotensin II receptor blockers on the risk of COVID-19 mortality.
32476472 2020. COVID-19: ACE2centric infective disease?


32389131 2020. A case of COVID-19 with an ultralong incubation period.
32427018 2020. Several neonates reported positive for COVID-19.


32476537 2020. Early experience with COVID-19 patients at academic hospital in Southwestern United States.


32418532 2020. Counter-regulatory 'Renin-Angiotensin' System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected patients.
32389117 2020. A Viewpoint on Angiotensin-Converting Enzyme 2, Anti-Hypertensives and Coronavirus Disease 2019 (COVID-19).
32348232 2020. A Patient with COVID-19 Disease in a Referral Hospital in Iran: A Typical Case.



32506768 2020. Clinical features and outcomes of COVID-19 patients with benign prostatic hyperplasia in aging male: A retrospective study of 18 cases.
32506743 2020. No current evidence supporting risk of using Ibuprofen in patients with COVID-19.
32363628 2020. Management of older people during the COVID-19 outbreak: Recommendations from an Italian experience.
32473603 2020. Maternal mortality from COVID-19 in Mexico.
32438521 2020. Update on clinical outcomes of women with COVID-19 during pregnancy.
32428290 2020. Severe COVID-19 in a pregnant patient admitted to hospital in Wuhan.
32510581 2020. Clinical characteristics and laboratory results of pregnant women with COVID-19 in Wuhan, China.
32330289 2020. Be aware of misdiagnosis-Influenza A H1N1 in a pregnant patient with suspected COVID-19.
32510283 2020. EXPRESS: COVID-19 and stroke in Iran; a case series, and effects on stroke admissions.



32267662 2020. Pregnancy and Sars-Cov-2: A Novel Virus in a Unique Population



32418475 2020. Who are the Most At-Risk Older Adults in the COVID-19 Era? It's Not Just Those in Nursing Homes.
32250655 2020. Call to Action: Announcing the Traditional, Complementary and Integrative Health and Medicine COVID-19 Support Registry.



32511148 2020. COVID-19 and Its Potential Effect on Patients With Rheumatic Diseases in Latin America.
32364930 2020. Circadian rhythm sleep-wake disorders and the COVID-19 pandemic.
32364928 2020. Dental sleep medicine perspectives post-COVID-19: interprofessional adaptation and directions.


32441246 2020. Does obstructive sleep apnea lead to increased risk of COVID-19 infection and severity?
32356516 2020. Potential influences of obstructive sleep apnea and obesity on COVID-19 severity.
32484776 2020. COVID-19 and obstructive sleep apnea.
32347205 2020. Narcolepsy and COVID-19: sleeping on an opportunity?
32449619 2020. Preliminary Data Suggests That Biologics in Dermatology Are Not Associated With Adverse COVID-19 Outcomes.
32464084 2020. The first two months of COVID-19 pandemic in Bosnia and Herzegovina: Single-center experience.
32415815 2020. Lessons Learned from COVID-19 Pandemic in Italy.


32454503 2020. Stroke in COVID-19 and SARS-CoV-1.



32508037 2020. Mental health status and related influencing factors of COVID-19 survivors in Wuhan, China.


32508024 2020. Clinical characteristics and risk factors for mortality among inpatients with COVID-19 in Wuhan, China.
32508041 2020. Significance of clinical phenomes of patients with COVID-19 infection: A learning from 3795 patients in 80 reports.
32507407 2020. COVID 19-An eye on the virus.
32505211 2020. Lung ventilation function characteristics of survivors from severe COVID-19: a prospective study.


32505652 2020. Detrimental effects of metabolic dysfunction-associated fatty liver disease and increased neutrophil-to-lymphocyte ratio on severity of COVID-19.
32505980 2020. Relationship between COVID-19 and obesity.
32469464 2020. Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19.
32463179 2020. Exposure to DPP-4 inhibitors and COVID-19 among people with type 2 diabetes. A case-control study.
32463166 2020. Why is hyperglycemia worsening COVID-19 and its prognosis?
32451317 2020. The contribution of diabetic micro-angiopathy to adverse outcomes in COVID-19.
32506222 2020. COVID-19: Impact of and on Diabetes.



32438449 2020. The Dilemma of Renin Angiotensin System Blockers in Coronavirus Disease (Covid-19): Insights on the Lung Fluid Handling and Gas Exchange in Heart Failure Patients.


32507518 2020. Does active smoking worsen Covid-19?
32460417 2020. COVID-19 - neurologists stay aware!



32505514 2020. COVID-19 infection during the third trimester of pregnancy: Current clinical dilemmas.
32504135 2020. Point-of-care lung ultrasound in three neonates with COVID-19.
32339038 2020. ST-Segment-Elevation Myocardial Infarction Care and COVID-19: The Value Proposition of Fibrinolytic Therapy and the Pharmacoinvasive Strategy.
32500721 2020. Approach to Acute Cardiovascular Complications in COVID-19 Infection.
32482087 2020. Incidence of New-Onset and Worsening Heart Failure Before and After the COVID-19 Epidemic Lockdown in Denmark: A Nationwide Cohort Study.



32386189 2020. ACE Ins/Del genetic polymorphism and epidemiological findings in COVID-19.
32386188 2020. No significant correlation between ACE Ins/Del genetic polymorphism and COVID-19 infection.



32423908 2020. Early Outcomes of Outpatient Management of Kidney Transplant Recipients with Coronavirus Disease 2019.
32390405 2020. COVID-19 Viral Load of an Infected Family in China.


32414711 2020. The renin-angiotensin system - a therapeutic target in COVID-19?
32462940 2020. Characteristics of Children With Reactivation of SARS-CoV-2 Infection After Hospital Discharge.
32468411 2020. COVID-19 and Asthma: Reflection During the Pandemic.
32507883 2020. Covid-19: the renin-angiotensin system imbalance hypothesis.


32463005 2020. The COVID-19 Pandemic: A Challenge for the Cardiovascular Health.
32442082 2020. Severe acute respiratory syndrome coronavirus 2 is penetrating to dementia research.
32448405 2020. Characteristics of patients with COVID-19 pneumonia at Hvidovre Hospital, March-April 2020.
32475056 2020. Psoriasis, COVID-19 and acute respiratory distress syndrome: focusing on the risk of concomitant biological treatment.


32474988 2020. Non-complicated evolution of COVID-19 infection in a patient with psoriasis and psoriatic arthritis during treatment with adalimumab.
32406078 2020. COVID-19 in an elderly patient treated with secukinumab.



32478942 2020. Covid-19 infection in psoriasis patients treated with cyclosporin.
32430456 2020. Outcomes in Patients With Hyperglycemia Affected by Covid-19: Can We Do More on Glycemic Control?
32409505 2020. COVID-19 in People With Diabetes: Urgently Needed Lessons From Early Reports.
32409504 2020. Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study.
32409502 2020. Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China.
32409499 2020. Obesity Is a Risk Factor for Greater COVID-19 Severity.
32409498 2020. Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication.
32496012 2020. Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 infection.
32482296 2020. COVID-19: Perspectives from people with diabetes.


32423922 2020. More advice on the use of ibuprofen for COVID-19.
32468357 2020. An unresponsive COVID-19 patient.


32432700 2020. Return to sports after COVID-19 infection.


32498076 2020. Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study.


32449762 2020. Acute coronary syndromes during COVID-19.
32432723 2020. Renin-angiotensin system and SARS-CoV-2 infection: there is a before and after.
32432704 2020. Renin-angiotensin-aldosterone system dysregulation and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.


32464637 2020. The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin system.
32501480 2020. Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: effects on blood pressure control and mortality.
32501477 2020. Antihypertensive drugs in COVID-19 infection.
32511752 2020. COVID-19 and End Stage Renal Disease.
32511751 2020. SARS-CoV-2: what is known and what there is to know. Focus on coagulation and lipids.
32469251 2020. The gendered impact of coronavirus disease (COVID-19): do estrogens play a role?
32453009 2020. Dangerous interactions of gastrointestinal drugs with experimental treatments for COVID-19.
32282549 2020. Chronic liver disease is not associated with severity or mortality in Coronavirus disease 2019 (COVID-19): a pooled analysis.
32485082 2020. ACE-inhibitors and Angiotensin-2 Receptor Blockers are not associated with severe SARS-COVID19 infection in a multi-site UK acute Hospital Trust.




32470281 2020. La bronquiolitis en el ano del COVID-19.
32505489 2020. ROLE OF REHABILITATION DEPARTMENT FOR ADULT COVID-19 PATIENTS: THE EXPERIENCE OF THE SAN RAFFAELE HOSPITAL OF MILAN.
32401850 2020. Coronavirus e o Coracao
32401847 2020. O Coracao e a COVID-19: O que o Cardiologista Precisa Saber.
32401844 2020. COVID-19: Dados Atualizados e sua Relacao Com o Sistema Cardiovascular.
32491075 2020. Implicacoes Cardiovasculares em Pacientes Infectados com Covid-19 e a Importancia do Isolamento Social para Reduzir a Disseminacao da Doenca.


32491073 2020. O Efeito da Doenca de Coronavirus 2019 nas Doencas Cardiovasculares.
32386125 2020. Capturing patient-reported outcomes during the COVID-19 pandemic: Development of the COVID-19 Global Rheumatology Alliance Patient Experience Survey.
32458534 2020. Mild course of Coronavirus disease 2019 and spontaneous severe acute respiratory syndrome coronavirus 2 clearance in a patient with depleted peripheral blood B-cells due to treatment with rituximab.
32472827 2020. First Successful Treatment of Coronavirus Disease 2019 Induced Refractory Cardiogenic Plus Vasoplegic Shock by Combination of Percutaneous Ventricular Assist Device and Extracorporeal Membrane Oxygenation: A Case Report.
32512532 2020. Lived experiences of the corona survivors (patients admitted in COVID wards): A narrative real-life documented summaries of internalized guilt, shame, stigma, anger.


32471884 2020. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series.
32467124 2020. 80-year-old man with dyspnoea and bilateral groundglass infiltrates: an elusive case of COVID-19.
32503812 2020. Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study.


32469077 2020. Covid-19 in Bone Marrow Transplant Recipients: Reflecting on a Single Centre Experience.




32438482 2020. Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with multiple myeloma receiving systemic anti-cancer therapy.




32420611 2020. More on 'Association between ABO blood groups and risk of SARS-CoV-2 pneumonia'.
32420609 2020. Clinical outcome of coronavirus disease 2019 in haemato-oncology patients.
32420608 2020. Patients with sickle cell disease and suspected COVID-19 in a paediatric intensive care unit.
32452530 2020. Abdominal fluid samples (negative for SARS-CoV-2) from a critically unwell patient with respiratory COVID-19.
32408910 2020. Interdisciplinary and Collaborative Approaches Needed to Determine Impact of COVID-19 on Older Adults and Aging: CAG/ACG and CJA/RCV Joint Statement.
32470162 2020. Management of a patient presenting with anterior STEMI with concomitant COVID-19 infection early in the course of the U.S. pandemic.



32427288 2020. ACE2 Receptor Expression in Testes: Implications in COVID-19 Pathogenesis.


32444450 2020. SARS-CoV-2 infection in ambulatory and hospitalised Spanish children.
32422078 2020. Effects of SARS-CoV-2 infection on pregnant women and their infants: A retrospective study in Wuhan, China.
32338533 2020. INFECTIONS IN PREGNANCY WITH COVID-19 AND OTHER RESPIRATORY RNA VIRUS DISEASES ARE RARELY, IF EVER, TRANSMITTED TO THE FETUS: EXPERIENCES WITH CORONAVIRUSES, HPIV, hMPV RSV, AND INFLUENZA.
32320546 2020. Criterios para la gestion de personas especialmente vulnerables y trabajadores/as especialmente sensibles frente al SARS-CoV-2 en las empresas de Cataluna en el contexto de pandemia.
32506699 2020. Incidence of COVID-19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data?
32475091 2020. Cardiovascular conditions and COVID-19.


32376670 2020. Covid-19: the challenge of patient rehabilitation after intensive care.
32366505 2020. Covid-19 and pregnancy.


32434891 2020. Covid-19 and cardiovascular disease.
32398229 2020. Covid-19: Low skilled men have highest death rate of working age adults.
32393504 2020. Covid-19: Known risk factors fail to explain the increased risk of death among people from ethnic minorities.
32357954 2020. Covid-19 is no worse in immunocompromised children, says NICE.
32217618 2020. Covid-19: risk factors for severe disease and death.
32213482 2020. Covid-19 and long term conditions: what if you have cancer, diabetes, or chronic kidney disease?
32209544 2020. Covid-19: most patients require mechanical ventilation in first 24 hours of critical care.
32327432 2020. Covid-19: Doctors should be alert for signs of myocardial injury, says NICE.
32291260 2020. Covid-19: Nine in 10 pregnant women with infection when admitted for delivery are asymptomatic, small study finds.
32303575 2020. Case series of coronavirus (SARS-CoV-2) in a military recruit school: clinical, sanitary and logistical implications.
32467101 2020. Symptom burden and clinical profile of COVID-19 deaths: a rapid systematic review and evidence summary.
32378464 2020. Long-term conditions and severe acute respiratory syndrome SARS-CoV-2 (COVID-19).


32484906 2020. Prevalence and Mortality due to Outbreak of Novel Coronavirus Disease (COVID-19) in beta-Thalassemias: The Nationwide Iranian Experience.


32479664 2020. A Case Series of MGUS and COVID-19.


32475821 2020. The Stanford Hall consensus statement for post-COVID-19 rehabilitation.


32311273 2020. Managing COVID-19-Positive Maternal-Infant Dyads: An Italian Experience.
32493522 2020. The impact of the Covid-19 Pandemic on Stroke Volume.


32471876 2020. Registries Offer Insights on COVID-19-Cancer Connection.
32398243 2020. Impact of PD-1 blockade on severity of COVID-19 in patients with lung cancers.
32427636 2020. ACE Inhibitors and ARBs in Patients with COVID-19: Friend or Foe?
32496364 2020. Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients With Coronavirus Disease 2019: Friend or Foe?
32427637 2020. The Novel Coronavirus Disease (COVID-19) and Its Impact on Cardiovascular Disease.


32209890 2020. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study.
32432519 2020. Does the compromised sleep and circadian disruption of night and shiftworkers make them highly vulnerable to 2019 coronavirus disease (COVID-19)?
32511019 2020. COVID-19 infection at nighttime.
32498625 2020. SARS-CoV-2/COVID-19 and physical distancing: risk for circadian rhythm dysregulation, advice to alleviate it, and natural experiment research opportunities.



32473009 2020. Age-dependent gender differences of COVID-19 in mainland China: comparative study.
32472683 2020. Detectable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human breast milk of a mildly symptomatic patient with coronavirus disease 2019 (COVID-19).
32472676 2020. Predictors for Severe COVID-19 Infection.



32444880 2020. Clinical Features and Outcomes of 105 Hospitalized patients with COVID-19 in Seattle, Washington.
32442294 2020. Therapy with agents acting on the renin-angiotensin system and risk of SARS-CoV-2 infection.
32442285 2020. Association of renin-angiotensin-aldosterone system inhibitors with COVID-19-related outcomes in Korea: a nationwide population-based cohort study.
32442265 2020. Characterization of an asymptomatic cohort of SARS-COV-2 infected individuals outside of Wuhan, China.
32442259 2020. Renin-angiotensin-aldosterone system inhibitors impact on COVID-19 mortality: What's next for ACE2?
32433729 2020. Symptomatic Infants have Higher Nasopharyngeal SARS-CoV-2 Viral Loads but Less Severe Disease than Older Children.
32211755 2020. Epidemiological and Clinical Predictors of COVID-19.

32502247 2020. Inverse association between chronic hepatitis B infection and COVID-19: immune-exhaustion or coincidence?


32444393 2020. Clinical Features of Maintenance Hemodialysis Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.


32441332 2020. Clinical course of coronavirus disease-2019 in pregnancy.



32470948 2020. Why does COVID-19 disproportionately affect older people?
32499448 2020. Comparison of clinical characteristics and outcomes of patients with coronavirus disease 2019 at different ages.


32496339 2020. Lipase Elevation in Patients With COVID-19.
32483005 2020. Liver Enzyme Elevation in Coronavirus Disease 2019: A Multicenter, Retrospective, Cross-Sectional Study.


32512038 2020. IgG Antibody Response to SARS-CoV-2 Infection and Viral RNA Persistence in Patients on Maintenance Hemodialysis.
32459524 2020. Obesity and COVID-19: Immune and metabolic derangement as a possible link to adverse clinical outcomes.



32491949 2020. Understanding the age divide in COVID-19: Why are children overwhelmingly spared?
32432918 2020. Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells.
32401670 2020. Treatment of COVID-19-exacerbated asthma: should systemic corticosteroids be used?


32436646 2020. Clinical outcome in solid organ transplant recipients with COVID-19: A single-center experience.
32503857 2020. Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies.
32469504 2020. Heralding Healthcare Professionals: Recognition of Neurological Deficits in COVID-19.


32420961 2020. Report of a series of healthy term newborns from convalescent mothers with COVID-19.
32420955 2020. Preliminary epidemiological analysis on children and adolescents with novel coronavirus disease (2019-nCoV) in a central area of Calabria region.


32420950 2020. The medical concerns of patients with thalassemias at the time of COVID-19 outbreak: The personal experience and the international recommendations.
32420949 2020. Rare Anaemias, Sickle-Cell Disease and COVID-19.
32420948 2020. SARS-CoV-2 infection in children in Parma.
32420942 2020. COVID19: potential cardiovascular issues in pediatric patients.
32420941 2020. Novel coronavirus infection and children.
32420939 2020. Assessment and treatment of older individuals with COVID 19 multi-system disease: Clinical and ethical implications.
32420934 2020. Tobacco smoking and COVID-19 pandemic: old and new issues. A summary of the evidence from the scientific literature.
32420930 2020. Primum non nocere. The SARS-CoV-2 pandemic course in oldest.
32420925 2020. Implications of SARSr-CoV 2 infection in thalassemias: Do patients fall into the "high clinical risk" category?
32474914 2020. Anxiety and depression levels among pregnant women with COVID-19.



32470131 2020. The COVID-19 Rehabilitation Pandemic.


32508193 2020. Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies.


32511678 2020. Use of RAAS inhibitors and risk of clinical deterioration in COVID-19: results from an Italian cohort of 133 hypertensives.
32380565 2020. COVID-19 in Newborns and Infants-Low Risk of Severe Disease: Silver Lining or Dark Cloud?
32438425 2020. COVID-19 in Pregnant Women: Case Series from One Large New York City Obstetrical Practice.
32428964 2020. The Relationship between Status at Presentation and Outcomes among Pregnant Women with COVID-19.
32403141 2020. Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review.
32503058 2020. Vertical Transmission of SARS-CoV-2: What is the Optimal Definition?
32467494 2020. In response to: Simpson R and Robinson L: Rehabilitation following critical illness in people with COVID-19 infection.
32467490 2020. The place of early rehabilitation in ICU for Covid-19.



32471004 2020. Early COVID-19 infection after lung transplantation.
32471001 2020. COVID-19 in elderly kidney transplant recipients.
32492753 2020. Recovery from COVID-19 following Hepatitis C, Human Immunodeficiency Virus Infection and Liver Transplantation.
32483909 2020. Renal Infarct in a COVID-19 Positive Kidney-Pancreas Transplant Recipient.
32476258 2020. Clinical Outcomes and Serologic Response in Solid Organ Transplant Recipients with COVID-19: A Case Series from the United States.
32431287 2020. Critical Care Management of Patients with COVID-19: Early Experience in Thailand.
32419694 2020. Case Report: COVID-19 Presenting as Acute Undifferentiated Febrile Illness-A Tropical World Threat.


32503849 2020. Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab.
32503848 2020. Response to: 'Severe COVID-19 associated pneumonia in 3 patients with systemic sclerosis treated with rituximab' by Avouac et al.
32205336 2020. Are my patients with rheumatic diseases at higher risk of COVID-19?
32354774 2020. Non-steroidal anti-inflammatory treatment during covid-19: friend or foe? Response to: 'Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID)' by Giollo et al.
32354773 2020. Diagnostic and therapeutic challenges for patients with ANCA-associated vasculitides at the time of COVID-19. Response to: 'Rituximab for granulomatosis with polyangiitis in the pandemic of COVID-19: lessons from a case with severe pneumonia' by Guilpain et al.
32321723 2020. What is the true incidence of COVID-19 in patients with rheumatic diseases? ===008===weiter dann



32451362 2020. Do underlying cardiovascular diseases have any impact on hospitalised patients with COVID-19?
32425272 2020. Early manifestation of ARDS in COVID-19 infection in a 51- year-old man affected by Mounier-Kuhn Syndrome.


32457005 2020. Flattening the disability curve: Rehabilitation and recovery after COVID-19 infection.



32450334 2020. The interplay of hypertension, ACE-2 and SARS-CoV-2: Emerging data as the "Ariadne's thread" for the "labyrinth" of COVID-19.


32440857 2020. Clinical course of COVID-19 in patients with pre-existing decompensated cirrhosis: initial report from China.
32386449 2020. Liver injury is associated with severe Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of retrospective studies.
32359177 2020. Longitudinal association between markers of liver injury and mortality in COVID-19 in China.


32527699 2020. El SRAA y el SARS-CoV-2: el acertijo a resolver.
32451303 2020. Hipertension y COVID-19: cuidados con los manguitos de presion arterial.


32439915 2020. Downregulation of ACE2 induces overstimulation of the renin-angiotensin system in COVID-19: should we block the renin-angiotensin system?
32523133 2020. SARS-CoV-2 downregulation of ACE2 and pleiotropic effects of ACEIs/ARBs.
32483311 2020. COVID-19 patients with hypertension have more severe disease: a multicenter retrospective observational study.
32436403 2020. Evidence That Renin-Angiotensin System Inhibitors Should Not Be Discontinued Due to the COVID-19 Pandemic.




32461911 2020. Progression of CXR features on a COVID-19 survivor.


32457811 2020. The lethal sex gap: COVID-19.
32473971 2020. Are there any association between COVID-19 severity and immunosuppressive therapy?
32489118 2020. Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitors.
32405087 2020. Continue ACE inhibitors/ ARB'S till further evidence in Coronavirus disease 2019 (COVID-19).


32405088 2020. Cardiological society of India position statement on COVID-19 and heart failure.
32317806 2020. Carpal Fracture and COVID-19 Infection: Observation from Thailand.
32410003 2020. Pathophysiology of COVID-19: Why Children Fare Better than Adults?


32504454 2020. Manifestations in Neonates Born to COVID-19 Positive Mothers.
32495219 2020. Clinical Features and Treatment Protocol in Eleven Chinese Children with Mild COVID-19.
32370577 2020. Risk factors for disease progression in hospitalized patients with COVID-19: a retrospective cohort study.
32462545 2020. Treatments Administered to the First 9152 Reported Cases of COVID-19: A Systematic Review.


32415334 2020. Recurrence of COVID-19 after recovery: a case report from Italy.


32394344 2020. COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients.
32390091 2020. Clinical characteristics of 194 cases of COVID-19 in Huanggang and Taian, China.



32532944 2020. Prognosis of COVID-19: Changes in laboratory parameters.
32532943 2020. Differences among confirmed and not-confirmed COVID-19 patients at "D.Cotugno" hospital, Naples (Italy): what we learned from first suspected cases?


32532938 2020. COVID-19 and pregnancy: a review of current knowledge.




32397011 2020. Epidemiological, clinical, and virological characteristics of 465 hospitalized cases of coronavirus disease 2019 (COVID-19) from Zhejiang province in China.
32516795 2020. Asthma and the Coronavirus Disease 2019 Pandemic: A Literature Review.
32418736 2020. Why are women better protected from COVID-19: Clues for men? Sex and COVID-19.


32425514 2020. Covid-19 and COPD: A Personal Reflection.
32410206 2020. Clinical characteristics and drug therapies in patients with the common-type coronavirus disease 2019 in Hunan, China.
32266754 2020. COVID-19: Risk groups, mechanistic insights and challenges.


32492533 2020. Clinical Features and Short-term Outcomes of Elderly Patients With COVID-19.
32470606 2020. Clinical Characteristics of Critically Ill Patients Co-infected with SARS-CoV-2 and the Influenza Virus in Wuhan, China.
32464272 2020. Uganda's First 100 COVID-19 Cases: Trends and Lessons.


32417248 2020. SARS-CoV-2 infection diagnosed only by cell culture isolation before the local outbreak in an Italian seven-week-old suckling baby.



32535301 2020. Comparison of Hospitalized Patients with pneumonia caused by COVID-19 and influenza A in children under 5 years.
32497798 2020. A Follow-up Study of Recovered Patients with COVID-19 in Wuhan, China.


32335337 2020. Hypertension prevalence in human coronavirus disease: the role of ACE system in infection spread and severity.
32444771 2020. Insight into the relationship between obesity-induced low-level chronic inflammation and COVID-19 infection.
32514077 2020. COVID-19 and fat embolism: a hypothesis to explain the severe clinical outcome in people with obesity.
32480136 2020. Asymptomatic COVID-19 infection in a child with nasal foreign body.
32451563 2020. Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis.
32458212 2020. Patients with chronic kidney disease have a poorer prognosis of coronavirus disease 2019 (COVID-19): an experience in New York City.
32451579 2020. The baby lung and the COVID-19 era.




32385628 2020. Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?
32474850 2020. Clinical features of 1487 COVID-19 patients with outpatient management in the Greater Paris: the COVID-call study.


32430652 2020. COVID-19: counter-intuitive data on smoking prevalence and therapeutic implications for nicotine.
32424634 2020. Antagonizing the renin-angiotensin-aldosterone system in the era of COVID-19.
32514683 2020. Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?: Comment.



32470485 2020. Does asthma affect morbidity or severity of Covid-19?
32450087 2020. ACE2, TMPRSS2, and furin gene expression in the airways of people with asthma-implications for COVID-19.
32417136 2020. COVID-19 in a patient with severe chronic rhinosinusitis with nasal polyps during therapy with dupilumab.
32417445 2020. Asthma prolongs intubation in COVID-19.


32405123 2020. Optimizing Care for Atopic Dermatitis Patients During COVID-19 Pandemic.



32470515 2020. Ramipril in High Risk Patients with COVID-19.


32383778 2020. A Unique Presentation of Delirium in a Patient with Otherwise Asymptomatic COVID-19.
32383809 2020. Risk Factors for Mortality in 244 Older Adults With COVID-19 in Wuhan, China: A Retrospective Study.
32329525 2020. Characteristics and Palliative Care Needs of COVID-19 Patients Receiving Comfort-Directed Care.
32379114 2020. Characteristics and Early Prognosis of COVID-19 Infection in Fracture Patients.



32417380 2020. Coronavirus Disease-2019 in Heart Transplant Recipients in Southeastern Michigan: A Case Series.


32439095 2020. Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19.
32400044 2020. The importance of repeat testing in detecting coronavirus disease 2019 (COVID-19) in a coronary artery bypass grafting patient.
32340070 2020. ACE inhibitors and COVID-19: We don't know yet.
32474332 2020. Tetralogy of Fallot palliation in a COVID-19 positive neonate.
32450473 2020. Elevated cardiac biomarkers are associated with increased mortality for inpatients with COVID-19: A retrospective case-control study.



32516940 2020. COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge.
32512688 2020. A Cohort of Patients with COVID-19 in a Major Teaching Hospital in Europe.
32489501 2020. Serious Conditions in COVID-19 Accompanied With a Feature of Metabolic Syndrome.



32412150 2020. COVID-19 and Indigenous Peoples: An imperative for action.
32485619 2020. Epidemiological and clinical features of 200 hospitalized patients with corona virus disease 2019 outside Wuhan, China: A descriptive study.
32278300 2020. Challenges of SARS-CoV-2 and lessons learnt from SARS in Guangdong Province, China.
32361327 2020. Predictive factors for disease progression in hospitalized patients with coronavirus disease 2019 in Wuhan, China.
32361323 2020. Clinical features of pediatric patients with coronavirus disease (COVID-19).
32311650 2020. Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China.


32305882 2020. Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome.
32454427 2020. Children are protected against SARS-CoV-2 infection.
32447256 2020. Community-acquired viral respiratory infections amongst hospitalized inpatients during a COVID-19 outbreak in Singapore: co-infection and clinical outcomes.
32434708 2020. SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients.
32425663 2020. Evidence and possible mechanisms of rare maternal-fetal transmission of SARS-CoV-2.
32417675 2020. Characterisation of COVID-19 Pandemic in Paediatric Age Group: A Systematic Review and Meta-Analysis.
32333494 2020. Racial variations in COVID-19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti-androgens a potential treatment for COVID-19?
32402680 2020. COVID-19 in lung-transplanted and cystic fibrosis patients: Be careful.


32521120 2020. Does glycemic control rescue type 2 diabetic patients from COVID-19-related deaths?
32509886 2020. Novel coronavirus disease 2019 and perinatal outcomes.


32386431 2020. SARS-CoV-2 asymptomatic infection in a patient under treatment with dupilumab.


32414666 2020. A severe-type COVID-19 case with prolonged virus shedding.



32410276 2020. RNA conversion of COVID-19 in respiratory and alimentary specimens during asymptomatic convalescence.


32530994 2020. COVID-19 in a Patient with Liver Cirrhosis.
32530989 2020. Abnormal Liver Function Tests of Patients with Coronavirus Disease 2019 in Mainland China: A Systematic Review and Meta- Analysis.
32519326 2020. Independent Correlates of Hospitalization in 2040 Patients with COVID-19 at a Large Hospital System in Michigan, United States.


32495088 2020. Prevalence of SARS-CoV-2 Antibodies Among Healthcare Workers at a Tertiary Academic Hospital in New York City.


32362394 2020. First cases of COVID-19 in heart transplantation from China.
32362390 2020. COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal.
32253113 2020. COVID-19: Yet another coronavirus challenge in transplantation.
32340870 2020. COVID-19 in a lung transplant recipient.


32522278 2020. Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis.
32473194 2020. Liver tests abnormalities in COVID-19: trick or treat?
32446714 2020. High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry.
32445883 2020. Lack of genetic evidence that fatty liver disease predisposes to COVID-19.
32437831 2020. Reply to: 'Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis'.
32526252 2020. High rates of 30-day mortality in patients with cirrhosis and COVID-19.


32434789 2020. Diffuse pneumonitis from coronavirus HKU1 on checkpoint inhibitor therapy.
32423535 2020. Comparison of short-term mortality between mechanically ventilated patients with COVID-19 and influenza in a setting of sustainable healthcare system.



32371823 2020. Respiratory Distress in Postanesthesia Care Unit: First Presentation of Coronavirus Disease 2019 in a 17-Year-Old Girl: A Case Report.
32516467 2020. Testing Asymptomatic Emergency Department Patients for Coronavirus of 2019 (COVID-19) in a Low Prevalence Region.
32344458 2020. Characteristics of Emergency Department Patients With COVID-19 at a Single Site in Northern California: Clinical Observations and Public Health Implications.



32418781 2020. COVID-19 and Gynecomastia: What is the Relationship?


32425432 2020. Renin-Angiotensin System Inhibitors and COVID-19: Potential Therapeutics Rather Than Perpetrators.


32444942 2020. Are patients with Down syndrome vulnerable to life-threatening COVID-19?



32386441 2020. Public Health Agency of Sweden's Brief Report: Pregnant and postpartum women with severe acute respiratory syndrome coronavirus 2 infection in intensive care in Sweden.
32386440 2020. Severe maternal morbidity and mortality associated with COVID-19: The risk should not be downplayed.



32521068 2020. COVID-19 is milder in children possibly due to cross immunity.



32395673 2020. Clinical and Radiographic Presentations of COVID-19 among Patients Receiving Radiation Therapy for Thoracic Malignancies.



32458356 2020. The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing.
32390064 2020. COVID-19 in older adults.
32489711 2020. Comorbid Chronic Diseases are Strongly Correlated with Disease Severity among COVID-19 Patients: A Systematic Review and Meta-Analysis.
32509416 2020. Acute Respiratory Decompensation Requiring Intubation in Pregnant Women with SARS-CoV-2 (COVID-19).


32400858 2020. Are Patients With Alcohol Use Disorders at Increased Risk for Covid-19 Infection?


32406119 2020. Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic.
32406090 2020. Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic. Authors' reply.
32455491 2020. Low prevalence of bronchial asthma and chronic obstructive lung disease among intensive care unit patients with COVID-19.
32506509 2020. Clinical characteristics of COVID-19 patients combined with allergy.
32524611 2020. Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status.
32479648 2020. Is asthma protective against COVID-19?
32498691 2020. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease.
32512291 2020. Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease.


32502882 2020. Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial.


32414525 2020. COVID-19 in healthcare workers.
32386808 2020. Prevalence of IgG antibodies to SARS-CoV-2 among emergency department employees.


32475761 2020. Dexmedetomidine and worsening hypoxemia in the setting of COVID-19: A case report.


32444295 2020. Atypical presentation of COVID-19.


32427676 2020. Shanghai Zhongshan Experience on Digestive Endoscopic Procedures During 2020 COVID-19 Pandemic.
32519406 2020. Prolonged SARS-CoV-2 shedding and mild course of COVID-19 in a patient after recent heart transplantation.
32515085 2020. COVID-19 in recent kidney transplant recipients.


32524732 2020. Worse progression of COVID-19 in men: Is Testosterone a key factor?
32520728 2020. Anesthesiologists' and intensive care providers' exposure to COVID-19 infection in a New York City academic center: a prospective cohort study assessing symptoms and COVID-19 antibody testing.



32444415 2020. Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China.
32471903 2020. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.
32439956 2020. Management of newborns exposed to mothers with confirmed or suspected COVID-19.


32474140 2020. Maternal choline and respiratory coronavirus effects on fetal brain development.
32434431 2020. Cardiovascular disease, heart failure and COVID-19.
32408793 2020. Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: A systematic review, meta-analysis and meta-regression.
32403977 2020. The Renin-Angiotensin system and SARS-CoV-2 infection: A role for the ACE2 receptor?
32362035 2020. Treating COVID-19 in Rural America.
32396220 2020. Unequal Distribution of COVID-19 Risk among Rural Residents by Race and Ethnicity.
32282964 2020. A Commentary on Rural-Urban Disparities in COVID-19 Testing Rates per 100,000 and Risk Factors.
32277775 2020. Caring for Miners During the Coronavirus Disease-2019 (COVID-19) Pandemic.


32352913 2020. Cesarean Section in a Pregnant Woman with COVID-19: First Case in Portugal.
32533756 2020. Physiological advantages of children against COVID-19.
32533572 2020. COVID-19 and Down syndrome.
32239761 2020. COVID-19 in a designated infectious diseases hospital outside Hubei Province, China.
32412919 2020. Gender and Age Differences Reveal Risk Patterns in COVID-19 Outbreak.


32531620 2020. Pediatric COVID-19: Systematic review of the literature.


32530714 2020. Cigarette Smoking and COVID-19: A Complex Interaction.
32530707 2020. Reply to: Cigarette Smoking and COVID-19: A Complex Interaction.



32381561 2020. Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.
32475835 2020. Patients with lupus with COVID-19: University of Michigan experience.
32475834 2020. Patients with systemic lupus erythematosus using hydroxychloroquine or chloroquine develop severe COVID-19 at similar frequency as patients not on antimalarials: need to explore antithrombotic benefits for COVID-19 coagulopathy. Response to: 'Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine' by Carbillon et al.
32475832 2020. Response to: 'Patients with lupus with COVID-19: University of Michigan experience' by Wallace et al.
32475831 2020. Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.
32471900 2020. Response to: Correspondence regarding research letter to the editor by Mathian et al, 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine by Nikpour et al.


32471898 2020. Correspondence regarding research letter to the editor by Mathian et al, 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'.


32457048 2020. Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US 'hot spot'.
32451345 2020. Response to: 'Are patients with systemic lupus erythematosus at increased risk for COVID-19?' by Favalli et al.
32451344 2020. Are patients with systemic lupus erythematosus at increased risk for COVID-19?
32434823 2020. Rheumatic diseases in intensive care unit patients with COVID-19.
32467245 2020. Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based study.



32415836 2020. Response to COVID-19 and ACEI/ARB: NOT ASSOCIATED?
32415832 2020. COVID-19 and ACEI/ARB: NOT ASSOCIATED?



32460973 2020. Age-related difference in the rate of COVID-19 mortality in women versus men.
32439389 2020. Clinical Characteristics of 46 Pregnant Women with a SARS-CoV-2 Infection in Washington State.
32391520 2020. Placental abruption in a twin pregnancy at 32 weeks' gestation complicated by COVID-19, without vertical transmission to the babies.
32391519 2020. Clinical course of severe and critical COVID-19 in hospitalized pregnancies: a US cohort study.
32518902 2020. Coronavirus disease 2019 in pregnancy: early lessons.
32437114 2020. Early Rehabilitation for Critically Ill Patients With COVID-19: More Benefits Than Risks.
32228322 2020. COVID-19 pandemic, coronaviruses, and diabetes mellitus.
32315543 2020. An Asymptomatic Patient with COVID-19.
32369262 2020. Kidney transplantation with presymptomatic COVID-19-positive surgeon.
32412159 2020. First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study.
32406181 2020. Mild COVID-19 in a pediatric renal transplant recipient.
32400965 2020. Coronavirus disease 2019 and transplantation: The combination of lopinavir/ritonavir and hydroxychloroquine is responsible for excessive tacrolimus trough level and unfavorable outcome.
32400931 2020. Viral shedding prolongation in a kidney transplant patient with COVID-19 pneumonia.
32400099 2020. Novel Corona Virus 2019 pneumonia in a kidney transplant recipient.
32400084 2020. SARS-CoV-2 infection in two patients following recent lung transplantation.
32400074 2020. COVID-19 pneumonia in lung transplant recipients: Report of 2 cases.
32400013 2020. A case of coronavirus disease 2019-infected liver transplant donor.
32314685 2020. Case Report: The First Case of COVID-19 in Bhutan.
32452644 2020. Caution in the management of SARS-CoV-2 infection in males.
32436355 2020. Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients.
32357288 2020. SARS-CoV-2 pandemic and repercussions for male infertility patients: A proposal for the individualized provision of andrological services.
32472773 2020. A COVID-19 Conundrum: Obstructive Sleep Apnea (OSA) and Non-Invasive Ventilation (NIV).
32413342 2020. COVID-19 in diabetic patients: Related risks and specifics of management.
32419766 2020. Assessing Differential Impacts of COVID-19 on Black Communities.
32419765 2020. Understanding COVID-19 Risks and Vulnerabilities among Black Communities in America: The Lethal Force of Syndemics.



32422077 2020. COVID-19 and Angiotensin-Converting Enzyme Inhibitor/Angiotensin-Receptor Blocker Therapy.
32422062 2020. Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.
32491919 2020. Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review.
32383812 2020. SARS-CoV-2 and Multiple Sclerosis: Not All Immune Depleting DMTs are Equal or Bad.


32418848 2020. Early mobilization in hospitalized patients with COVID-19.
32434818 2020. Comorbidities and rheumatological diseases at the time of COVID-19. Response to: 'Rheumatic diseases in intensive care unit patients with COVID-19' by Moiseev et al.
32532753 2020. Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases.



32411770 2020. Clinical characteristics of 60 discharged cases of 2019 novel coronavirus-infected pneumonia in Taizhou, China.


32395487 2020. Clinical characteristics of Coronavirus Disease 2019 and development of a prediction model for prolonged hospital length of stay.
32395474 2020. The effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension.
32440661 2020. Clinical Characteristics of COVID-19 Infection in Newborns and Pediatrics: A Systematic Review.
32440660 2020. Analysis of Maternal Coronavirus Infections and Neonates Born to Mothers with 2019-nCoV; a Systematic Review.
32336565 2020. Situacion clinica de infeccion por SARS-CoV-2 en pacientes con carcinoma broncogenico: contexto actual.



32518045 2020. Severe and fatal forms of COVID-19 in children.


32526068 2020. Perspectives of patients with rheumatic diseases in the early phase of COVID-19.


32304393 2020. Contributory Role of Positron Emission Tomography in a Left Ventricular Assist Device Recipient at the Time of COVID-19 Pandemic.



32526039 2020. Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience.


32522306 2020. COVID-19 in adult patients with CHD: a matter of anatomy or comorbidities?
32414805 2020. Prevalence of COVID-19 among patients with rheumatic diseases: the need to await results from large collaborative studies. Response to: 'COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs' by Conticini et al.
32414804 2020. COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs.
32404341 2020. Response to: 'Patients with lupus are not protected from COVID-19: a comment' by Sawalha, 'No evidence so far on the protective effect of hydroxycloroquin to prevent COVID-19: response to the Comment by Joob and Wiwanitkit' by Romao et al and 'SLE patients are not immune to COVID-19: importance of sending the right message across' by Goyal.
32404340 2020. No evidence so far on the protective effect of hydroxychloroquine to prevent COVID-19: response to the comment by Joob and Wiwanitkit.
32522741 2020. Biologics, spondylitis and COVID-19.
32523145 2020. COVID-19 y el sistema renina, angiotensina, aldosterona. Una relacion compleja.
32523141 2020. Infeccion por coronavirus en pacientes con diabetes.
32523139 2020. Recomendaciones para la atencion de pacientes con insuficiencia cardiaca y COVID-19.
32531146 2020. Maternal transmission of SARS-COV-2 to the neonate, and possible routes for such transmission: A systematic review and critical analysis.
32220899 2020. Covid-19 and long term conditions: what if you have cancer, diabetes, or chronic kidney disease?
32532739 2020. Covid-19: People in most deprived areas of England and Wales twice as likely to die.
32532737 2020. Covid-19: Government will belatedly publish recommendations for protecting ethnic minorities.
32527762 2020. Risks to Bangladeshi children and young people during covid-19 outbreak.
32527732 2020. Ethnicity and covid-19.
32522740 2020. Obesity and covid-19: the role of the food industry.


32354809 2020. Managing patients with COVID-19 infections: a first-hand experience from the Wuhan Mobile Cabin Hospital.
32532764 2020. COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs.


32522556 2020. The impact of asthma on mortality in COVID-19 patients.
32519912 2020. Effects of altered photoperiod due to COVID-19 lockdown on pregnant women and their fetuses.


32527466 2020. SARS-CoV-2 as a protective factor for cardiovascular mortality?
32294229 2020. COVID-19 vaginal delivery - A case report.
32513532 2020. Altered COVID-19 receptor ACE2 expression in a higher risk group for cerebrovascular disease and ischemic stroke.
32450906 2020. Impact of sex and gender on COVID-19 outcomes in Europe.
32426991 2020. Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis.
32490680 2020. Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19.
32428835 2020. Advances in the relationship between coronavirus infection and cardiovascular diseases.
32362005 2020. Correspondence: Importance of the validated serum biochemistry and hemogram parameters for rapid diagnosis and to prevent false negative results during COVID-19 pandemic.
32381073 2020. A child with household transmitted COVID-19.
32460871 2020. Diagnosis of COVID-19 in children: the story evolves.
32517687 2020. COVID-19 cancer conundrum-evidence driving decisions or the lack of it?
32493370 2020. Lactate dehydrogenase and susceptibility to deterioration of mild COVID-19 patients: a multicenter nested case-control study.
32444460 2020. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.
32444366 2020. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study.
32409488 2020. Use of all cause mortality to quantify the consequences of covid-19 in Nembro, Lombardy: descriptive study.
32513659 2020. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study.


32385047 2020. Off the back burner: diverse and gender-inclusive decision-making for COVID-19 response and recovery.
32532758 2020. Hypothesis to explain the severe form of COVID-19 in Northern Italy.
32513864 2020. Ethnic and racial disparities in COVID-19-related deaths: counting the trees, hiding the forest.
32455170 2020. Understanding COVID-19 in children may provide clues to protect at-risk populations.
32499538 2020. Poor outcome in patients with acute leukemia on intensive chemotherapy and COVID-19.
32528121 2020. Hematopoietic stem cell transplantation from an infected SARS-CoV2 donor sibling.
32483288 2020. Containment of a traceable COVID-19 outbreak among healthcare workers at a hematopoietic stem cell transplantation unit.


32534738 2020. Presenting symptoms of COVID-19 in children: a meta-analysis of published studies.
32534737 2020. COVID-19 and improved prevention of hospital-acquired infection.
32439072 2020. Obesity as a risk factor for poor outcome in COVID-19-induced lung injury: the potential role of undiagnosed obstructive sleep apnoea.
32384171 2020. COVID-19 treatment in patients with comorbidities: Awareness of drug-drug interactions.
32348554 2020. Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic.
32379921 2020. Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies.
32379902 2020. COVID-19 in a patient with pre-existing acute lymphoblastic leukaemia.


32473945 2020. COVID-19, hypercoagulation and what it could mean for patients with psychotic disorders.
32470593 2020. Can COVID-19 related mental health issues be measured?
32464158 2020. Correlation between immune response and self-reported depression during convalescence from COVID-19.
32464156 2020. Depression and anxiety among adolescents during COVID-19: A cross-sectional study.
32416290 2020. Immediate psychological distress in quarantined patients with COVID-19 and its association with peripheral inflammation: A mixed-method study.



32454138 2020. Lifestyle risk factors, inflammatory mechanisms, and COVID-19 hospitalization: A community-based cohort study of 387,109 adults in UK.
32479748 2020. Analysis of clinical and demographic heterogeneity of patients dying from COVID-19 in Brazil versus China and Italy.


32405915 2020. Characteristics and outcomes of patients with breast cancer diagnosed with SARS-Cov-2 infection at an academic center in New York City.
32271625 2020. Should Infants Be Separated from Mothers with COVID-19? First, Do No Harm.
32428080 2020. Vulnerabilidade a formas graves de COVID-19: uma analise intramunicipal na cidade do Rio de Janeiro, Brasil.
32428076 2020. COVID-19 e tabagismo: uma relacao de risco.
32404451 2020. Coronavirus disease 2019 in children: Surprising findings in the midst of a global pandemic.
32532719 2020. Symptom management and end-of-life care of residents with COVID-19 in long-term care homes.


32502522 2020. Use of Renin-Angiotensin System Blockers During the COVID-19 Pandemic: Early Guidance and Evolving Evidence.
32494330 2020. Coronavirus Disease 2019 With Acute Respiratory Distress Syndrome Mimicking Heart Failure Exacerbation: Time to Rethink.
32535705 2020. Is Hypertension a Real Risk Factor for Poor Prognosis in the COVID-19 Pandemic?


32515033 2020. Severity and risk of COVID-19 in cancer patients: An evidence based learning.


32526093 2020. Dermatological therapies with relevance to COVID-19.



32517822 2020. Factors associated with the duration of hospitalisation among COVID-19 patients in Vietnam: A survival analysis.
32526060 2020. What did we learn from the previous coronavirus epidemics and what can we do better: a neuroinfectiological point of view.
32516861 2020. Clinical characteristics and prognostic factors in COVID-19 patients aged >/=80 years.


32535689 2020. Challenges in Neonatal COVID-19 Infection.
32535876 2020. Successful management of the first reported case in Austria of COVID-19 with ARDS.
32525566 2020. Low prevalence of IgG antibodies to SARS-CoV-2 in cancer patients with COVID-19.
32522559 2020. Covid-19 and inflammatory bowel disease: questions on incidence, severity, and impact of treatment?


32536009 2020. Comment on "Psoriasis, COVID-19 and acute respiratory distress syndrome: focusing on the risk of concomitant biological treatment".


32503837 2020. Type 1 Diabetes and COVID-19: Preliminary Findings From a Multicenter Surveillance Study in the U.S.
32533988 2020. COVID19 in South Asians/Asian Indians: Heterogeneity of data and implications for pathophysiology and research.
32492745 2020. Kardiale Biomarker und COVID-19-Phanotypen und Interpretation.
32378797 2020. Epidemiology and clinical features of emergency department patients with suspected COVID-19: Initial results from the COVID-19 Emergency Department Quality Improvement Project (COVED-1).
32533613 2020. Epidemiology and clinical features of emergency department patients with suspected COVID-19: Results from the first month of the COVED Quality Improvement Project (COVED-2).


32531040 2020. Association between renin-angiotensin system inhibitors and COVID-19 complications.


32535885 2020. High mortality in COVID-19 patients with mild respiratory disease.
32531806 2020. Obesity, adipokines and COVID-19.
32522810 2020. Fighting on two fronts: drug-drug interactions in people living with HIV infected with SARS-CoV-2.


32525813 2020. Renin-angiotensin system and SARS-CoV-2 interaction: underlying mechanisms and potential clinical implications.
32535573 2020. COVID-19 IN DIABETES PATIENTS IN UKRAINE: LESSONS FOR DOCTORS AND PATIENTS.
32436422 2020. Men and COVID-19: Adding a gender lens.
32518091 2020. COVID-19: A UK Children's Hospital Experience.
32530392 2020. The prevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG antibodies in intensive care unit (ICU) healthcare personnel (HCP) and its implications-a single-center, prospective, pilot study.
32517835 2020. Delayed Recognition of Community Transmission of COVID-19 Resulting in Healthcare Worker Infections.



32393351 2020. Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19.
32527257 2020. Impact of diabetes mellitus on clinical outcomes in patients affected by Covid-19.



32426242 2020. Novel coronavirus-related acute respiratory distress syndrome in a patient with twin pregnancy: A case report.
32523874 2020. Multidisciplinary team management and cesarean delivery for a Jordanian woman infected with SARS-COV-2: A case report.
32385549 2020. COVID-19, Angiotensin Receptor Blockers, and the Brain.
32501455 2020. Down Syndrome and COVID-19: A Perfect Storm?
32405955 2020. Management of Patients with Cerebellar Ataxia During the COVID-19 Pandemic: Current Concerns and Future Implications.
32407464 2020. Corona Viruses and the Chemical Senses: Past, Present, and Future.
32437696 2020. Clinical Characteristics and Outcomes of 421 Patients With COVID-19 Treated in a Mobile Cabin Hospital.
32473172 2020. COVID-19 infection among medical staff in Wuhan: A retrospective study from a single-center.
32533957 2020. Individualizing risk prediction for positive COVID-19 testing: results from 11,672 patients.
32395696 2020. Lung involvement in patients with coronavirus disease-19 (COVID-19): a retrospective study based on quantitative CT findings.
32435272 2020. Clinical characteristics of 9 cancer patients with SARS-CoV-2 infection.
32411496 2020. Pulmonary Rehabilitation for Patients with Coronavirus Disease 2019 (COVID-19).
32496917 2020. Response by Cohen et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19".
32496914 2020. Response by Zhang et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19".
32393409 2020. Does intranasal naloxone administration increase the risk of 2019 coronavirus disease transmission?
32473151 2020. Laboratory abnormalities in children with mild and severe coronavirus disease 2019 (COVID-19): A pooled analysis and review.



32405079 2020. Dynamic changes in routine blood parameters of a severe COVID-19 case.
32404011 2020. Clinical characteristics of coronavirus disease 2019 (COVID-19) patients with hypertension on renin-angiotensin system inhibitors.
32462378 2020. Clinical features of hemodialysis patients with COVID-19: a single-center retrospective study on 32 patients.
32434304 2020. Does the Clinical Spectrum of Coronavirus Disease 2019 (COVID-19) Show Regional Differences?
32425706 2020. We Know Liver Biochemistries Are Elevated in COVID-19, But Should We Be Concerned?


32407784 2020. Cardiac and Muscle Injury Might Partially Contribute to Elevated Aminotransferases in COVID-19 Patients.
32407783 2020. Clinical Characteristics of COVID-19 in Patients With Liver Injury.
32425338 2020. Extrapulmonary manifestations of COVID-19: Radiologic and clinical overview.


32535188 2020. Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy.
32382755 2020. Association of higher body mass index (BMI) with severe coronavirus disease 2019 (COVID-19) in younger patients.
32382748 2020. Lessons from COVID-19 in children: Key hypotheses to guide preventative and therapeutic strategies.
32409825 2020. Analysis of the infection status of the health care workers in Wuhan during the COVID-19 outbreak: A cross-sectional study.


32407459 2020. Risk Factors of Severe Disease and Efficacy of Treatment in Patients Infected with COVID-19: A Systematic Review, Meta-Analysis and Meta-Regression Analysis.
32392337 2020. SARS-CoV-2 (COVID-19): What do we know about children? A systematic review.
32392330 2020. The Effects of Pregnancy on Women with COVID-19: Maternal and Infant Outcomes.
32527714 2020. Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab.


32526275 2020. Risk factors for disease progression in mild to moderate COVID-19 patients- a multi-center observational study.


32502644 2020. Excretion of SARS-CoV-2 in human breast milk.
32535147 2020. Ibuprofen use and clinical outcomes in COVID-19 patients.
32535148 2020. Low risk for SARS-CoV2 symptomatic infection and early complications in pediatric patients during the ongoing CoVID19 epidemics in Lombardy.
32324898 2020. Incidence of Adverse Drug Reactions in COVID-19 Patients in China: An Active Monitoring Study by Hospital Pharmacovigilance System.



32471656 2020. Is SARS-CoV-2 associated with liver dysfunction in COVID-19 patients?
32418852 2020. The liver injury and gastrointestinal symptoms in patients with Coronavirus Disease 19: A systematic review and meta-analysis.
32474884 2020. Are patients with rheumatologic diseases on chronic immunosuppressive therapy at lower risk of developing severe symptoms when infected with COVID-19?


32515168 2020. Clonal haematopoiesis and COVID-19: A possible deadly liaison.



32516844 2020. Comment on Han et al: Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China.
32515500 2020. Clinical and epidemiological characteristics of 320 deceased Covid-19 patients in an Italian Province: a retrospective observational study.
32530534 2020. Dyspnea: the vanished warning symptom of COVID-19 pneumonia.


32530509 2020. Association of cardiac biomarkers and comorbidities with increased mortality, severity, and cardiac injury in COVID-19 patients: A meta-regression and Decision tree analysis.
32530499 2020. The epidemiology and clinical characteristics of co-infection of SARS-CoV-2 and influenza viruses in patients during COVID-19 outbreak.
32530494 2020. Clinical outcomes of 402 patients with COVID-2019 from a single center in Wuhan, China.
32525575 2020. The possible impairment of respiratory-related neural loops may be associated with the silent pneumonia induced by SARS-CoV-2.
32525558 2020. New IgM seroconversion and positive RT-PCR test after exposure to the virus in recovered COVID-19 patient.


32519760 2020. Diagnosis of COVID-19 pneumonia despite missing detection of viral nucleic acid and initially inconspicuous radiologic findings.


32310017 2020. COVID-19 and stroke-A global World Stroke Organization perspective.
32522462 2020. Association of asthma and its genetic predisposition with the risk of severe COVID-19.
32535884 2020. Nursing home physician with normal chest X-ray and probable COVID-19 based on 18F-FDG PET/CT imaging.
32519921 2020. COVID-19 in a severe eosinophilic asthmatic receiving benralizumab - a case study.
32527675 2020. SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients.



32434403 2020. Pregnancy affected by SARS-CoV-2 infection: a flash report from Michigan.
32429786 2020. COVID-19 pneumonia and pregnancy; a systematic review and meta-analysis.
32419544 2020. COVID 19 in neonates.


32533777 2020. Clinical Characteristics of COVID-19 in patients with pre-existing ILD: A retrospective study in a single center in Wuhan, China.




32406001 2020. COVID-19 with rheumatic diseases: a report of 5 cases.
32447647 2020. Electronic nicotine delivery systems (ECs) and COVID-19: the perfect storm for young consumers.
32446267 2020. What solid organ transplant healthcare providers should know about renin-angiotensin-aldosterone system inhibitors and COVID-19.
32520227 2020. Neonatal SARS-CoV-2 infection.
32520225 2020. COVID-19 in solid organ transplantation patients: A systematic review.
32428112 2020. Expert recommendations for the care of newborns of mothers with COVID-19.
32428111 2020. Why is SARS-CoV-2 infection milder among children?
32410714 2020. Patients with COVID-19 in 19 ICUs in Wuhan, China: a cross-sectional study.
32513232 2020. Non-febrile COVID-19 patients were common and often became critically ill: a retrospective multicenter cohort study.
32498689 2020. Mortality rates of patients with COVID-19 in the intensive care unit: a systematic review of the emerging literature.
32426751 2020. The Clinical Presentation and Immunology of Viral Pneumonia and Implications for Management of Coronavirus Disease 2019.



32452888 2020. ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019.
32371611 2020. Acute Physiology and Chronic Health Evaluation II Score as a Predictor of Hospital Mortality in Patients of Coronavirus Disease 2019.
32528774 2020. Coronavirus Disease 2019 (COVID-19) in a Renal Transplant Patient.
32391234 2020. A Hemodialysis Patient with Severe COVID-19 Pneumonia.
32489751 2020. Managing Acute Portal Hypertensive Gastropathy Bleed During the Time of COVID-19 Pandemic: Novelty or Necessity?



32432015 2020. Neonatal Coronavirus 2019 (COVID-19) Infection: A Case Report and Review of Literature.


32411566 2020. Nifedipine and Amlodipine Are Associated With Improved Mortality and Decreased Risk for Intubation and Mechanical Ventilation in Elderly Patients Hospitalized for COVID-19.


32528785 2020. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Mimicking as Pulmonary Tuberculosis in an Inmate.



32399342 2020. A Case of a COVID-19-positive Patient.



32483507 2020. Coronavirus Disease 2019 (COVID-19) Can Masquerade as Acute Postoperative Periprosthetic Joint Infection.


32467810 2020. Coronavirus Disease 2019 (COVID-19) in Cancer Patients.


32382587 2020. Cardiac Troponin-I may be a predictor of complications and mortality in COVID-19 patients.
32385891 2020. Systemic immunobiological, immunosuppressant, and oncologic agents for the treatment of dermatologic diseases during the SARS-CoV-2 (COVID-19) pandemic emergency: A quick review for a quick consultation.


32378293 2020. Update on COVID-19 Effects in Dermatology Specialty.


32406114 2020. Psychological effects of COVID-19 on parenting and maternal-fetal mental health.
32468230 2020. Novel Coronavirus Disease (COVID-19) and Biologic Therapy for Psoriasis: Successful Recovery in Two Patients After Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
32425701 2020. Cigarette Smoke Exposure and Inflammatory Signaling Increase the Expression of the SARS-CoV-2 Receptor ACE2 in the Respiratory Tract.
32447101 2020. Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports.
32447100 2020. COVID-19 symptoms masking inaugural ketoacidosis of type 1 diabetes.
32416321 2020. Patients with diabetes are at higher risk for severe illness from COVID-19.
32452598 2020. In response: Diabetes is a risk factor for the progression and prognosis of COVID-19.
32426928 2020. The diabetic lung: An easy target for SARS-CoV-2?
32438331 2020. Diabetes and metabolic syndrome as risk factors for COVID-19.
32388332 2020. SARS-CoV-2 infection and glucose homeostasis in pregnancy. What about antenatal corticosteroids?
32402930 2020. Letter to the editors in response to: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic (Cure et al.).
32388330 2020. Interactions between antihyperglycemic drugs and the renin-angiotensin system: Putative roles in COVID-19. A mini-review.
32502958 2020. Proposed guidelines for screening of hyperglycemia in patients hospitalized with COVID-19 in low resource settings.
32473903 2020. Does poor glucose control increase the severity and mortality in patients with diabetes and COVID-19?
32473904 2020. Reply to the letter of Mahajan and Gaur in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.).
32473902 2020. Letter in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.).
32438328 2020. Obesity as a predictor for a poor prognosis of COVID-19: A systematic review.
32526625 2020. Multimorbidity and SARS-CoV-2 infection in UK Biobank.
32311651 2020. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic.
32315948 2020. Case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: What should we have in mind during the COVID-19 pandemic?
32406594 2020. The clinical characteristics and outcomes of patients with diabetes and secondary hyperglycaemia with coronavirus disease 2019: A single-centre, retrospective, observational study in Wuhan.
32319200 2020. Therapeutic uncertainties in people with cardiometabolic diseases and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19).
32446795 2020. Association of diabetes mellitus with disease severity and prognosis in COVID-19: A retrospective cohort study.
32446801 2020. SARS-CoV-2 and diabetes: New challenges for the disease.
32446798 2020. Characteristics and outcomes of COVID-19 positive patients with diabetes managed as outpatients.


32524609 2020. COVID-19 in Australian health care workers: early experience of the Royal Melbourne Hospital emphasises the importance of community acquisition.
32519352 2020. The possible protective role of alpha-synuclein against the SARS-CoV-2 infections in patients with Parkinson's disease.
32515393 2020. Long term complications and rehabilitation of COVID-19 patients.
32515389 2020. COVID-19 in children: Epidemiology, presentation, diagnosis and management.



32515378 2020. Clinical features, diagnosis and management of COVID-19 patients in the outdoor setting.
32329797 2020. Characteristics of Hospitalized Adults With COVID-19 in an Integrated Health Care System in California.
32530453 2020. Factors Associated With Surgical Mortality and Complications Among Patients With and Without Coronavirus Disease 2019 (COVID-19) in Italy.
32302270 2020. Managing COVID-19 in Patients With Cancer: A Double Blow for Oncologists.



32531754 2020. Covid-19 in a patient with multiple sclerosis treated with natalizumab: May the blockade of integrins have a protective role?



32360400 2020. Hyperglycemia and the worse prognosis of COVID-19. Why a fast blood glucose control should be mandatory.
32533989 2020. Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A narrative review.
32531325 2020. Clinical characteristics and outcomes of COVID-19 hospitalized patients with diabetes in the United Kingdom: A retrospective single centre study.
32442557 2020. Lack of type 1 diabetes involvement in SARS-COV-2 population: Only a particular coincidence?
32416121 2020. Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients.
32407746 2020. Prevalence of diabetes mellitus in 2019 novel coronavirus: A meta-analysis.


32278764 2020. COVID-19 and diabetes: Knowledge in progress.
32179126 2020. Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed.
32472191 2020. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study.
32405783 2020. Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature.
32473875 2020. Intellectual and developmental disability and COVID-19 case-fatality trends: TriNetX analysis.
32529474 2020. Does Ibuprofen Worsen COVID-19?
32527380 2020. SARS-CoV-2 in the Employees of a Large University Hospital.
32519943 2020. Hospital Admission in Children and Adolescents With COVID-19.


32499091 2020. (Mis-)understanding COVID-19 and digit ratio: Methodological and statistical issues in Manning and Fink (2020).
32419720 2020. Understanding COVID-19: Digit ratio (2D:4D) and sex differences in national case fatality rates.


32535547 2020. Merits and culprits of immunotherapies for neurological diseases in times of COVID-19.
32407284 2020. Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March-April 2020.



32497001 2020. Viral RNA Load in Mildly Symptomatic and Asymptomatic Children with COVID-19, Seoul.


32521222 2020. Clusters of Coronavirus Disease in Communities, Japan, January-April 2020.
32390285 2020. SARS-CoV-2 testing and outcomes in the first 30 days after the first case of COVID-19 at an Australian children's hospital.
32515651 2020. Clinical characteristics of foreign-imported COVID-19 cases in Shanghai, China.
32449100 2020. Incidentally discovered COVID-19 in low-suspicion patients-a threat to front line health care workers.



32475769 2020. Consecuencias de la COVID-19 sobre las personas con diabetes.
32425489 2020. RECOMENDACIONES Y MANEJO PRACTICO DE LA GESTANTE CON COVID-19: SCOPING REVIEW.
32425488 2020. Prevencion y tratamiento del Covid-19 en la poblacion pediatrica desde una perspectiva familiar y comunitaria.
32422280 2020. Two important controversial risk factors in SARS-CoV-2 infection: Obesity and smoking.
32374248 2020. Characteristics of disease progress in patients with coronavirus disease 2019 in Wuhan, China.
32460927 2020. Association of hypertension with the severity and fatality of SARS-CoV-2 infection: A meta-analysis.
32430084 2020. Outbreak of COVID-19 in a family, Wenzhou, China.



32488522 2020. Risk of neuropsychiatric disorders in offspring of COVID-19-infected pregnant women and nutritional intervention.


32388565 2020. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors.
32388547 2020. Plasma angiotensin-converting enzyme 2: novel biomarker in heart failure with implications for COVID-19.
32383763 2020. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy.
32383758 2020. SARS-CoV-2 receptor ACE2 expression in the human heart: cause of a post-pandemic wave of heart failure?



32523932 2020. Should the Management of Embolic Stroke in the Elderly Be Changed if They Also Have COVID-19?
32523931 2020. Fatal Ischaemic Stroke During COVID-19 and Acute Lung Injury.



32523924 2020. Long-term Positivity to SARS-CoV-2: A Clinical Case of COVID-19 with Persistent Evidence of Infection.





32383239 2020. Diabetes or endocrinopathy admitted in the COVID-19 ward.



32307717 2020. COVID-19 diagnosis does not rule out other concomitant diseases.
32404898 2020. Diabetes and COVID-19: evidence, current status and unanswered research questions.
32379084 2020. Daily pool testing of nasopharyngeal self-obtained swaps of healthcare professionals with definite COVID-19 exposition.
32424571 2020. Burden and prevalence of prognostic factors for severe COVID-19 in Sweden.


32530584 2020. Natural History of Asymptomatic SARS-CoV-2 Infection.
32516853 2020. Publication of COVID-19 case reports: are we hurrying?



32521564 2020. Viral enanthema in oral mucosa: a possible diagnostic challenge in the COVID-19 pandemic.


32515518 2020. Postnatal SARS-CoV-2 Infection and Immunological Reaction: A Prospective Family Cohort Study.


32519809 2020. What we know so far about Coronavirus Disease 2019 in children: A meta-analysis of 551 laboratory-confirmed cases.


32529643 2020. Mechanisms and evidence of vertical transmission of infections in pregnancy including SARS-CoV-2.
32434211 2020. Viral and host factors related to the clinical outcome of COVID-19.
32516274 2020. Prone Positioning for Pregnant Women With Hypoxemia Due to Coronavirus Disease 2019 (COVID-19).
32516273 2020. Rates of Maternal and Perinatal Mortality and Vertical Transmission in Pregnancies Complicated by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Co-V-2) Infection: A Systematic Review.
32428215 2020. SARS-COV-2 pandemic: the significance of underlying conditions.
32513036 2020. Disparate Nasopharyngeal and Tracheal COVID-19 Diagnostic Test Results in a Patient With a Total Laryngectomy.
32520362 2020. What Are the Newest Effects of COVID-19 in Children?



32525645 2020. Comparison of the Clinical Features of SARS-CoV-2, Other Coronavirus and Influenza Infections in Infants Less Than 1-Year-Old.
32525644 2020. Three Hypotheses About Children COVID19.
32520888 2020. Clinical Analysis of 25 COVID-19 Infections in Children.
32522783 2020. Severe Coronavirus Bronchiolitis in the Pre-COVID-19 Era.


32417144 2020. Active smoking and severity of coronavirus disease 2019 (COVID-19): The use of significance testing leads to an erroneous conclusion.
32499172 2020. Active smoking and severity of coronavirus disease 2019 (COVID-19): Differences in measurement of variables could cause errors in the results.
32439289 2020. Active smoking and COVID-19: a double-edged sword.
32192856 2020. Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19).
32532661 2020. Management and outcomes of post-acute COVID-19 patients in Northern Italy.



32493595 2020. Delayed umbilical cord clamping and breastfeeding after childbirth in mothers affected by COVID 19: Recommended or not?
32456886 2020. Is termination of early pregnancy indicated in women with COVID-19?
32425299 2020. Prolonged viral persistence in COVID-19 second trimester pregnant patient.
32425298 2020. Covid-19 during pregnancy: a case series from an universally tested population from the north of Portugal.
32425297 2020. SARS-CoV-2 infection in very preterm pregnancy: experiences from two cases.
32405137 2020. Prone positioning and high-flow oxygen improved respiratory function in a 25-week pregnant woman with COVID-19.
32439245 2020. Vaginal delivery in a woman infected with SARS-CoV-2 - The first case reported in Portugal.


32424745 2020. SARS-COV-2 infection in children and newborns: a systematic review.
32495147 2020. Characteristic of COVID-19 infection in pediatric patients: early findings from two Italian Pediatric Research Networks.
32495145 2020. COVID-19 in children: patiently and critically evaluate the scientific evidence.
32391719 2020. Cardiovascular disease and COVID-19: les liaisons dangereuses.


32385648 2020. Clinical and radiological changes of hospitalised patients with COVID-19 pneumonia from disease onset to acute exacerbation: a multicentre paired cohort study.


32430431 2020. Smoking, ACE-2, and COVID-19: Ongoing Controversies.
32430427 2020. COVID-19 and vaping: risk for increased susceptibility to SARS-CoV-2 infection?


32398296 2020. Arterial hypertension and the risk of severity and mortality of COVID-19.
32381497 2020. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge.
32366490 2020. Reply to: "Current smoking is not associated with COVID-19".
32350106 2020. Current smoking is not associated with COVID-19.
32373997 2020. Outbreak of COVID-19 infection in children: fear and serenity.
32534910 2020. Clinical Characteristics and Outcome for Four SARS-CoV-2-infected Cancer Patients Treated with Immune Checkpoint Inhibitors.
32475747 2020. Urinary Frequency as a Possibly Overlooked Symptom in COVID-19 Patients: Does SARS-CoV-2 Cause Viral Cystitis?
32405138 2020. Reply to Peng He, Xiaohui Wang, and Hao Li's Letter to the Editor re: Yu Xiao, Kaiyu Qian, Yongwen Luo, et al. Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Renal Failure Patients: A Potential Covert Source of Infection. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.03.025.
32345521 2020. Re: Yu Xiao, Kaiyu Qian, Yongwen Luo, et al. Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Renal Failure Patients: A Potential Covert Source of Infection. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.03.025.
32431289 2020. Mortality impacts of the coronavirus disease (COVID-19) outbreak by sex and age: rapid mortality surveillance system, Italy, 1 February to 18 April 2020.
32400362 2020. Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10 April 2020.
32519618 2020. Incidence and Immunologic Analysis of Coronavirus Disease (COVID-19) in Hemodialysis Patients:A Single-Center Experience.
32519617 2020. Coronavirus Disease (COVID-19) in Kidney and Liver Transplant Patients: A Single-Center Experience.


32482250 2020. Prior and novel coronaviruses, Coronavirus Disease 2019 (COVID-19), and human reproduction: what is known?
32535599 2020. Coronavirus Disease 2019 in Pregnancy: A Clinical Management Protocol and Considerations for Practice.


32391384 2020. COVID and the Renin-Angiotensin System: Are Hypertension or Its Treatments Deleterious?
32405974 2020. Organ function support in patients with coronavirus disease 2019: Tongji experience.
32435649 2020. Diabetic Kidney Disease and COVID-19: The Crash of Two Pandemics.
32426363 2020. Age-Dependent Risks of Incidence and Mortality of COVID-19 in Hubei Province and Other Parts of China.
32426362 2020. Covid-19: A Dynamic Analysis of Fatality Risk in Italy.
32391367 2020. The Malnutritional Status of the Host as a Virulence Factor for New Coronavirus SARS-CoV-2.


32426311 2020. Novel Coronavirus Disease 2019 Infection in Children: The Dark Side of a Worldwide Outbreak.
32411652 2020. Gender Differences in Patients With COVID-19: Focus on Severity and Mortality.
32456461 2020. Clinical sequelae of the novel coronavirus: does COVID-19 infection predispose patients to cancer?
32437750 2020. Symptom profiles and risk factors for hospitalization in patients with SARS-CoV-2 and COVID-19: A Large Cohort from South America.
32479824 2020. Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients with Inflammatory Bowel Disease.
32479823 2020. Impact of Anti-TNF and Thiopurines medications on the development of COVID-19 in patients with inflammatory bowel disease: A Nationwide VA cohort study.
32446696 2020. Initial Gastrointestinal Manifestations in Patients with SARS-CoV-2 in 112 patients from Veracruz (Southeastern Mexico).
32442561 2020. COVID-19 in Liver Transplant Recipients: An Initial Experience from the U.S. Epicenter.
32425229 2020. Focusing on gastrointestinal symptoms in COVID-19 is far from enough.


32422208 2020. Associations between Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blocker Use, Gastrointestinal Symptoms, and Mortality among Patients with COVID-19.


32407807 2020. Could Patients With Inflammatory Bowel Disease Treated with Immunomodulators or Biologics Be at Lower Risk for Severe Forms of Covid-19?




32534808 2020. Cancer patients affected by COVID-19: Experience from Milan, Lombardy.
32527955 2020. COVID-19 in patients with sickle cell disease - a case series from a UK Tertiary Hospital.


32338805 2020. Tobacco use and vaping in the COVID-19 era.


32531138 2020. Clinical course and treatment efficacy of COVID-19 near Hubei Province, China: a multicentre, retrospective study.
32515076 2020. COVID-19 in pancreas transplant recipients.
32521074 2020. COVID-19 in Lung Transplant Recipients.



32533615 2020. Incidental COVID-19 in a Heart-Kidney Transplant Recipient with Malnutrition and Recurrent Infections: Implications for the SARS-CoV-2 Immune Response.


32530409 2020. Rethinking the First COVID-19 Death in Turkey.
32530408 2020. Acute Respiratory Failure in COVID-19 Pneumoniae: The Best Interface for an Optimal Management. A South Italian Experience.
32522535 2020. Clinical features of discharged COVID-19 patients with an extended SARS-CoV-2 RNA positive signal in respiratory samples.
32391676 2020. [Follow-up testing of viral nucleic acid in discharged patients with moderate type of COVID-19].
32391658 2020. [Management of COVID-19: the Zhejiang experience].
32434635 2020. [Coronavirus disease 2019 and hypertension in 2 children].
32186171 2020. [Using the big data ofinternet to understand coronavirus disease 2019's symptom characteristics: a big data study].
32102140 2020. [Facing the pandemic of 2019 novel coronavirus infections: the pediatric perspectives].
32023678 2020. [Facing the pandemic of 2019 novel coronavirus infections: the pediatric perspectives].
32450631 2020. [The analysis of clinical characteristics of 34 novel coronavirus pneumonia cases in Ningxia Hui autonomous region].
32087623 2020. [Comparison of the clinical characteristics between RNA positive and negative patients clinically diagnosed with coronavirus disease 2019].
32026671 2020. [Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].
32061198 2020. [Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia].
32061066 2020. [Clinical features of 2019 novel coronavirus pneumonia in the early stage from a fever clinic in Beijing].
32294816 2020. [Bronchoalveolar lavage fluid was used to diagnose two cases of 2019-nCoV infection].
32294812 2020. [Diagnosis and treatment of disease 2019 novel coronavirus infection suitable for Military support Hubei medical team].
32527345 2020. [Clinical analysis of 23 patients with coronavirus disease 2019 in Xinyang City of Henan Province].



32527341 2020. [Analysis of the clinical characteristics and early warning model construction of severe/critical coronavirus disease 2019 patients].
32527340 2020. [Nationwide survey on clinical treatment of coronavirus disease 2019 in 9 provinces and municipalities].
32394688 2020. [Chronic granulocytic leukemia with COVID-19 pneumonia: a case report].
32149486 2020. [COVID-19 with post-chemotherapy agranulocytosis in childhood acute leukemia: a case report].


32157848 2020. [Practice and Reflection on the Battle against COVID-19 by Guangdong Medical Aid Team in the city of Honghu].
32388946 2020. [Screening and management of asymptomatic infection of 2019-novel coronavirus].


32064855 2020. [Analysis of the first cluster of cases in a family of novel coronavirus pneumonia in Gansu Province].


32474034 2020. Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient.
32474047 2020. Drinking no-links to the severity of COVID-19: a systematic review and meta-analysis.
32474043 2020. Estimation of Renin-Angiotensin-Aldosterone-System (RAAS)-Inhibitor effect on COVID-19 outcome: A Meta-analysis.
32474042 2020. Fatality rate of COVID-19 in patients with malignancies: a sytematic review and meta-analysis.
32474041 2020. Cancer in intensive care unit patients with COVID-19.


32474033 2020. Markers of liver injury and clinical outcomes in COVID-19 patients: A systematic review and meta-analysis.
32474032 2020. COVID-19 patients with hypertension have more severity condition, and ACEI/ARB treatment have no infulence on the clinical severity and outcome.
32473236 2020. Ethnicity profiles of COVID-19 admissions and outcomes.


32473231 2020. Cardiovascular disease as a risk factor of disease progression in COVID-19: The corrected effect size and forest plot.
32445728 2020. Asymptomatic infection and atypical manifestations of COVID-19: Comparison of viral shedding duration.


32416124 2020. Cardiac troponins predict mortality in patients with COVID-19: A meta-analysis of adjusted risk estimates.
32425274 2020. Effects of age and sex on recovery from COVID-19: Analysis of 5769 Israeli patients.
32417313 2020. Unfavorable outcomes in pregnant patients with COVID-19.
32417309 2020. Impacts of immunosuppression and immunodeficiency on COVID-19: A systematic review and meta-analysis.
32405109 2020. Clinical course of severe and critically ill patients with coronavirus disease 2019 (COVID-19): A comparative study.
32407757 2020. Age but not sex may explain the negative effect of arterial hypertension and diabetes on COVID-19 prognosis.
32502509 2020. The association between severe or death COVID-19 and autoimmune disease: a systematic review and meta-analysis.


32283155 2020. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis.
32142929 2020. Corona Virus Disease 2019, a growing threat to children?


32112886 2020. Characteristics of COVID-19 infection in Beijing.
32525829 2020. Different outcome of COVID-19 in members of a family.
32525828 2020. Epidemiological and clinical characteristics of COVID-19 patients in Nantong, China.
32382746 2020. Clinical characteristics of patients with COVID-19 in Japan: a single-center case series.
32405329 2020. COVID-19 transmission and blood transfusion: A case report.
32534945 2020. Clinical characteristics of COVID-19 in Saudi Arabia: A national retrospective study.


32528233 2020. SARS-CoV-2 COVID-19 susceptibility and lung inflammatory storm by smoking and vaping.
32489403 2020. COVID-19: An update from England's high consequence infectious diseases intensive care unit leads.
32494896 2020. COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies.
32525402 2020. Atypical Presentation of Novel Coronavirus Disease 2019 in a Peritoneal Dialysis Patient.



32449328 2020. Seventy-two Hours, Targeting Time from First COVID-19 Symptom Onset to Hospitalization.
32383171 2020. Asymptomatic cases with SARS-CoV-2 infection.


32410245 2020. The clinical characteristic of eight patients of COVID-19 with positive RT-PCR test after discharge.


32401361 2020. Clinical characteristics of rehospitalized patients with COVID-19 in China.



32293710 2020. Hyperglycemia, hydroxychloroquine, and the COVID-19 pandemic.
32343428 2020. Three Taiwan's domestic family cluster infections of coronavirus disease 2019.
32330313 2020. Asymptomatic COVID-19 infection in late pregnancy indicated no vertical transmission.
32320084 2020. Response to Char's comment: Comment on Li et al.: COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis.
32281653 2020. Reply to: "Reporting of all cardiac medications and their outcome in COVID-19".


32275072 2020. Vaginal delivery report of a healthy neonate born to a convalescent mother with COVID--19.
32475799 2020. A case of COVID-19 with long duration of viral shedding.
32527700 2020. First COVID-19 mortality case in Taiwan with bacterial co-infection by national surveillance of critically ill patients with influenza-negative pneumonia.


32494855 2020. Mild COVID-19 symptoms despite treatment with teriflunomide and high-dose methylprednisolone due to multiple sclerosis relapse.
32494856 2020. COVID-19 in teriflunomide-treated patients with multiple sclerosis.


32405091 2020. Severe COVID-19 in Children and Young Adults in the Washington, DC Metropolitan Region.
32407719 2020. Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 (COVID-19) at a Tertiary Care Medical Center in New York City.
32452978 2020. Prolonged fecal shedding of SARS-CoV-2 in pediatric patients. A quantitative evidence synthesis. others
32276139 2020. COVID-19 in a patient with long-term use of glucocorticoids: A study of a familial cluster
32276140 2020. Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients
32283499 2020. Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers
32228738 ä. Mortality Rate of Infection With COVID-19 in Korea From the Perspective of Underlying Disease
32256706 2020. COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?
32134381 2020. Lack of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, China
C7141546 ä. Is low sodium intake a risk factor for severe and fatal COVID-19 infection?
32269089 2020. ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19
32307025 ä. Could COVID-19 represent a negative prognostic factor in patients with stroke?
32355869 ä. The Dermatologist?s Perspective: Why is COVID-19 mortality lower in females than males?
32253068 2020. Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy
32335513 2020. Incidence and Clinical Course of COVID-19 in Patients with Connective Tissue Diseases: A Descriptive Observational Analysis
32334645 2020. Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection
32332856 ä. COVID-19 in persons with haematological cancers
32303807 ä. Electronic cigarette and vaping should be discouraged during the new coronavirus SARS-CoV-2 pandemic
32339776 2020. Covid-19, TMPRSS2, and whether android regulation affects pandemic virus gender incidence and age distribution of disease
32320740 ä. Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019
32302077 ä. Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China
32289171 ä. Cardiac drugs and outcome in COVID-19: Reply
32289168 ä. Cardiac drugs and outcome in COVID - 19
32379903 2020. Outcome of a patient with refractory Hodgkin lymphoma on pembrolizumab, infected with SARS-CoV-2
32369615 2020. Favourable outcome of coronavirus disease 2019 in a 1-year-old girl with acute myeloid leukaemia and severe treatment-induced immunosuppression
32266501 ä. Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19



32320270 2020. Obesity a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms
32259878 ä. A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID?19: Will cases of psoriasis increase after COVID?19 pandemic?


32367558 2020. Dermatological diseases presented before COVID-19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID-19?


32310015 2020. Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature


32347572 2020. Outcome of Parkinson s Disease Patients Affected by COVID-19


32360210 2020. Letter to the Editor: Fasting plasma glucose associated with mortality rate in T2DM patients with COVID-19 infection
32386796 ä. Children are at risk from COVID-19
32324968 2020. Does high cardiorespiratory fitness confer some protection against pro-inflammatory responses after infection by SARS-CoV-2?
32413819 2020. Vitamin D concentrations and COVID-19 infection in UK Biobank
32291196 2020. Is low sodium intake a risk factor for severe and fatal COVID-19 infection?

Meine Werkzeuge
Namensräume
Varianten
Aktionen
Navigation
Werkzeuge
Blogverzeichnis - Blog Verzeichnis bloggerei.deBlogverzeichnis